Herpesviruses and morbilliviruses of aquatic and terrestrial carnivores by Harder, T.C. (Timm)
Herpesviruses and morbilli viruses 
of aquatic and terrestrial carnivores 

Herpesviruses and morbilliviruses 
of aquatic and terrestrial carnivores 
Herpesvirussen en morbillivirussen 
van zeezoogdieren en op het land levende vleeseters 
Proefschrift 
ler verkrijging van de graad van doctor 
aan de Erasmus Universiteit Rotterdam 
op gezag van de Rector Magnificus 
Prof. Dr. P.W.c. Akkermans M.A. 
en volgens besluit van het College voor Promoties. 
De open bare verdediging zal plaatsvinden op 
woensdag 29 oktober 1997 om 15.45 uur 
door 
Timm C. Harder 
geboren te Rendsburg, Duitsland, in 1963. 
Promotie commissie 
Promotor 
Overige leden 
Prof. Dr. A.D.M.E. Osterhaus 
Prof. Dr. H .A. Verbrugh 
Prof. Dr. E. Claassen 
Prof. Dr. J. T. van Oirschot 
'The studies described in this thesis were conducted at the Department of Virology, Erasmus Uni-
versity Rotterdam, the Netherlands, and at the Institute of Virology, Hannover Veterinary School, 
Germany. 
The studies were financially supported by grants from the European Union (HCM-project ERBCH-
BGCT920106), from the Ministry of Culture and Science, Lower Saxony, Germany (No. 210.2-
7620/9-21-1/90), and from the Dutch Seal Rehabilitation and Research Center at Pieterburen. 
Printing costs were covered by the Dutch Seal Rehabilitation and Research Center at Pieterburen. 
Cover design by the author of this thesis. The em TEX software package with the 'Script' style family 
(Frank Neukam, 1992) has been used for typesetting. 
Printed at Febodruk B.V., Enschede, the Netherlands. 
Those that hold 
that all things are governed by fortune had not erred, 
had they not persisted there. 
Sir Thomas Browne 
(cited after: Joseph Conrad, Chance, 1913) 
Fur Michaela, Marcel und Nora 
Contents and abbreviations 
List Qf abbreviations 
AF 
BHV 
CDV 
CHV 
CNS 
Con A 
CrFK 
CTL 
DMEM 
DMV 
EBV 
EBNA-l 
EHV 
EIA 
ELISA 
F 
FCS 
FFU 
FHV 
Gp 
H 
HCMV 
HHV 
HRPO 
HSV-l 
HVS-2 
IE 
IL-2 
IPMA 
kb 
KN 
L 
LMP-2 
M 
MAb 
MDCK 
ML 
MOl 
MV 
iv 
Antibody affinity 
Bovid herpesvirus 
Canine distemper virus 
Canid herpesvirus 
Central nervous system 
Concanavalin A 
Crandell-Rees feline kidney cells 
Cytotoxic T cell 
Dulbecco's modified Eagle's medium 
Dolphin morbillivirus 
Epstein-Barr virus 
Epstein-Barr virus nuclear antigen-l 
Equid herpesvirus 
Enzyme immunoassay 
Enzyme-linked immunosorbent assay 
Fusion (-gene, -protein) 
Fetal calf serum 
Focus-forming units 
Felid herpesvirus 
Glycoprotein 
Haemagglutinin (-gene, -protein) 
Human cytomegalovirus 
Human herpesvirus 
Horseradish peroxidase 
Herpes simplex virus-l 
Herpesvirus saimiri-2 
Immediate early regulatory proteins 
Interleukin-2 
Immune-peroxidase monolayer assay 
Kilo base pairs 
Kinetic neutralization 
Large (-gene, -protein) 
Epstein-Barr virus late membrane protein-2 
Matrix (-gene, -protein) 
Monoclonal antibody 
Madin Darby canine kidney cells 
Modified-live attenuated (vaccine) 
Multiplicity of infection 
Measles virus 
N 
nAb 
NDso 
NK 
ODE 
ONST 
ORF 
P 
PBMC 
PBST 
PDV 
PHA 
PhHV 
PLA 
PMV 
PPRV 
ROC 
RPV 
SeHV-l 
SeKC 
SHV-l 
SPF 
SSPE 
TCIDso 
U, 
U, 
UTR 
VF 
VZV 
wt 
Contents and abbreviations 
Nucleocapsid (-gene, -protein) 
Neutralizing antibody 
Neutralizing dose 50% endpoint 
Natural killer cells 
Old dog encephalitis 
CDV vaccine strain 'Onderstepoort' 
Open reading frame 
Phospho (-gene, -protein) 
Peripheral blood mononuclear cell 
Phosphate-buffered saline supplemented with Tween 20 
Phocid distemper virus 
Phythaemagglutinin 
Phocid herpesvirus 
Peroxidase-linked antibody assay 
Porpoise morbillivirus 
Peste-des-petits-ruminants virus 
CDV vaccine strain 'Rockborn' 
Rinderpest virus 
Seal herpesvirus-l 
Seal kidney cells 
Suid herpesvirus-l (pseudorabies virus) 
Specific pathogen-free 
Subacute sclerosing encephalitis 
Tissue culture-infectious dose 50% endpoint 
Unique long fragment 
Unique short fragment 
Untranslated region 
Visual fields 
Varicella zoster virus 
Wild-type 
v 
Contents and abbreviations 
Table of contents 
Chapter 1 General introduction 
1.1 Aspects of herpesvirus biology. 
1.2 Aspects of morbillivirus biology. 
Aim and outline of the thesis 
Chapter 2 Herpesviruses of seals, dogs and cats 
vi 
2.1 Comparative immunological characterization of type-
specific and conserved B-cell epitopes of pinniped, felid and 
canid herpesviruses. Arch. Virol. (1994) 136,335-347. 
2.2 Characterization of phocid herpesvirus-1 and -2 as putative 
Q- and "I-herpesviruses of North American and European 
pinnipeds. J. Gen. Virol. (1996) 77, 27-35. 
2.3 Age-related disease in recurrent outbreaks of phocid her-
pesvirus type-l infections in a seal rehabilitation center: 
Evaluation of diagnostic methods. Vet. Rec. (1997) 140, 
500-503. 
2.4 Molecular characterization and baculovirus expression 
of the glycoprotein B of a seal herpesvirus (phocid 
herpesvirus-1). Virology (1997) 227, 343-352. 
2.5 Major immunogenic proteins of phocid herpesviruses type-
1 and type-2 and their antigenic relationships to proteins 
of felid and canid herpesvirus. Submitted. 
2.6 Serosurvey for phocid herpesvirus-1 and phocid herpesvi-
rus-2 in marine mammals from Alaska and Russia, 1978 -
1994. J. Wildl. Dis .• in press. 
1 
3 
13 
21 
23 
25 
39 
53 
63 
79 
93 
Contents and abbreviations 
Chapter 3 Morbilliviruses of seals, dogs and cats 103 
3.1 Intertypic differentiation and detection of intratypic vari- 105 
ants among canine and phocid distemper morbillivirus iso~ 
lates by kinetic neutralization using a novel immunoplaque 
assay. J. Virolog. Meths. (1993) 41. 77-92. 
3.2 Phylogenetic evidence for canine distemper virus in Seren- 119 
geti's lions. Vaccine (1995) 13, 521-523. 
3.3 Canine distemper virus from diseased large felids: biologi- 125 
cal properties and phylogenetic relationships. J. Gen. Virol. 
(1996) 77, 397-405. 
Chapter 4 Discussion 139 
4.1 Herpesviruses of pinnipeds - clinical impact and phyloge- 141 
netic relationships. 
4.2 Morbilliviruses and morbillivirus diseases of marine mam- 151 
mals. Infect. Agent. Dis. (1995) 4, 125-130. 
4.3 Canine distemper virus - a morbillivirus in search of new 159 
hosts? Trends Microbiol. (1997) 5. 120-124. 
4.4 Summary 169 
• References 177 
• Curriculum vitae 205 
• Publications 205 
• Acknowledgements 209 
vii 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
Chapter 1 
General introduction 

Section 1.1 
Aspects of herpesvirus biology 
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Harder, T.e., Plotz, J., Liess, B. (1991a). 
Antibodies against European phocine herpesvirus isolates detected in sera of Antarctic seals. 
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Introduction 
The Herpesviridae represent a family of diverse and complex viruses of vertebrates (Roizman 
et al., 1992; Roizman, 1996) and are believed to be of comparatively ancient origin (Karlin 
el al., 1994a; McGeoch et al., 1995). Many mammalian species are host to more than one 
herpesvirus species. In humans, e.g., an eighth distinct herpesvirus species has recently been 
discovered (Chang et al., 1994; Moore et aI., 1996). Disease associated with lytic herpesvirus 
infection in their natural hosts varies considerably from mild, superficial mucocutaneous 
lesions, acute respiratory disease, benign Iymphoproliferative disorders to fatal generalized 
infections and congenital malformations (Peterslund, 1991). Besides certain viral factors, 
immuno-(in)competence of the natural host constitutes a major pathogenic factor (Fawl & 
Roizman, 1994). Some herpesviruses also display transforming properties (e.g. Meinl et al., 
1995; Thorley-Dawson el al., 1996) or act as co-factors in tumorigenesis (Nazarin, 1979; 
Khanna et al., 1995; Mesri et al., 1996). Herpesviruses characteristically establish life-long 
latenl infections in their hosts (Stevens, 1994). Periodically, latent (silent) virus can become 
reactivated leading to limited lytic replication and shedding of infectious particles. Latently 
infected hosts, therefore, represent the major herpesvirus reservoir. 
Figure 1. Electronmicroscopic photography of phocid herpesvirus type-l (courtesy of Dr. J.S. 
Teppema. RIVM Bilthoven, The Netherlands). Bar indicates 100 nm. 1 - Lipid envelope with 
spikes; 2 - Tegument; 3 - Capsid; 4 - Intact virion, outer surface with glycoprotein projections. 
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Table 1. Herpesviridae - Taxonomy and genome properties of some herpesviruses of medical 
and veterinary concern (modified from Roizman et al., 1992). 
Genome properties 
Official designation (ommon name G+C% Type Size (kB) 
o--Herpesvirinaet 
Simplexviru$l 
Human herpesvirus-! Herpes simplex virus-I 67 E 152 
Human herpesvirus-2 Herpes simplex virus-2 69 E 152 
Varicelloviru·s 
Human herpesvirus-3 Varicella-zoster virus 46 D 125 
Equine herpesvirus-l Equine abortion virus 57 D 150 
Suid herpesvirus-l Pseudorabies virus 74 D 140 
Felid herpesvirus Feline rhinotracheitis virus 46 D 134 
(anid herpesvirus Canine herpesvirus 32 
Not assigned to genus. 
Gallid herpesvirus-2 Marek's disease virus 47 E 180 
{3-Herpesvirinae 
Cytomegalovirus 
Human herpesvirus-5 Human cytomegalovirus 57 E 229 
Muromegalovirus 
Murid herpesvirus-! Murine cytomegalovirus 59 F 235 
Roseolovirus 
Human herpesvirus-6 42 A 162 
Human herpesvirus-7 44 A 140 - 160 
'''j-Herpesvirinae 
Lymphocryptovirus ('Yl) 
Human herpesvirus-4 Epstein-Barr virus 60 C 172 
Rhadinovirus (.l'2) 
Saimirine herpesvirus-2 Herpesvirus saimiri 46 B 155 
Bovid herpesvirus-4 50 B 145 
Alcelaphine herpesvirus-l Malignant catarrhal fever virus 61 B 160 
13 - herpesviruil 
Equine herpesvirus-2 57 A 192 
1 Subfamily, 
2 Genus, 
3 proposed by Telford e/ al., 1993, 
- no data available, 
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Herpesvirus classification 
Membership in the Herpesviridae family is substantiated primarily on basis of virion morpho-
logy (Rixon, 1993). Herpesviruses form quasi-sphaerical particles ranging in diameter between 
150 - 200 nm (Fig. 1). The outer host cell-derived lipid bilayer is spiked with several viral 
glycoprotein (gp) and non-gp transmembrane proteins. Underneath the envelope the tegu-
ment, an amorph proteinaceous mass, is located. An icosahedric capsid of 100 - 110 nm in 
diameter is embedded within the tegument and harbours a double-stranded DNA genome. 
At least 33 proteins are known to contribute to the virion architecture of the human herpes 
simplex virus-l (HSV-l; Roizman & Sears, 1996). 
Three subfamilies of herpesviruses (the a-, {3- and ,,(-Herpesvirinae) are distinguished main-
ly according to certain biological characteristics (duration of the replication cycle, host cell 
tropisms and location of latency). Nucleotide sequence data, available for a growing num-
ber of herpesviruses species, confirmed and justified this classification in most cases. Table 
1 presents a brief overview of the taxonomic status and the molecular properties of some 
herpesviruses of medical and veterinary concern. 
Genome organization 
The size of the double-stranded DNA genome of different herpesviruses species varies widely 
between 125 to 235'>1<B, and so does the G+C content which ranges between 32% to 74% 
(Tab. 1). Six different genome types (A-F) are distinguished on basis of presence and arrange-
ment of reiterated sequences in relation to unique sequences. The genomes comprise a coding 
capacity ranging from approximately 70 (a-herpesviruses) to up to 200 ({3-herpesviruses) ge-
nes (McGeoch, 1989). Genes are densely packed in a consecutive order along the genome 
and are either separated by short intergenic sequences or overlap slightly (Davison, 1993). 
Open reading frames (ORFs) are located on both strands. A core of about 40 genes arranged 
in several characteristic blocks is conserved between all herpes viruses. Families of related 
genes described, e.g., for Epstein-Barr virus, EBV (Baer et a/., 1984), human cytomegalovi-
rus, HCMV (Weston & Barrell, 1986) or in the unique short (Us) region of a-herpesviruses 
(McGeoch, 1990) are believed to have arisen by gene duplication and divergence from ancient 
progenitors of presumably non-herpesviral origin. 
Lytic replication 
Viral integral membrane glycoproteins (gps) mediate both attachment to receptor molecules 
at the host cell surface and penetration via fusion of viral and cellular membranes at neu-
tral pH values (reviewed by Spear, 1993). At least ten gps have been identified in HSV-l 
infected cells, many of which have also been detected in the virion envelope. Along with 
their location as integral proteins in the virion envelope and - at least for some - also in the 
infected host cell membrane, the gps are major targets of the immune surveillanc~. Certain 
gp 'families' (e.g. gB, gH and gL) are encoded by members of all herpesvirus subfamilies 
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Table 2. Herpes simplex virus-l glycoproteins and their equivalents in canid (CHV) and felid 
(FHV) herpesviruses (modified from Crabb & Studdert. 1995). 
HSV glycoprotein Homologues 
Designation Genet Ascribed function 
gB UL27 Penetration, fusion 
gC UL44 Adsorption, C3b receptor 
gD US6 Penetration, fusion 
gE US8 Fc receptor (complex with gl) 
gG US4 n.d. 
gH UL22 Penetration, fusion, complex with gL 
gl US7 Fe receptor (complex with gEl 
gJ' US5 n.d. 
gK UL53 Fusion 
gL ULl see gH 
gM ULI0 n.d. 
I Numbering according to McGeoch et al., 1988, 
'.2 Essentially required for replication in cell cultures, 
3 Limbach et al., 1994; Remond et al., 1996, 
Essential2 CHV3 
+ gB 
gC 
(+) gD 
n.d. 
n.d. 
+ n.d. 
n.d. 
n.d. 
n.d. 
+ n.d. 
n.d. 
4 Maeda et al., 1990; Maeda et al., 1991; Spatz et al., 1994; Willemse et al., 1995, 
5 Predicted from the HSV-l nucleotide sequence. n.d. - no data. 
FHV' 
gB 
gC 
gD 
gE 
gl 
gH 
gl 
n.d. 
n.d. 
n.d. 
n.d. 
analysed so far and were found to be indispensable for viral replication in cell cultures; other 
gp-encoding genes can be deleted while the mutant remains replication-competent (Spear, 
1993; Mettenleiter et al., 1994). However, wild-type (wt) isolates in general retain all of the 
'non-essential' gps indicating that these gps confer a certain selective advantage in vivo. 
Table 2 comprises a list of HSV-l-encoded gps and their attributed functions. Gps identified 
up to now in herpesviruses of terrestrial carnivores are indicated for comparison. 
Insight into the molecular events associated with attachment of herpesviruses to their tar-
get cells and knowledge of the interacting receptors and ligands which are diverse for the 
different herpesvirus subfamilies is still limited (Fingeroth et al., 1984; WuDunn & Spear, 
1989; Karger & Mettenleiter, 1993; Norkin, 1995; Zhu et al., 1995; Montg0mery et al., 1996; 
Whitbeck et al., 1997). Following penetration by fusion at neutral pH values at the cell mem-
brane, the capsid/tegument complex is transported through the cytoplasm and viral DNA 
along with at least a part of the tegument proteins is released through the nuclear pores. 
Circularization or concatemerization of the genome(s) precedes initiation of the transcription 
process. Herpesviruses encode a strong a-trans-inducing factor (a tegument protein) which, 
in co-operation with cellular transcription factors, triggers transcription of immediate early 
(IE or a-) genes. Their products, in turn, further control a tightly ordered temporal cascade 
of gene e,Xpression involving a series of cis- and trans -acting elements (Batterson & Roizman, 
1984; Hay & Ruyechan, 1992). During the early or j1-phase, the viral nucleic acid metabolism 
and DNA replication machinery is activated. Virion DNA is replicated in the nucleus by a 
8 
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rolling circle mechanism yielding concatemeric· progeny genomes in a head-to-tail order. Pro-
teins synthesized in the late or I'-phase fulfil mainly architectural functions. Capsids, while 
assembling in the nucleus, are loaded with a single-unit genome copy. Encapsidated DNA 
appears to exist in a liquid crystalline state (Booy et al., 1991). Packaged capsids are released 
from the nucleus into the cytoplasm. The exact pathways involved in tegumentation, enve-
lopment and final egress of virions are still a matter of debate (Roffman et al., 1990; Torrisi 
et al., 1992; Rixon, 1993). A lytic replication cycle of a-herpesviruses is comparatively short 
and always associated with rapidly spreading, extensive cytolytic destruction in permissive 
cell cultures. Replication of (J- and I'-herpesviruses, in contrast, is much more delayed and 
often cytopathic alterations are less striking. 
lytic replication of herpesviruses inevitably results in death of the host cell. However, 
many target cells of herpesviruses maintain vital functions and are postmitogenically fixed 
(e.g. neurons). loss of such cells cannot be compensated. The host-herpesvirus relationship, 
therefore, must be meticulously balanced to an equilibrium. Consequently, exacerbation from 
these intricate mechanisms may result in generalized, fatal disease which can be seen in 
susceptible aberrant host species and in immuno-immature (fetus, neonate) or Immuno-
compromised individuals of the natural host species. 
Latency 
Establishment, maintenance and periodical reactivation from presumably life-long persisting 
latent infection are hallmarks of herpesvirus biology (Rock, 1993). Initiation of latent in-
fection is assumed to be an early event after penetration and should occur before efficient 
transcription of IE genes is launched. Sites and cell types where herpesviruses establish latent 
infection as well as the molecular events associated with latency vary between members of 
the different subfamilies: o-herpesviruses establish latent infections predominantly in neuro-
nal cells. lymphoid cell types are targets of I'-herpesvirus latent infections. Little is known 
about latency of (J-herpesviruses. At present it can not even be excluded that so-called 'la-
tent' ,a-herpesvirus infections instead are chronic productive infections at a very low level 
(Koszinowski et al., 1994). Whatever the mechanisms, during latency the virus efficiently 
escapes from immune surveillance. 
Cells that are latently infected by herpesviruses appear to contain several copies of the viral 
genome in an episomal form (Stevens, 1994). Gene expression of a-herpesviruses apparently 
falls completely silent during latency, since the so-called latency-associated transcripts (LAT 5) 
probably remain untranslated (McGeoch et al., 1993; Feldman, 1994). In contrast, at least 
two viral proteins (EBNA-1 and LMP2) are expressed in resting B cells which constitute a 
reservoir of latent EBV infection (Thorley-Lawson et al., 1996). In spite of the fact that these 
proteins are potent immunogens and targets of cytotoxic T cells (CTls), the cells survive. 
The molecular events associated with the reactivation process are not fully understood. 
Experimentally, latent herpesvirus infections have been succesfully reactivated by an array of 
measures including local traumas, social stress or glucocorticoid application. Clinical symp-
toms during a reactivation phase (recurrent infections) are generally mild or even asympto-
9 
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matic while still significant titers of infectious virus can be shed (Enquist, 1994). As such, 
latently infected hosts, so-called :carriers', create the most crucial epidemiological impact. 
Host immune responses 
Upon primary herpesvirus infection, humoral and cellular immune responses are induced which 
- at least in immuno-competent natural hosts - confine lytic virus replication locally and ensure 
virus elimination from these sites. However, neither establishment of latency nor re-infections 
are prevented. Instead, herpesviruses have evolved a plethora of sophisticated immune evasion 
mechanisms which have only partially been unraveled (Bielefeldt-Ohmann & Babiuk, 1988; 
Hsu et a/., 1990; Gregory et al., 1991; Banks & Rouse, 1992; Koszinowksi et al., 1994; Hill 
et al., 1995; levitskaya et aI., 1995; Burgert, 1996; Hengel et al., 1996). 
Host immune responses are stimulated and directed against an array of viral proteins of 
which IE regulatory proteins and viral membrane gps appear to hold a prominent place. In 
particular, gps of the gB, gC and gO family have been shown to induce neutralizing antibodies 
as well as cytotoxic T cells (Para et al., 1985; Witmer et al., 1990; Eis-Hubinger et al., 1993; 
Ghiasi et al., 1994; Pereira, 1994; Tewari et al., 1994). While CTls seem to be pivotal in 
the elimination of virus-infected cells following primary infection, antibodies are believed to 
play an important role in limiting spread of virus after reactivation from latency (Nash & 
Wildly, 1983; Simmons & Nash, 1989; Rinaldo et al., 1993). Reactivation from latency is not 
inhibited by a sustained herpesvirus-specific immune response. 
Vaccine development 
Major obstacles hampering the development of eflicacious and safe herpesvirus vaccines are 
the complexity of these viruses and, in particular, their ability to establish life-long latent 
infections. The ideal herpesvirus vaccine - which as yet is not available - would not only 
prevent disease following primary infection by wt virus, but would also block the establishment 
of latency. However, if clinical disease following primary infection poses the major problem of 
a certain herpesvirus infection, then sole protection against disease still is a desirable option 
(Inglis, 1995). 
Modified-live attenuated (Ml) herpesviral vaccines for use in humans have not been li-
censed yet (Burke, 1993) with the single exception of a Varicella zoster virus (VZV) vaccine 
(Oka strain), originally designed to protect leukemic children from lethal chicken pox (Bergen 
et al., 1990; Gershon, 1995). In veterinary medicine, in contrast, Ml herpesviral vaccines are 
widely used in the prevention of a-herpesvirus induced diseases of both livestock and pet 
animals. Marker vaccines featuring genetically engineered deletion mutant strains which are 
phenotypically attenuated are gradually replacing traditional vaccine strains and allow sero-
logic discrimination of vaccinated and wt virus infected animals (Van Oirschot et al., 1990; 
Van Drunen Littel-van den Hurk et al., 1993; Mettenleiter et al., 1994). These vaccines have 
proven quite eflicient in prevention of disease, but they do not inhibit wt virus infection under 
field conditions and establish latent infections themselves. Nevertheless, vaccinated animals 
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were shown to have less frequent episodes of reactivation and shed lower titers of virus for a 
shorter period as compared to non-vaccinated controls (reviewed by Young & Smith, 1995). 
To circumvent the above mentioned problems of ML herpesvirus vaccines, recombinant 
subunit vaccines have been evaluated and succesfully tested in several animal models and for 
use in humans (Morein & Merza, 1991; Langenberg et al., 1995). 
Herpesvirus infections of aquatic and terrestrial carnivores 
While herpesvirus infections and their association with respiratory, ocular and reproductive 
diseases in dogs and cats have been well known for a long time, the earliest report of herpes-
virus infections in aquatic carnivores only originates from 1984 when an a-herpesvirus was 
found the cause of a major disease outbreak among newborn harbour seals (Phoca vituli-
na) in a Dutch seal sanctuary (Osterhaus et al., 1985; Borst et al., 1986): Mortality rates 
peaked at about 50%. Fatal cases were mainly attributed to generalized infections causing 
focal hepatitis, nephritis and encephalitis. In milder cases, the symptoms were restricted to 
the upper respiratory tract, occasionally leading to pneumonia. Herpesvirus isolates recover-
ed from these cases and originally designated seal herpesvirus-1 (SeHV-1) were shown to 
be serologically closely related to the authentic a-herpesviruses of dogs (canid herpesvirus, 
CHV) and cats (felid herpesvirus, FHV) (Osterhaus et al., 1985). SeHV-1, now referred to 
as phocid herpesvirus (PhHV) was also shown to replicate in cells of feline origin emphasi-
zing the close relationship of these viruses and giving rise to speculations concerning mutual 
interspecies transmission (Harder et al., 1991a; Stenvers et al., 1992a). Serosurveys showed 
that PhHV or closely related herpesvirus species are prevalent in several pinniped species 
worldwide including also those of Arctic and Antarctic habitates (Vedder et al., 1987; Harder 
et al., 1991a; Stenvers et al., 1992b; Stuen et al., 1995). 
In the course of the 1988 seal mass mortality, an epizootic caused by the formerly undes-
cribed phocid distemper morbillivirus (PDV) which resulted in loss of approximately 17.000 
seals in northwestern European waters, PhHV was initially suspected a primary causative 
agent (Osterhaus, 1988). Later on, the generalized PhHV infections frequently seen in mori-
bund seals of all ages clearly had to be interpreted as a sequel of a severe immunosuppression 
owing to an underlying PDV infection (Osterhaus et al., 1988). However, co-infections with 
PhHV were considered to have signficantly contributed to the high mortality rates, parti-
cularly among adult harbour seals (Zhang et al., 1988; Stenvers et al., 1992a). Likewise, 
aggravation of acute canine distemper and measles cases by canine herpesvirus and herpes 
simplex virus infections, respectively, have been documented (Orren et al., 1981; Harder, 
unpublished). 
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General introduction 
Introduction 
Taxonomically considered, morbilliviruses are a genus of the Paramyxoviridae family (Pringle, 
1994): The agent causing measles in humans is the type species of this genus which up to 
now comprises five further members all of which infect animal hosts (Tab. 1). Morbillivi-
ruses consist of a non-segmented linear single-stranded RNA genome of negative polarity 
comprising about 15900 bp. The RNA is enclosed in a helical nucleocapsid formed by the N 
protein. In addition, mature ribonucleoprotein complexes also contain copies of the phospho-
(P) and large (L) proteins. The host cell-derived lipid envelope is spiked with transmembrane 
haemagglutinin (H) and fusion (F) glycoproteins. Internally, the envelope is stabilized by a 
layer of the matrix (M) protein. The diameter of virions varies between 150 to 250 nm (Fig. 
1). 
Morbilliviruses are highly contagious and transmission occurs predominantly via aerosols 
(Appel, 1969; Black, 1991). In susceptible hosts, an acute febrile and multisystemic disease is 
induced (Appel et al., 1981). Induction of severe immunosuppression is a hallmark of morbil-
livirus infections. In addition, the morbilliviruses of carnivores are also highly neurotropic and 
capable of inducing chronic persistent infections of the central nervous system (eNS) (Van-
develde & Zurbriggen, 1995). Once introduced into a naive host population, morbilliviruses 
provoke a rapidly spreading epidemic associated with high mortality rates in hosts of all age 
classes. Provided a surviving host population of sufficient size and density, morbilliviruses will 
establish endemic infections where disease is usually restricted to offsprings with declining 
maternal immunity (Black, 1966). The human population clearly fulfils the criteria to allow 
perpetuation of measles virus (MV). Measles, therefore, will continue to account for more 
than a million deaths of children annually in underdeveloped countries unless an extensive 
vaccination coverage is guaranteed (Black, 1991; Rota et al., 1996). 
Figure 1. Eledronmicros-
copic photography of pho-
cid distemper virus (PDV) 
(courtesy of Dr. J.S. Tep-
pema, RIVM Bilthoven, The 
Netherlands). Bar indicates 
100 nm. 1 - Lipid envelo-
pe, spiked with Hand F gly-
coproteins; 2 - Nucleocap-
sid, protruding from disrup-
ted virion. 
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Table 1. Morbilliviruses - Taxonomy, host spectrum and clinical impact. 
Morbillivirus species 
Measles virus (MV) 
Rinderpest virus (RPV) 
Peste-des-petits 
ruminants virus (PPRV) 
Cetacean distemper virus l 
Canine distemper virus (COV) 
Natural host spectrum 
Humans (Primates) 
Artiodacty/a 
Artiodactyla 
Cetacea 
Carnivora2 
Phocid distemper virus (POV) Pinnipeda 
Associated diseases 
Measles; giant cell pneumonia; 
subacute sclerosing panencephalitis; 
inclusion body encephalitis . 
Cattle plague 
Pneumoenteritis of sheep and goats 
Distemper 
Distemper; osteodystrophia; 
old dog encephalitis (ODE) 
Distemper 
1 Includes dolphin distemper virus (OMV), and porpoise morbillivirus (PMV), 
2 Notable exceptions until 1994: Felidae, Ursidae. 
Genome organization 
Close to its 3' end, the morbillivirus genome harbours a promotor region where binding of 
the virion-derived RNA-dependent RNA polymerase, composed of the L and, probably also 
of the P protein, is initiated (Blumberg et al., 1988). Transcription of mRNAs proceeds in 
a predominantly monocistronic pattern from gene to gene which are in the order 3'-UTR-
N-P(C,V)-M-UTR-F-H-L-UTR-5' (UTR - untranslated regions). A nontranscribed consensus 
intergenic trinucleotide separates sequence motifs utilized for polyadenylation and for re-
initiation of transcription, respectively, of adjacent genes (Crowley et al., 1988). Between 
the ORFs of the M and F genes an unusually long UTR (up to 1.0 kb) is located whose 
function is not well understood (Hase! et al., 1987; Evans et al., 1990; Cathomen et al., 
1995). Owing to a certain likelihood of dissociation of the transcriptase complex at each 
gene junction, a gradient of mRNA abundancies from the most 3' (N) gene to the most 5' 
(L) gene is generated whereby synthesis of the different viral proteins is economized according 
to the amounts required (Barrett et al., 1991). Apart from rare read-through transcripts, all 
mRNAs, except for the P gene transcript, are monocistronic. The P mRNA codes for at least 
three proteins: The P protein itself is encoded by the longest ORF of the P gene (Barrett et 
al., 1985). The small non-structural C protein is generated from an alternate reading frame 
(Bellini et al., 1985). A second non-structural protein, termed V, is derived from an edited 
P mRNA in which an untemplated G residue is inserted at a defined position shifting the 
reading frame of the distal quarter of the P mRNA (Cattaneo et al., 1989; Haas et al., 1995). 
V and P proteins, therefore, share identical N-terminal amino acid sequences (Martens et al., 
1995). 
Positive-stranded antigenomic full-length RNA which, after encapsidation, serves as a tem-
plate for genome replication is produced late in the infectious cycle and is dependent on a 
critical amount of progeny Nand P protein in the infected cell. 
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Virus replication 
Selection of and attachment to host cells is mediated by the H protein (Stern et al., 1995). 
The membrane co-factor CD46 - possibly in complex with moesin molecules - acts as a 
cellular receptor for MV on human cells (Naniche et al., 1993; Dunster et al., 1994; Schneider-
Schaulies et al., 1995a). Interestingly, MV strains exhibiting an attenuated phenotype, in 
contrast to virulent isolates, efficiently down-reg~late membrane CD46 (Schneider-Schaulies 
et al., 1995c; Bartz et al., 1996). Cells which become devoid of CD46, however, are rendered 
more susceptible to complement-mediated lysis. In vivo, these cells can be expected to be 
more rapidly cleared: an effect that might contribute to the pathogenicity of MV (Schnorr 
et aI., 1995). A reverse genetic system, recently developed for MV, will further aid in pin-
pointing virulence determinants (Radecke et al., 1995). Recently, the CD9 equivalent has 
been identified as a co-factor of receptor-mediated entry of CDV whereby an as yet unknown 
65 - 75 kD protein has been suspected to represent the primary cellular receptor (Loffler et 
al., 1997). 
Upon receptor interactions, sterical processes expose the fusion domaine, a highly hydro-
phobic region of the F protein, which mediates fusion with the cellular membrane at neutral 
pH values (Wild & Buckland, 1995). All subsequent steps of replication occur in the cyto-
plasm. Several host cell proteins have been identified as possible co-factors for morbillivirus 
replication (Moyer et al., 1990; Oglesbee et a/., 1996). The role of the non-structural C and 
V proteins remains to be fully elucidated (Wardrop & Briedis, 1991; Radecke & Billeter, 
1996). Posttranslational modifications of morbillivirus proteins include phosphorylation (N, 
P, V, possibly L) and N-linked glycosilation in the exocytic pathways (H and F). Further ma-
turation of the F protein essentially consists of endoproteolytic cleavage at a furin-sensitive 
consensus sequence yielding two disulfide-linked fragments (F1-F2). The new N-terminus of 
the F, fragment represents the fusion domaine (Morrison & Portner, 1991). Virions which ha-
ve exclusively incorporated un cleaved F proteins are non-infectious. Virus progeny is released 
by budding from the cell surface. 
Pathogenesis and immune response 
Primary target cells following aerosol transmission of morbilliviruses are found in the respi-
ratory epithelia and may include descendants of the monocyte/macrophage lineage (Appel, 
1969; Esolen et al., 1993). Centripetal dissemination of progeny virus via tributary Iymphno-
des establishes infection of central lymphatic tissues. Virus is redisseminated from these 
tissues via a cell-associated viremia toward epithelia of various organs. Virus is excreted with 
all body secretions. Severe immunopathological changes which have been attributed, at least 
in part, to lytic morbillivirus replication in lymphoid and myeloid cells determine a global 
immunosuppression (Krakowka et al., 1980; Casali et al., 1989). More recent data obtained 
for MV suggest a role of decreased IL-12 production by monocytes which is downregulated 
by signal transduction via the CD46 molecule following binding of the MV H-protein (Karp 
et al., 1996). Development of opportunistic infections which even may occlude the under-
lying primary cause, contribute significantly to mortality rates in the course of morbillivirus 
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epizootics (Beckford et al., 1985). 
Acute morbillivirus-induced disease is manifested at the respiratory (MV, CDV, PDV, 
DMV, PPRV) and at the gastrointestinal tract (CDV, RPV, PPRV) (Yamanouchi, 1980). 
Skin affections have been d~scribed in MV and CDV infections, including a maculo-papular 
rash characteristic of MV infection in humans (Griffin & Bellini, 1996). Except for RPV and 
PPRV infections, involvement of the CNS is another hallmark of morbillivirus infections. 
CDV and PDV are known to exhibit a possibly strain-dependent neuroinvasiveness leading 
to acute encephalomyelitis in an estimated 20 - 70% of naturally occuring distemper cases 
(Blixenkrone-M~lIer et al., 1993). MV-associated encephalomyelitis occurs at strikingly lower 
frequencies (0.1%) (Johnson et al., 1984; Schneider-Schaulies et al., 1995b). In addition, 
CDV is also known to be able to establish fatal chronic persistent infection of the CNS which 
is characterized by widespread and massive demyelinisation of both white and gray matters 
(Vandevelde & Zurbriggen, 1995). More subtle changes, due to persistent CDV infections of 
the CNS and leading to progressive motor and behavorial alterations, have been described 
as old dog encephalitis (ODE) which may be similar to a rarely described chronic persisting 
MV CNS infection in humans, correlated with subacute sclerosing panencephalitis (SSPE) 
(Lincoln et al., 1971). 
Survivors of natural morbillivirus infections mount a life-long protective immunity which 
is based on neutralizing antibodies (nAbs), directed against the Hand F gps, and on cns, 
specific for various viral protein targets (Norrby, 1991). NAb appear crucial for the prevention 
of (re-)infection and for limiting virus dissemination (Chen et al., 1990). The H protein is 
the main target of nAbs which are highly species-specific (Giraudon & Wild, 1985; Shesh-
beradaran & Norrby, 1986). Some neutraliziation-relevant epitopes have also been located 
on the F protein (Malvoisin & Wild, 1990). The majority of F-specific Abs, however, broad-
ly cross-reacts between the different morbillivirus species and may inhibit direct cell-to-cell 
spread of virus by fusion (Sheshberadaran et al., 1986; Sato et al., 1989). 
A complicated and often fatal course of MV infection in patients with pronounced T 
cell deficiencies in comparison to those with B cell disorders points toward a paramount 
importance of T cell-mediated immunity in recovery from infection (Norrby, 1991; Beauverger 
et al., 1996; Griffin & Bellini, 1996). MV-specific cns of both MHC-class I and -II restriction 
have been detected and characterized at the clonal level (Van Binnendijk et aI., 1989 & 1990). 
Epidemiology and control 
Morbilliviruses are transmitted horizontally although intrauterine CDV infections have be-
en described (Krakowka et al., 1977; Black, 1991). Course and outcome of morbillivirus 
infect.ions are modulated by strain-dependent viral properties and by the host's immunocom-
petence, constitution and possibly also by its genetic background. In addition, size, density, 
and immune status of the respective host population are pivotal factors (Black, 1966; Aaby 
et al., 1988). Owing to a comparatively short infectious period and their fragility outside in 
the environment, morbilliviruses require rapid transmission before being either eliminated by 
their hosts or before having eliminated the hosts themselves. This implies a dense population 
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to sustain an endemic morbillivirus status. The observed critical community size below which 
MV infections will not persist amounts to 250.000 - 400.000 (Keeling & Grenfell, 1997). 
Since survivors of infection in principle seem to be refractory to reinfection, morbilliviruses 
depend on the rate of offspring production to establish an endemic status. Among the morbil-
liviruses, CDV occupies the broadest spectrum of natural hosts and interspecies transmissions 
frequently do occur. In contrast, humans appear to constitute the only natural reservoir of 
MV. Eradication of MV, therefore, may be a promising perspective, provided a continuing 
and extensive supply of vaccines worldwide (Shepard, 1994; Rota et al., 1996). 
In general, modified-live (ML) morbillivirus vaccines have proven safe and efficient in pre-
venting disease. The safety of high-dose MV ML vaccines, however, has recently been chal-
lenged by reports indicating immunosuppressive side-effects in children when administered at 
less than one year of age (Hussey et al., 1996). With respect to a resurgence of measles and 
distemper, respectively, associated with a genetic and, possibly, also antigenic drift observed 
in currently circulating MV wt isolates, a continuing assessment of the efficacy of commercial 
MV and CDV vaccines concerning their protective capacities against contemporary wt strains 
is mandatory (Atkinson & Orenstein, 1992; Weiss, 1992; Rima et al., 1995a & 1997; Rota et 
al., 1995). Recent attempts to further improve morbillivirus vaccines include the production 
of recombinant animal poxviruses, ISCOM-based subunit vaccines consisting of the viral H 
and F membrane gps as well as synthetic peptides (Varsanyi et al., 1987; Visser et al., 1992; 
Romero et al., 1995; Obeid et al., 1995). None of these developments, however, has yet 
succeeded in replacing the traditional ML morbillivirus vaccines. 
Morbillivirus infections of aquatic and terrestrial carnivores 
In April 1988, unusually high mortality rates were observed among harbour seals ranging in 
the Danish Kattegat. The seals predominantly exhibited respiratory but also gastrointestinal 
and nervous symptoms. The disease spread rapidly around Skagen into the German and Dutch 
Wadden Sea, crossed the North Sea towards the British Islands and further into Irish waters. 
When in the fall of 1988 the epizootic had ceased, an estimated 17.000 seals, equivalent 
to 60% of the population in some areas, had succumbed to the disease (Heide-J¢rgensen 
et al., 1992). Due to the epizootic disease pattern, an infectious agent was suspected at its 
basis. Apart from a plethora of parasites and bacteria, several virus species were isolated from 
diseased seals, including picorna-, herpes- and morbilliviruses (Cosby et al., 1988; Osterhaus, 
1988; Osterhaus et al., 1988; Liess et al., 1989; Have et al., 1991; Frey et al., 1989). By 
fulfilment of the postulates of Henle and Koch, morbilliviruses were identified as the primary 
causative agent (Osterhaus et al., 1988, 1989a; Harder et al., 1990, 1992; Visser et al., 1992). 
Concerted follow-up antigenic and molecular studies allowed the classification of the so-called 
seal morbillivirus as a separate, previously unknown morbillivirus species, now designated 
phocid distemper virus, PDV (Kennedy et al., 1988a; Orvell et al., 1990; Visser et al., 1990; 
Haas et al., 1991; Kovamees et al., 1991a). CDV represents the closest relative of PDV among 
the morbilliviruses (Blixenkrone-M¢lIer, 1993). Later on, PDV was shown to be endemic in 
many seal populations worldwide including Arctic and Antarctic species (Bengstson et al., 
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1991; Henderson et al., 1992; Markussen & Have, 1992; Ross et al., 1992). Introduction 
of PDV by migrating Arctic seals into the European harbour seal population, until then 
naive to morbilliviruses, would be a plausible but, to this end, unprovable explanation for the 
1988 epizootic (Dietz et al., 1989). Environmental pollution was of major public concern as a 
possible aggravating co-factor of the epizootic. Careful longitudinal studies of two seal cohorts 
being fed on fish from the Northern Atlantic or from the comparatively highly contaminated 
Baltic Sea indeed demonstrated negative impacts of organochlorine burdens on the immune 
system of seals, with impaired T cell responses and lowered NK cell activities being most 
notable (De Swart et al., 1995; Ross et al., 1996). 
Consecutive virological studies led to the discovery of further new members of the morbil-
livirus genus (dolphin and porpoise morbillivirus), responsible for epizootics associated with 
high mortality rates among cetacean species in the Mediterraenean Sea in 1990/1991 (striped 
dolphin, Stenella coeruloalba) and in the North Sea (harbour porpoise, Phocoena phocoena) 
in 1990, respectively ( Kennedy et al., 1988b; Domingo et al., 1990; Barrett et al., 1993; 
Visser et al., 1993a). 
Chronologically in parallel with the European seal mass mortality, a similar epizootic was 
reported from Siberian Lake Baikal seals (Phoca sibirica) which were also found to die from 
a morbillivirus infection (Grachev et al., 1989; Osterhaus et al., 1989b). The agent in these 
cases, however, proved to be a true strain of CDV (Visser et al., 1993b; Mamaev et al., 
1995). Any epidemiological links to the European seal epizootic, therefore, Were ruled out. 
CDV infections of aquatic mammals probably were not unprecidented according to a report in 
which a distemper-like disease was described in crabeater seals (Lobodon carcinophagus) off 
the Antarctic coast in 1955; simultaneously, canine distemper occured in sled dogs brought 
to the same area of Antarctica (Laws & Taylor, 1957). 
A recent and most unexpected morbillivirus epizootic among wildlife carnivores was repor-
ted in 1994 from lions (Panthera leo), ranging in the Tanzanian Serengeti National Park: 
up to 30% of the population were killed (Morell, 1994). Before, small scale outbreaks of 
distemper-like disease have occured in big cats kept in North American zoos (Appel et al., 
1995). While the identity of the Serengeti lion morbillivirus remained obscure, the outbreaks 
in the US exotic Felidae have serologically been linked to CDV-like viruses. 
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Aim and outline of the thesis 
With respect to their biology, herpesviruses and morbilliviruses hold almost diametrically op-
posed positions within the spectrum of viruses. However, during the last decade, these viruses 
created the most significant impact on aquatic and - in addition to the canine parvovirus 
pandemia and the feline immunodeficiency virus infections - also on wildlife terrestrial carni-
vores. This study aims at the characterization of these viruses at the molecular level in order 
to elucidate the phylogenetic and epidemiological relationships of herpes" and morbilliviruses 
in land-based and aquatic carnivores, respectively. , 
Despite the evidence that potentially highly pathogenic herpesviruses (SeHV) are prevalent 
worldwide in many pinniped populations, some of them highly endangered, atiempts toward 
a more detailed characterization of SeHV were not communicated when the work described in 
this thesis commenced. Chapter 2 is dedicated to the diagnosis, identification· and molecular 
characterization of seal herpesviruses and their phylogenetic relationships .to herpesviruses of 
dogs and cats. These studies led to the distinction of two separate'se'al herpesvirus species 
of Q- and 'Y-herpesvirus lineage, respectively. A significant age-dependen't clinical impact 
of PhHV infections in hospitalized seals is demonstrated. As a first'step toward a vaccine 
confering protection against PhHV-induced disorders, major immunogenic 'ptoteins of this 
virus are identified, including the glycoprotein B (gB) equivalent. The gB-encoding gene has 
been sequenced and expressed in insect cells. Perspectives for a future subunit 'PhHV vaccine 
are evaluated. 
In chapter 3, general aspects of the antigenic and phylogenetic relationships of morbilli-
viruses of seals, dogs and cats are studied. Furthermore, investigations are presehted which 
unravel the molecular identity of morbilliviruses involved in recent distemper outbreaks among 
exotic Felidae in the USA and the Tanzanian Serengeti National Park. 
An extensive summarizing discussion is presented in chapter 4. The main focus is on the 
phylogenetic relationships of morbilli- and herpesviruses of aquatic and terrestrial carnivores. 
Lines of future research with regard to molecular epidemiology and ptevention of disease 
associated with these viruses are discussed. 
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Herpesviruses of seals, dogs and cats 

Section 2.1 
Comparative immunological characterization of type-specific and 
conserved B-cell epitopes of pinniped. felid and canid herpesviruses. 
Michaela Lebich, Timm C. Harder, Hans-Richard Frey, Ilona K.G. Visser, 
Albert D.M.E. Osterhaus and Bernd Liess 
Arch. Virol. (1994) 136, 335-347. 

2.1 - Antigenicity profiles of phocid herpesviruses 
Abstract - Murine monoclonal antibodies (MAbs) were generated against phocid herpesviruses 
(PhHV 2557/Han88 and 7848/Han90) isolated from European harbour seals (Phoca vilulina), and 
against strain both felid (FHV strain FVR 605) and canid herpesviruses (CHV isolate 5105/Han89). 
MAbs were characterized with respect to certain biological properties and used to outline antige-
nicity profiles of isolates of PhHV (n=8), FHV (n=7) and CHV (n=3) in enzyme immunoassays 
employing fi.xed infected cells. A close antigenic relationship between herpesviruses derived from 
pinnipeds and terrestrial carnivores became evident: The majority of the MAbs was directed against 
epitopes which were expressed by at least two of the viral species tested. A number of MAbs detected 
epitopes which were conserved between all isolates of PhHV, FHV and CHV. A few MAbs recogni-
zed type-specific 8-cell epitopes and facilitated the identification of single viral species. Moreover, 
the PhHV isolate 7848/Han90 was antigenically distinguishable both from seven other phocid her-
pesvirus isolates and from FHV or CHV. PhHV 7848/Han90 proved to be antigenically distinct 
from all other viruses tested when examined by cross neutralization utilizing various reconvalescent 
and hyperimmune sera. Although more data are needed to ensure that PhHV 7848/Han90 indeed 
is a new genuine seal herpesvirus, the preliminary clustering of two groups of phocid herpesvirus 
isolates, tentatively designated PhHV-l (type isolate 2557/Han88) and PhHV-2 (represented by 
7848/Han90), seems to be justified. By using selected MAbs an unambiguous identification and 
typing of herpesvirus isolates derived from marine mammals and terrestrial carnivores is significantly 
facilitated. 
Introduction 
Herpesvirus infections associated with pneumonia and focal hepatitis in hospitalized harbour 
seal pups (Phoca vilulina) have been initially described in 1985 (Osterhaus el al., 1985). The 
so-called phocid herpesviruses (PhHV) were considered a-herpesviruses (Roizman el al., 
1992) with respect to their physico-chemical composition, a short replicative cycle leading to 
rapid mass destruction of susceptible seal kidney cell cultures, and an antigenic relationship 
to both felid and canid herpesviruses (FHV, CHV) detected by cross neutralization assays 
(Osterhaus et al., 1985). 
Since 1985 further herpesviruses were isolated from a California sea lion (Zalophus califor-
nianus) (Kennedy-Stoskopf el al., 1986) and, more frequently, from harbour seals during the 
1988 European morbillivirus seal mass mortality (Osterhaus, 1988; Frey el al., 1989). Sero-
surveys indicated that infections of pinnipeds by PhHV or other closely related herpesviruses 
occur frequently and worldwide, including Arctic and Antarctic seal species (Vedder el al., 
1987; Harder et al., 1991a; Stenvers et al., 1992b). Firm data on the incidence and kind of 
clinical disease in free-ranging seal populations due to herpesvirus infections is lacking. An 
association with respiratory disease and abortion, however, has been suspected (Harder et 
al., 1991a; Stenvers el al., 1992b). 
In the course of a natural infection, as described by Osterhaus el al. (1985), a mortality 
rate of about 50% was observed in hospitalized seal pups. Fatal, natural infections of adult 
seals associated with high titres of herpesvirus in central nervous tissues have been reported 
in cases of concomitant infections with virulent phocid distemper morbillivirus (PDV) (Zhang 
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et al., 1989). In contrast, experimental infection of susceptible juvenile harbour seals by the 
PhHV isolate 2501/Han88 resulted in an almost subclinical infection (Horvat et al., 1989). 
Apparently, the symptomatology due to PhHV infections may be variable, depending on the 
seal's age, properties of the virus strain and concomitant infections, among other factors. 
Evidence for an immunological relationship between PhHV and felid as well as canid her-
pesviruses is based on data obtained from cross neutralization experiments (Osterhaus et al., 
1985; Harder et aI., 1991a; Stenvers et al., 1992b). Further attempts to characterize pinniped 
herpesviruses have not been reported. 
Monoclonal antibodies (MAbs) proved to be excellent tools both for taxonomic and dia-
gnostic purposes in various herpesvirus species (Cropper et al., 1992; Dubuisson et al., 1989; 
Friedli et al., 1987). In order to specify the antigenic relationships among recent herpesvirus 
isolates of aquatic mammals and terrestrial carnivores, monoclonal antibodies' were raised 
against two isolates of PhHV and a strain of both FHV and CHV. Here we show that the 
newly established panel of MAbs is useful for an unambiguous typing of isolates. Furthermore, 
we will provide evidence for the existence of two types of phocid herpesviruses which can be 
differentiated with respect to biological, immunological and epidemiological characteristics. 
Materials and methods 
Viruses and Cells - Isolates and strains of PhHV, FHV, CHV and SHV-I used in this study are 
summarized in Tab. 1. The majority of these isolates has been described earlier (Frey, 1972; Bittle 
et al., 1975; Povey, 1975; Borst et al., 1986; Osterhaus et al., 1985; Frey et al., 1989; Truyen et 
al., 1989; Harder et al., 1991a). The PhHV-isolates 2010jHan89 and 7848jHan90 were isolated 
in primary seal kidney cultures. Isolate 2010/Han89 originated from lung tissue homogenates of 
a carcass of an adult seal. Cultivation of peripheral mononuclear blood cells of an adult harbour 
seal showing severe respiratory disease yielded isolate 7848/Han90. Both -isolates, like other phocid 
herpesviruses, replicated in a clone of CrFK cells (Crandell et al., 1973), requiring no phase of 
adaptation. Canine herpesviruses were isolated in primary canine kidney cell cultures: 5105/Han89 
originated from lung tissues of a dog with concomitant distemper virus infection; CHV 11191/Han91 
and 11361/Han91 were isolated from kidney and liver tissues, respectively, of newborn pups of two 
different litters which died due to generalized disease, For further propagation of CHV the canine 
fibroblast cell line A 721 was employed (Binn et al., 1980). Herpesvirus isolates of feline origin 
were recovered by use of a feline semicontinuous cell line (cat fetus cells2) or CrFK cells from 
oropharyngeal or conjunctival swabs of cats with upper respiratory disease or conjunctivitis (Harder 
et aL, 1993a). The suid herpesvirus-l isolate was also grown on CrFK cells. All viruses were subjected 
to at least three cycles of plaque purification before further use in this study. 
For the preparation of concentrated virion suspensions large scale roller cultures of CrFK (PhHV, 
FHV) or A 72 cells (CHV) were harvested when viral cytopathic destruction was advanced, usualw 
Iy after three days of incubation. Following one freeze/thaw-cycle cellular debris was removed by 
centrifugation at 10.000 x G (15 minutes, 4QC). Clarified supernatants were sUbjected to ultracenw 
trifugation for 1 hour at 85.000 x G. The pellets were resuspended in TNE-buffer (10 mM Tris-HCI, 
I Kindly donated by Or. S. Kolbl, Bundesanstalt fUr Virusseuchenbekampfung, Vienna, Austria 
'Supplied by Dr. K. Danner, Behringwerke AG, Marburgjlahn, F.R.G. 
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pH 7.4, 100 mM NaCl, 1 mM EDTA) and centrifuged through a sucrose cushion (30% w/v in TN E) 
at 85.000 x G for 2 hours. Virion-enriched pellets were resuspended in TNE-buffer and repelleted at 
85.000 x G for 40 minutes. The pellets were reconstituted in 5x volume of TNE-buffer, aliquoted 
in 0.2 ml portions and stored at - 800 ( until use. 
Monoclonal antibodies - Splenocytes obtained from Balb/c mice which had been hyperim-
munized with concentrated virion suspensions emulsified in equal volumes of Freund's complete 
and incomplete adjuvant, respectively, were fused with cells of the X 63-AG 8.653 myeloma line 
(Kearney et al., 1978) according to standard protocols. Hybridoma were grown in selective medium 
(Littlewoods et al., 1968) to which as a source of cytokines supernatant of a fetal bovine splenocyte 
culture stimulated with Concanavalin A was added to 20% (v/v). The peroxidase-linked antibody 
assay (PLA) was used to identify hybridoma colonies secreting antigen-specific antibodies. Concen-
trates of MAbs were obtained by immune-affinity chromatography from cell culture supernatants 
of stabile producing hydridoma lines which had undergone at least two cycles of single-cell cloning 
by limiting dilution. 
Peroxidase-linked antibody assay (PLA) - The PLA technique, an enzyme-linked immuno 
assay employing heat-fixed infected cells, was adopted from Harder et al. (199b). Antibody-
containing solutions were applied to heat-fixed cultures in microtitre plates and incubated for two 
hours at room temperature or overnight at 4°C. For the initial screening of hybridoma colonies, 
supernatant was added in a single dilution of 1/2 in PBST. Bound antibodies were detected by using 
horseradish-peroxidase (HRPO)-Iabeled caprine-anti-murine-lgG, and 3-amino-9-ethylcarbazole 
serving as the chromogen. The highest dilution of a MAb solution readily enabling signal detection 
by light microscopy was recorded as its PLA-titre. 
For photografic documentation of the intracellular herpesviral antigen accumula high contrast im-
munocytochemical staining was achieved by use of 3,3'- diaminobenzidine and subsequent gold/silver 
enhancement according to Lazar & Taub (1992). Hematoxylin was used for counterstaining (Morris, 
1990). 
Plaque reduction neutralization assay (PRNT) - MAb concentrates were diluted to a protein 
concentration of approximately 25 - 50 Jig ml- 1 in OMEM to be tested for neutralizing capacities 
against 50 - 100 plaque forming units (pfu) of their homologous virus (PhHV 2557/Han88, PhHV 
7848/Han90, FHV FVR 605 and CHV 5105/Han89). A polyclonal serum known to neutralize 
the respective virus in a microneutraliz assay (see below) served as positive control. A neutralizing 
MAb raised against the H-protein of phocid distemper virus (POV) represented the negative control 
(Harder et al., 199b). Virus-MAb or -polyclonal serum mixtures were incubated overnight at 4°C 
before inoculation in duplicate onto monolayers of susceptible (either CrFK or A 72) cells for an 
adsorption period of 2 hours. In a parallel series, virus-MAb mixtures were incubated in the presence 
of 4% (v/v, final) of ginuea pig complement. After incubation for 72 hours plaques formed by PhHV 
2557/Han88, FHV FVR 605, and CHV 5105/Han89 were macroscopically visible. In the case of 
PhHV 7848/Han90 the incubation period was prolonged to 6 days and a second overlay was added 
at day 4. Plaques were then immunocytochemically stained by the PLA-technique utilizing MAb 
7848 2.4D7 or 6E5 as the first layer. 
The percentage reductio'n of plaque formation by a certain MAb was calculated with respect to 
the number of plaques induced in the negative control. 
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Table 1. Origin of herpesviruses. 
Virus Host Disease Specimen Reference 
PhHV 
PB 84 Ph. vitu/ina respiratory kidney culture Osterhaus el .1. (1985) 
PB 6-11/85 Ph. vito/ina respiratory lung Osterhaus el .1. (1985) 
2158/Han88 Ph. vitulina respiratory lung Frey el .1. (1989) 
2160/Han88 Ph. vitu/ina respiratory liver Frey el .1. (1989) 
2501/Han88 Ph. vitulina respiratory I~ng Frey el .1. (1989) 
2557/Han88 Ph. vitu/ina respiratory leucocytes Frey el .1. (1989) 
2010/Han89 Ph. vitulina carcass lung this work 
7848/Han90 Ph. vitulina generalized leucocytes this work 
FHV 
FVR 605 Calus felis vaccine strain! Povey (1975) 
F2 Catus felis vaccine strain2 Bittle el .1. (1975) 
FHV/L '- Panthera leo encephalitis tonsil Truyen el .1. (1989) 
6084/Han90 Calus felis rhinotracheitis pharyng. swab Harder el .1. (1993a) 
6887/Han91 Catus Felis rhinotracheitis pharyng. swab Harder el .1. (1993a) 
299/Han91 Calus felis conjunctivitis conjunct. swab Harder el .1. (1993a) 
10499/Han91 Calus Felis rhinotracheitis pharyng. swab Harder el .1. (1993a) 
CHV 
5105/Han89 Canis familiaris respiratory lung Harder el .1. (1993a) 
11190/Han91 Canis familiaris3 generalized kidney this work 
11361/Han91 Canis familiaris3 generalized liver this work 
SHV-l 
48-1/Han68 Sus domesticus respiratory lung Frey (1972) 
1 Dr. K. Danner, Behringwerke AG, Marburg/Lahn, F.R.G.; 2 Dr. A. Aubert, Virbac Laboratories, 
Carosse, France; 3 Newborn whelps. 
Microneutralization assay (MNT) - Sera of naturally and experimentally herpesvirus~infected 
animals were assayed for their neutralizing capacities in the presence of 4% (v/v) guinea pig com~ 
plement solution against PhHV, FHV, CHV and SHV-l. The test was essentially performed as 
described (Harder et al., 1991a). 50% end point tit res were calculated according to Kaerber (1931). 
Results 
Growth properties of phocid herpesviruses in vitro 
All PhHV isolates replicated in primary seal kidney cells as well as in CrFK cells, but not 
in cells of canine origin. However, neither FHV nor CHV could be adapted to phocine cells 
by three blind passages (data not shown). Cytopathogenic effects induced by all PhHV isolates 
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Figure 1. Intracellular distribution of antigen in CrFK cells infected by phocid herpesvirus isolates 
identified by high contrast peroxidase~linked immunocytochemical staining utilizing different mono-
clonal antibodies. 1. Plaque of CrFK cells infected by PhHV-1 2557/Han88 and pan cytoplasmically 
stained using MAb PhHV-l 2557 3.103. 2. Perinuclear localization of antigen (open triangles) 
identified by MAb PhHV-2 7848 1.6C5 in CrFK cells infected by PhHV-2 7848/Han90. 3. Pan-
nuclear distribution pattern of antigen stained by MAb PhHV-2 7848 1.9A5 in CrFK cells infected 
by PhHV-2 7848/Han90. 4. Polar accumulation of antigen (closed arrow) in a nucleus of a CrFK 
cell infected by PhHV-2 7848/Han90 (MAb PhHV-2 7848 1.7C8). 
except 7848/Han90 were characterized by development of single rounded single cells gradually 
detaching from the vessel surface (Fig. 1). The onset of cytopathogenic effects induced by 
PhHV 7848/Han90 was delayed in comparison to other PhHV isolates and consisted mainly 
of syncytia formation. Under a semisolid overlay PhHV 2557/Han88. FHV and CHV strains 
generated macroscopically visible plaques of 1 - 3 mm in diameter within three days. Plaques 
induced by PhHV 7848/Han90. in contrast. did not exceed pin-point size even after prolonged 
incubation of six days. 
Accumulation sites of viral antigens in CrFK cells infected by PhHV 
A high-contrast peroxidase-linked immunocytochemical staining as~ay was used to demon-
strate the accumulation of PhHV viral antigens in infected cells (Fig. 1). Using the panel of 
MAbs raised against the PhHV isolates 2557/Han88 and 7848/Han90 three different patterns 
were identified (Tab. 2): 
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Table 2, Characterization of MAbs raised against phocid herpesvirus isolates 2557/Han88 
and 7848/Han90, felid herpesvirus strain FVR 605 and canid herpesvirus isolate 5105/Han89. 
MAb designation Antigen localization 1 Neutralization2 
PhHV 2557/Han883 
l.lH3", 2.2F2" cytoplasmic 100 
3.4B3, 3.4Gl, 3.4G6, 3.5Fl, cytoplasmic 60 - 90 
3.6A12, 3.6E7, 3.7B9 
2.3F4, 2.3F7, 2.5B4, 2.9A12, cytoplasmic ::; 20 
3.103, 3.3G8, 3.3H5, 3.5B9, 3.7G3 
3.2C8, 3.3E4 nuclear ::; 20 
PhHV 7848/Han90 3 
1.3E5, 2.4D7, 2.6E5 cytoplasmic ::; 20 
1.4C6, 1.6C5 perinuclear ::; 20 
1.7C8, 1.8C3, 1.9A5 nuclear ::; 20 
FHV FVR 6053 
1.4A1, 1.5H10, 1.8H6 cytoplasmic ::; 20 
CHV 5105/Han893 
2.3AIO cytoplasmic 70 
1.2G7, 1.5A2, 2.9F6 cytoplasmic ::; 20 
1 Tested by peroxidase~linked antibody assay. 
:2 Percentage reduction of plaque forming units of the homologous virus (50 pfu) by 25-50 Jig 
of antibody in the presence of 4% (v/v) of guinea pig complement. 
3 Virus used to raise the MAbs; .. MAbs did not require complement for neutralization. 
The majority of the MAbs stained viral antigen which was evenly distributed throughout 
the cytoplasm (Fig. 1.1). Antigens detected by MAbs 7848 1.4C6 and 1.6C5 showed a 
restricted perinuclear localization surrounding the nucleus like a corona. In early stages of 
viral replication this antigen was found in the cytoplasm near the poles of the nucleus (Fig. 
1.2). Some MAbs recognized viral antigen which was confined to the nucleus (Figs. 1.3, 
1.4). While nuclei of cells apparantly in early stages of viral replication revealed a scattered 
staining pattern (Fig. 1.4), enlarged nuclei of cells located in the centre of viral plaques were 
homogeneously filled with antigen (Fig. 1.3). 
Identification of conserved and type-specific epitopes of phocid. felid 
and canid herpesviruses 
The reactivity and aflinity of MAbs established against different herpesviruses was determined 
by use of an enzyme immunoassay employing fixed infected cells (peroxidase-linked antibody 
assay, PLA). As a measure of relative antibody affinity (AF-index) the ratio between the 
PLA-titre and the protein content (lgG) ml- I of a given MAb concentrate was calculated. 
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As shown in Fig. 2 out of 20 MAbs raised against PhHV 2557/Han88 all but one reacted 
with CHV isolates whereas nine had also a high affinity to most FHV strains. Three MAbs, 
namely 2557 2.3F4, 2.3F7 and 2.9A12, also weakly reacted with pseudorabies virus (data not 
shown). The PhHV isolate 7848/Han90 was distinguishable both from seven other phocid 
herpesvirus isolates as well as from CHV and FHV (Fig. 2): Only four of the 20 MAbs 
produced against PhHV 2557/Han88 also detected PhHV 7848/Han90 antigen. In contrast, 
the majority of MAbs raised against the latter virus recognized other PhHV isolates but 
displayed only limited reactivity with FHV and CHV. Most of the MAbs produced against 
FHV and CHV reacted with all PhHV isolates except PhHV 7848/Han90. 
The monoclonal antibodies 2557 3.6E7; 7848 1.4C6, 1.6C5, 1.7C8, 2.4D7; FVR 2.8H6 
and CHV 2.9F6 were found to bind antigen of other except their homologous virus species 
with very low affinity, if at all. Thus. these MAbs were used for identification of single viral 
species. In combination with cross reactive MAbs like 2557 3.3G8 and 3.1D3 an unambiguous 
antigenic identification and typing of herpesvirus isolates derived from terrestrial carnivores 
and pinnipeds using the PlA technique can easily be accomplished. 
In general, isolates of PhHV (except 7848/Han90) and CHV displayed homogeneous reac-
tivity patterns to the MAb panel. However, among felid herpesviruses, a diffuse intraspecies 
antigenic heterogeneity was detectable with some MAbs: MAb 5105 1.2G7, for example, mo-
derately reacted with FHV /l, FHV 6084, and 6887 but not with other FHV isolates including 
the vaccine strains. A general and concise clustering, e.g. into vaccine strains and isolates 
obtained from cats showing signs of rhinotracheitis or conjunctivitis. was not possible. 
Neutralization of viral infectivity by monoclonal antibodies 
A number of MAbs generated against PhHV 2557/Han88, FHV and CHV partially (40 - 80%) 
reduced the formation of plaques of their homologous virus when assayed in a comparatively 
high protein concentration of 25 - 50 I'g ml- I (Tab. 2). Only two MAbs generated against 
PhHV 2557/Han88 (l.1H3 and 3.2F2) completely neutralized viral infectivity even without 
complement supplementation and in higher dilutions. However, these MAbs were uncapable 
of cross neutralizing other herpesvirus species (data not shown). 
Differential neutralization by sera 
A complement-enhanced microneutralization assay was used to investigate whether PhHV 
7848/Han90 can also be distinguished f PhHV isolates by polyclonal antibodies derived 
from various naturally and experimentally herpesvirus-infected species. For use in this study 
pinniped sera were selected which displayed high neutralizing titres to the PhHV isolate 
2557/Han88. The majority of these sera also strongly neutralized CHV (Tab. 3). In addition, 
sera sampled from European harbour seals cross neutralized FHV whereas this was not 
achieved with sera of Antarctic Weddell seals. All sera, however, enabled the differentiation 
of the phocid herpesvirus isolate 7848/Han90 which appeared to be more distantly related 
to PhHV 2557/Han88 than FHV but not as distant as SHV-1. 
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Figure 2. Reactivity of monoclonal antibodies (MAbs) against phocid (PhHV), felid (FHV) and 
canid (CHV) herpesviruses analyzed by peroxidase--linked antibody assay. Reactivity gradations are 
based on affinity values (see material and methods for calculation): • strong, 9 weak, H - heteroge-
neous, 0 not detectable. With respect to the reactivity patterns the herpesvirus isolates and strains 
tested could be clustered as follows: PhHV-I (n=7): PB 84, PB 6-11/85, 2158/Han88, 2160/Han88, 
2501/Han88, 2557/Han88, 2010/Han89; PhHV-2 (n=I): 7848/Han90; FHV (n=7): FVR 605, 
F2, FHV /L, 6084/Han90, 6887/Han91, 299/Han91, 10499/Han91; CHV (n=3): 5105/Han89, 
11190/Han91, 11361/Han91. Underlined letters indicate single MAbs which were shown to com-
pletely neutralize their homologous virus independently from complement supplementation. 
Discussion 
Previous studies based on cross neutralization experiments employing reconvalescent seal 
sera have demonstrated an antigenic relationship between genuine herpesviruses isolated 
from cats, dogs and European harbour seals (Phoca vitutina) (Osterhaus et al., 1985; Harder 
et al., 1991a ; Stenvers et al., 1992b). More detailed comparisons of FHV and CHV led to 
the identification of some glycoproteins sharing a number of conserved epitopes (Limcumpao 
et al., 1990; Rota & Maes, 1990). 
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Table 3. Cross neutralization of phocid herpesviruses and antigenically related herpesviruses 
of terrestrial carnivores. 
Serum PhHV-l PhHV-2 FHV CHV SHV-l 
2557/Han88 7848/Han90 FVR 605 5105/Han89 48/Han68 
Weddell seals 
5255/91 651 ::;5 15 53 ::;5 
5257/91 40 ::;5 ::;5 8 ::;5 
5258/91 52 ::;5 ::;5 53 10 
5259/91 40 ::;5 ::;5 53 ::;5 
5272/91 52 ::;5 ::;5 28 ::;5 
Harbour seals 
3128/88 220 40 80 46 7 
3394/88 80 ::;5 28 130 ::;5 
3400/88 80 ::;5 92 113 ::;5 
7848/90 450 46 46 180 ::;5 
8549/92 48 ::;5 ::;5 ::;5 ::;5 
11135/92 450 ::;5 130 130 ::;5 
11142/92 370 ::;5 46 23 ::;5 
11164/92 192 26 23 32 ::;5 
11166/92 256 ::;5 160 32 ::;5 
11173/92 450 105 23 56 ::;5 
Reference sera 
725C 13 ::;5 ::;5 40 ::;5 
"FVR605S 14 ::;5 3100 ::;5 ::;5 
AK-F ::;5 <5 <5 ::;5 92 
1 Reciprocals of NDso. 
Sera nos. 5255 to 5272 were collected from Antarctic Weddell seals (Leptonychaetes weddel/iI) in 
1990 (Harder et al. 1991a). Nos. 3128 to 11173 originated from free-ranging harbour seals (Phoca 
vitulina) of the German wadden sea 1988 - 1992. Serum 725C resulted from a dog experimentally 
infected by CHV 5101/Han89 (Harder 1990, unpublished). The anti-FHV serum (aFVR605S) was 
raised in a sheep against FVR 605 (Dr. K. Danner. Behringwerke AG, Marburg, F.R.G.). A porcine 
field serum served as a reference for SHV-l-specific antibodies. 
By using a new panel of monoclonal antibodies raised against two PhHV isolates we con-
firm and extend these data. Eight phocid herpesvirus isolates obtained during 1984 - 1990 
from different harbour seals with different clinical syndromes were taken under study and 
compared to vaccine strains and recent field isolates of felid and canid herpesviruses. Seven 
PhHV isolates displayed a homogeneous pattern of reactivity to 35 MAbs. Isolates of seemin-
gly different pathogenicity (e.g. PhHV PB 84 and 2501/Han88) could not be distinguished. 
The isolate 7848/Han90. in contrast. differed in a number of epitopes defined by MAbs from 
other PhHV isolates as well as from FHV and CHV. Multiple cross neutralization experiments 
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employing reconvalescent sera of different seal species as well as reference sera to FHV or 
CHV and a serum from a SHV-1 infected pig gave further evidence that PhHV 7848jHan90 
is immunologically distinct, though distantly related, from all other viruses tested here. In ad-
dition, some in vitro properties, e.g. comparatively slow growth with predominant formation 
of syncytia, are not shared with other PhHV isolates. 7848jHan90 was isolated from leuco-
cytes, but not from other tissues of an adult harbour seal which succumbed to a respiratory 
disease. The isolation of herpesviruses from seals sharing the properties of 7848jHan90 had 
not yet been reported. Definite proof that 7848jHan90 indeed represents a new genuine seal 
herpesvirus thereby ruling out the possibility of a contamination, e.g. originating from fetal 
calf serum, must come from restriction enzyme analysis and sequence data of the genome. 
Until then the differentiation of two distinct groups of phocid herpesviruses and their tenta-
tive designation as PhHV-l (represented by PhHV 2557 jHan88) and PhHV-2 (represented 
by PhHV 7848jHan90) may be justified. 
Some diffuse and heterogeneous antigenic differences were also observed among vaccine 
strains of FHV and herpesvirus isolates recovered from diseased cats. However, a correlation 
of loss or presence of single antibody binding sites and clinical entities was not feasible. 
Isolates of the proposed PhHV-1 type displayed a pronounced cross relationship especially 
to CHV and to a lesser extent also to FHV. A similar situation was unraveled by cross 
neutralization experiments. Titres of neutralizing antibodies in sera derived from different 
pinniped species were generally highest against PhHV-1 (2557 jHan88). The majority of 
sera, at least those derived from European harbour seals, significantly cross neutralized CHV 
5105 and FHV FVR 605 in contrast to PhHV-2 (7848jHan90). The serUm of the seal 
from which PhHV-2 7848jHan90 was isolated displayed a high titre to PhHV-2. As an 
unexpected finding the titre of this serum against PhHV-1 was even higher. For an explanation 
it may be assumpted that seal 7848 has previously been infected by PhHV-1; upon a recent 
primary infection with PhHV-2 (7848jHan90) a presumably latent PhHV-1 infection was 
reactivated leading to a boost or an anamnestic response of PhHV-1 specific antibodies while 
PhHV-2-specific antibodies yet were not fully developed. However, it can not be excluded 
that infections with PhHV-2 are not inducing neutralizing antibodies as readily as PhHV-l. 
Serological follow-up studies in this case were not possible since the animal died within a few 
days. 
The host restriction of many a-herpesviruses both in vivo and in vitro is variable (Roizman 
et al., 1992). Some viruses, e.g. CHV, appear to be strictly confined to a single host spe-
cies while others such as pseudorabies virus are capable of crossing host species boundaries. 
Diseases induced by most a-herpesviruses in their natural hosts are commonly self-limiting. 
Aberrant host species. in contrast, are more prone to develop severe and often fatal clinical 
syndromes. Herpesviruses were isolated from the faeces of dogs showing signs of gastroen-
teritis. These isolates replicated in feline cell cultures and were indistinguishable from felid 
herpesvirus by cross neutralization (Everman et al., 1982), restriction enzyme analysis and 
Southern blotting (Rota et al., 1986). The infection of dogs with a felid herpesvirus variant 
provoked a clinical syndrome which is generally not seen in FHV infections of the natural 
host (Povey, 1979). Data whether PhHV is carrying any potential to cross the species boun-
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daries and infects members of the Canidae or Felidae families are presently not available. It 
is tempting to speculate that the latter would not be unlikely since both proposed types of 
PhHV did not require an adaptation phase to replicate productively in feline cell cultures. In 
contrast, cells of canine origin seem to be non-permissive. A system enabling an unambiguous 
ident.ification and differentiation of herpesviruses isolated from sea mammals and terrestrial 
carnivores would be desirable both for diagnostic and epidemiological reasons. For this pur-
pose some of the newly established MAbs are suitable (PhHV-1: 2557 3.6E7, PhHV-2: 7848 
1.4C6, FHV: FVR 8H6, CHV: 5105 2.9F6). Once an isolate is available it can be typed by 
PLA within a couple of hours avoiding the more time consuming, laborious and sophisticated 
restriction enzyme analysis. 
The panel of herpesvirus-specific MAbs characterized here may also aid in the diagnosis of 
herpesvirus infections in cetaceans which have recently been described in a harbour porpoise 
(Phocoena phocoena) showing encephalitis (Kennedy et al., 1992) and in Beluga whales 
(Delphinapterus leucas) with dermatitis (Martineau et al., 1988; Barr et al., 1989). 
In conclusion, using a large panel of MAbs we provided evidence that herpesviruses of 
harbour seals are antigenically related to, though distinct from felid and canid herpesvirus. 
Two groups of phocid herpesviruses, tentatively designated PhHV-1 and PhHV-2 were diffe-
rentiated by cross neutralization experiments and epitope-typing using the newly established 
MAb panel. While only a few antigenic differences between PhHV-1, CHV and FHV were 
detected PhHV-2 appears to be more distantly related to PhHV-1 isolates. Further work is 
in progress to characterize the genomes and proteins specified by PhHV-1 and -2 in order to 
confirm their classification as separate genuine pinniped herpesviruses. 
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37 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
Section 2.2 
Characterization of phocid herpesviruses-l and -2 
as putative alpha- and gamma-herpesviruses 
of North American and European pinnipeds 
Timm C. Harder, Michaela Harder, Helma W. Vos, Katariina Kulonen, 
Suzan Kennedy-Stoskopf, Bernd Liess, Max J.G. Appel 
and Albert D.M.E. Osterhaus 
J. Gen. Virol. (1996) 77, 27-35 

2.2 - Genetic characterization of PhHV isolates 
Abstract - To study the relationships between herpesviruses recently isolated from different 
pinniped species, antigenic and genetic analyses were performed. First, herpesviruses isolated from 
North American harbour seals (Phoca vitulina) , a California sea lion (Zalophus californianus) and 
a European grey seal (Halichoerus grypus) were examined in an enzyme immunoassay (EIA) with a 
panel of monoclonal antibodies which had previously been shown to allow typing of herpesviruses 
from European harbour seals into two distinct virus types: phodd herpesvirus type-l and type-
2 (PhHV-l and PhHV-2). The EIA data showed all but one of the isolates from seals ranging in 
United States coastal waters were PhHV-2-like while the European grey seal herpesvirus was PhHV-
I-like. Genetic characterization was facilitated by peR analysis using primers based on conserved 
regions of the glycoprotein Band D (gB and gD) genes of the antigenically closely related canid 
(CHV) and felid (FHV) herpesviruses. Specific amplified products were obtained with five isolates 
antigenically characterized as PhHV-I-like but not with five PhHV-2-like isolates. Sequence analysis 
of the PCR products confirmed greatest similarity to members of the genus Varicellovirus of the 
n-Herpesvirinae and in particular to CHV. Sequence analysis of two EeoRI fragments of the PhHV-2 
genome (European isolate 7848) revealed greatest similarity to 1'-herpesviruses and in particular 
equine herpesvirus-2. Although an unambiguous subgrouping was not feasible, this is the first 
evidence that PhHV-2 may be a putative ,-herpesvirus of pinnipeds. 
Introduction 
Herpesviruses which are antigenically closely related to felid and canid herpesvirus (FHV, 
CHV) have been isolated from pinnipeds (Osterhaus et al., 1985; Kennedy-Stoskopf et al., 
1986; Osterhaus & Vedder, 1988; Frey et al., 1989; Horvat et al., 1989; Lebich et al., 1994). 
Herpesvirus isolates obtained from European harbour seals (Phoca vitulina) are currently 
referred to as phocid herpesvirus (PhHV) and were tentatively classified as belonging to the 
subfamily a-Herpesvirinae (Osterhaus et al., 1985; Roizman et al., 1992). The clinical rele-
vance of herpesvirus infections in free-ranging pinniped populations is still poorly understood. 
However, in animals in captivity, severe outbreaks of herpesvirus infections have occurred ac-
counting for mortality rates of up to 50% among seal pups due to severe pneumonia and 
generalization of the herpesvirus infection (Osterhaus et al., 1985). 
The immunological relationships between European PhHV isolates and herpesviruses of 
terrestrial carnivores have been investigated with panels of monoclonal antibodies (MAbs) 
and with convalescent seal sera. These studies provided evidence for the existence of at least 
two different herpesviruses (PhHV-l, PhHV-2) in European harbour seal populations (Lebich 
et al., 1994). Isolates of the PhHV-1 type were antigenically closely related to, though distinct 
from CHV and FHV. PhHV-2, as yet represented only by a single isolate from a harbour 
seal of the German Wadden Sea, proved to be more distantly related to PhHV-l and the 
herpesviruses of cats and dogs. Serological surveys indicated that herpesviruses which are 
closely related to European PhHV-1 are also present in seal populations of Antarctica and 
the Northern Pacific (Vedder et a/., 1987; Harder et al., 1991a; Stenvers et al., 1992b). 
Here we present the data from a comparative analysis of herpesviruses recently isolated 
from North American and European pinniped species, obtained using a panel of MAbs, and 
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sequence data obtained by amplification of fragments of the gO and gB genes of PhHV-I-like 
viruses. In addition, sequences of EeoRI fragments of the PhHV-l genome are presented. 
Materials and methods 
Virus and cells - Plaque-purified reference isolates of PhHV-1 (PB84, 2557/Han88) PhHV-2 
(7848/Han90) and FHV (6887/Han90) were propagated in Crandell feline kidney cells (CrFK) 
while the CHV isolate 5105/Han89 was grown in Madin-Darby canine kidney (MDCK) cells as 
described (Lebich e/ al., 1994). Seal kidney cell cultures (seKC) were generated and maintained as 
described (Osterhaus e/ al., 1985). Vero cells used to mUltiply two previously undescribed phocid 
herpesvirus isolates (A93-2/2 and A93-2/11) were cultured in Oulbecco's modified Eagle's medium 
(DMEM) containing 2% fetal calf serum (FCS). The origin and cultural properties of newly isolated 
pinniped herpesviruses are summarized in Table 1. 
Replication kinetics of PhHV-l and -2 in CrFK cells - CrFK cells were seeded at 2 x lOs cells 
in 2 ml of medium into roller tubes and incubated stationary overnight. Medium was withdrawn 
and cultures were inoculated with PhHV-1 2557/Han88 or PhHV-2 7848/Han90 at an m.o.1. of 1. 
Adsorption was allowed to occur for two hours at 37°C while rolling. Then cultures were washed 
twice with PBS and reconstituted with 1 ml medium for further stationary incubation at 37°C. At 
set intervals two tubes each were withdrawn. Extracellular virus yield was measured in the pooled 
cell-free supernatants. Debris and cells were reconstituted in 1 ml of fresh cell culture medium and 
frozen at - 80°(. After defrosting and removal of cellular debris the cell-bound viral infectivity was 
titrated. Infectivity was measured in a microtitration assay based on the development of cytopathic 
changes (Frey e/ al., 1989). Titrations of PhHV-1 were incubated for 4 days while those of PhHV-2 
required up to 10 days before cytopathic changes had developed sufficiently. 
Immunological characterization of virus isolates - A selection of MAbs from a panel previously 
raised against European PhHV-1 and -2 isolates, FHV and CHV (8) was used to characlerize 
viral antigens in an enzyme immunoassay using heat-fixed infected cells as described (Lebich et 
al., 1994), except that instead of PBS containing Tween 20 double-distilled water was used in all 
washing steps. 
Preparation of DNA for peR - Herpesvirus-infected cell cultures showing advanced stages of 
viral cytopathic destruction were washed once with cold PBS; cells were then pelleted and lysed 
in 2 x vol. of a buffer containing 50 mM Tris (pH 8.0), 5 mM EDTA and 0.5% (v/v) Nonidet 
P-40 while incubating for 2 minutes on ice. Insoluble residues were pelleted and N-Iaurylsarcosinate 
(NLs, 0.5% [wlv] final concn) as well as Proteinase K (250 pg ml- 1 final concn) were added to 
the supernatant. Proteinase K digestion was allowed to proceed for 2 h at 45°C. Nucleic acids were 
recovered by ethanol precipitation after two phenol-chloroform extractions and reconstituted in 50 
III of double-distilled water of which 5 pi were used for PCR. Uninfected cell cultures (CrFK and 
Vero) were treated identically. 
Primer selection and polymerase chain amplification - Since nucleotide sequences of seal her· 
pesviruses have not been reported yet, primers were selected from sequences of CHV and FHV 
which had been found to be the closest relatives of PhHV-1 at the antigenic level (Lebich e/ al., 
1994). With the available limited sequence data of these viruses (Maeda e/ al., 1992, 1994; Spatz 
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Table 2, Partially degenerate PCR primers based on gB and gO gene equivalent sequences 
of canid, felid and equine (type 1) herpesviruses. 
Product sizes (bp) 
Designation Sequence (5' - 3) Location (CHV) CHV FHV 
gD-l gAA gTT Cgg TAT gT[A/T] AC 142 --> 158 
gD-2 AAT CCC AAT TCA TC[A/g] TC 415 <-- 431 290 287 
gB-l ACA ACT g TA T gg TCT gg 358 --> 374 
gB-2 CAC Cgg Tgg AgA TAg C 709 <-- 724 367 367 
1616 1632 
gB-3 gCT ACA g TT TgC CTA TgA 1431 --> 1448 
gB-4 gg T AgA AAT TCA CgA Tc[C/T] TC 1954 <-- 1973 543 540 
.. Primers were basically choosen from the CHV sequence. Nucleotides marked by a dot were selected 
from the corresponding sequences of FHV. whereas an asterisk marks nucleotides incorporated from 
EHV-I sequences (Whalley et al., 1991). 
+ Data according to Umbach et al., 1994; position 1: translation initiation ATg. 
++ Data according to Maeda et al., 1992, 1994; Spatz and Maes, 1993; Spatz et al., 1994; position 
1: translation initiation ATg. 
& Maes, 1993; Umbach et al., 1994; Spatz et al., 1994). reasonably well-conserved regions were 
pinpointed in genes encoding the glycoprotein equivalents Band D (Table 2). Primers were made 
degenerate at certain positions, also incorporating nucleotides of corresponding sequences of equine 
herpesvirus type-l (Whalley et al., 1991). DNA-PCR (Ampli Taq polymerase, GenAmp 9600: Perkin-
Elmer) was performed following an initial denaturation step at 94°C for 3 minutes and consisted 
of 33 cycles of 30" at 94'C, I' at 37, 45 or 55'C and l' at 72'C. A final elongation step at 72'C 
was allowed for 10 minutes. The PCR mixture consisted of 10 mM Tris-HCI (pH 8.3),50 mM KCI, 
0.1 % (v/v) Triton X-I00, 200 11M of each dNTP, 0.5 nM of sense and antisense primer and 2.5 U 
Ampli Taq polymerase. MgCl 2 was added separately from a stock to give the desired concentration. 
A 5 J~I volume of DNA prepared from tissue cultures was added while 20 pi of DNA solutions 
obtained from clinical specimens were added to give final volumes of 100 pI. Primer specificities 
were checked and PCR conditions optimized using DNA templates extracted from cell cultures 
infected with either CHV, FHV, PhHV-l PB84 or PhHV-2 7848/Han90. Annealing temperatures 
of 37, 45 and 55°C were evaluated as well as Mg2+ concentrations of I, 2. 3 and 4 mM. Other 
viral isolates (see Table 1) were subsequently assayed using the conditions found to be optimal 
with the above templates. Products were separated in agarose gels and visualized after ethidium 
bromide staining. Measures minimizing the risk of carry-over contaminations consisted of physical 
separation of pre- and post-PCR procedures, preparation of templates in a laminar flow cabinet, 
use of master mixes and aerosol-resistant tips. Negative controls (double-distilled water or medium) 
were routinely run in parallel. 
Cloning and partial sequencing of gB and gO gene equivalent PCR products - Products 
obtained from PCRs using gO specific primers with template DNA of four PhHV-l isolates (PB84, 
550/He193, Ja/PB94, A92-10/4) were cloned into a BtickyT plasmid vector (pCR II, InVitrogen). 
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Plasmids containing inserts of the correct size were selected and cycle-sequenced using T7 and 
M13 reverse primers in a DyeOeoxy terminator reaction (PRISM, Applied Biosystems). Samples 
were analysed on an automatic sequencer (model 373A, Applied Biosystems). Similarly, the 1.6 
kB gB specific amplificate of PhHV-I PB84 was cloned and partially sequenced from the 5'-end. 
Three clones of each amplificate were sequenced in order to correct for possible reading errors of 
the Ampli Taq Polymerase. Further sequence analysis was done with the Genetics Computer Group 
(GCG) software package (release 8.0). 
Southern blotting - peR amplificates were separated in 0.7% agarose gels and transferred by 
capillary blotting 6nto positively charged nylon membranes by standard procedures. Non-radioactive 
hybridizations Were carried out using an enhanced chemoluminiscence assay (ECl, Amersham); gB 
or gO specific PCR products reamplified from cloned PhHV-I PB84 PCR fragments were used as 
probes. Hybridization was for 4 h at 42°C. Subsequent washing steps were performed under low to 
moderate stringent conditions according to the manufacturer's recommendations. 
Cloning and sequencing of EcoRI fragments of PhHV-2 - Virions of the PhHV-2 isolate 
7848 were purified as described by Lebich el a/. (1994). DNA was extracted following exactly the 
protocol of Engels el al. (1983). DNA Was digested with EcoRI and fragments were cloned into 
pUC18. Specific clones were identified by non-radioactive colony blotting (ECl, Amersham) using 
full-length virion DNA as a probe. Two clones carrying PhHV-2-specific inserts of 315 and 788 bp 
were sequenced in completion as described abo~e. 
Results 
Biological properties and antigenic relationships of newly isolated 
pinniped herpesviruses from the United States Pacific and Atlantic 
coasts as compared to European PhHV-l and PhHV-2 
Replication kinetics of two reference isolates of PhHV-1 and -2 in CrFK cells were examined. 
Although the experimental design did not allow for single-step growth curves (the m.o.i. 
for both PhHV types was 1), a more rapid replication of the PhHV-I was evident (not 
shown). Virus replication was paralleled by focal appearance of rounded cells followed by the 
complete destruction of cell monolayers. In contrast, the infectivity of the PhHV-2 isolate 
remained mainly cell-associated and the onset of the viral cytopathic effect, characterized 
by the development of round cells and the formation of large syncytia, was markedly slower. 
Titers of cell associated infectivity peaked at about 105.0 TCID50 ml- 1 for both isolates. 
Typing with MAbs allowed a clustering of previously undescribed pinniped herpesviruses 
(Fig. 1). All but one of the American'harbour seal isolates and the California sea lion herpes-
virus (Zalo/CaI86) were classified as PhHV-2. A single MAb (PhHV-2 l.3E5) raised against 
the European PhHV-2 isolate 7848/Han90 discriminated between American and European 
PhHV-2-like isolates. All of the recent herpesvirus isolates from European seals and one 
isolate from an American harbour seal belonged to the PhHV-1 cluster. Minor antigenic dif-
ferences were also evident within this cluster. However, the American PhHV-1 isolate was 
not distinguishable from the European isolates. 
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~n.J8Iao1a1&8 
rals6d against: • 
PhHV·1.J1ka PhHV·2-ike 
• ~,t.t 
.ti"'l ,/Il// 
• PhHV·12&57Man88 
3..2C8, 3.3G8, 3.689 111111111111 111111111111111 
• 111111111111 !!!l !!!l ri!H~ !!!l 2.2F2 
• 111111111111 00000 1.1H3 
• PhHV·2 784&t1anOO 
109AS, 2.6E5 111111111111 111111111111111 
1.SE5 111111111111 IIID!!!lD!!!l 
1.4C6,2.407 !!!l!!!l!!!l!!!l 111111111111111 
1.6CS !!!l!!!lDD 111111111111111 
1.7C8.1.8C3 DD!!!l!!!l 111111111111111 
• FHVFVR605 
1.4A1 111111111111 00000 
1.5HtO !!!l!!!l!!!l!!!l 00000 
I.SH6 DD!!!l!!!l 00000 
• CHV 6105t1an89 
(.6A2,2.3A10 111111111111 00000 
1.207 !!!lD!!!l!!!l 00000 
2.9F6 DD!!!l!!!l 00000 
Figure 1. Reactivities of MAbs raised against various pinniped herpesvirus isolates analysed by 
an enzyme immunoassay employing fixed infected CrFK cells. Cross reactivity gradations were 
evaluated using arithmetic mean values of at least three titration experiments: Strong (M), weak 
("') and not detectable (0)) (titer::; 1:10). The differences in titer discriminating strong and weak 
reactions were at least one ioglO-step. * The PhHV-l isolate 2557/Han88 showed the same pattern. 
+ MAbs neutralized PhHV-l isolates in a complement-enhanced neutralization assay (Lebich et al., 
1994). 
Amplification. cloning and partial sequencing of a 1.6 kB gB equiva-
lent gene fragment of PhHV-l 
Primer specificities in PCR were determined with template DNA prepared from infected cell 
cultures. Suitable conditions for the amplification of a 1.6 kB fragment using partially de-
generate primers gB, and gB. from FHV, CHV and PhHV-l PB84 DNA templates were an 
annealing temperature of 45°C and a 1 mM concentration of Mg'+. PCR using these condi-
tions was attempted with template DNA of all other PhHV isolates. However, amplification 
of a fragment of the expected size which hybridized with the cloned gB specific fragment 
of PhHV-l PB84 was achieved only with CHV, FHV and pinniped herpesvirus isolates anti-
genically typed as PhHV-l (Fig. 2a). Similarly, no specific amplificates were obtained with 
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template DNA extracted from PhHV-2 infected cell cultures using the primer pairs gB, -
gB, or gB3 - gB" respectively (data not shown). The PhHV-l PB84 1.6 kB gB specific 
fragment was cloned and partially sequenced from its 5'-end. Alignments of a stretch of 
500 nucleotides (excluding primer sequences) to gB genes of FHV and CHV confirmed the 
specificity of the amplificate (Fig. 3A). Nucleotide identities of 79% and 75% to CHV and 
FHV, respectively, were observed in that region. 
kB 
2.0 
1.35 -
A 
PhHV·1 PhHV·2 
MFCCr12345VsB789 
16 -r:H~1U11 
Bp 
300-
200-
B 
PhHV·j PhHV·2 
MFCCr 1234 6Ve678 9 
I 
Figure 2. Amplification by PCR and detection by non-radioactive Southern blotting of 1.6 kB 
gB (A) and 290 bp gO (8) gene equivalent fragments from various pinniped herpesviruses and 
herpesviruses of terrestrial carnivores. Template DNA was extracted from infected cell cultures 
and probes were prepared from cloned gB (A) and gD (B) fragments, respectively, of the PhHV-l 
isolate PB84. Washing steps were carried out under moderately (A) or low (8) stringent conditions. 
M - marker, F - FHV 6887/Han90, C - CHV 5105/Han89, Cr - uninfected CrFK cells, 1 - PB84, 
2 - 2557/Han88, 3 - Ja/PB94, 4 - 550/HeI93, 5 . A92/10·4, Ve - uninfected Vero cells, 6 . 
7848/Han90, 7 - Zalo/CaI86, 8 . A92-10/5, 9 - A93-2/11. 
Figure 3 (opposite page). Sequence alignments (excluding primer sequences) of 500 nucleotides 
from the 5'-end of a 1.6 kB gB gene fragment of PhHV·l PB84 (A) and of a 256 bp fragment of the 
gD equivalent gene amplified by PCR from several PhHV·l isolates (B). Alignments of sequences 
were created with 'PileUp' of the GCG software package (release 8.0) setting gap creation weights 
to 3.0 and gap extension weights to 0.1. The sequences of felid herpesvirus (FHV·gB: #549775, 
FHV-gO: #030767) were extracted from the GenBank database; the sequences of canid herpesvirus 
gB and gO were taken from Limbach et al., 1994. Nucleotides identical to the sequence of PhHV-l 
PB84 are shown as dots. Alignment gaps are indicated by dashes (-). 
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1 100 
PBS4 AGC~GTA~GCCGTAGTCACTAACATGCATACTGATAGAGTACCTATAAAGG~CAAGAAATTACAGAATTGATCGATCGTAGGGGTATGTGCC'l'CTCAA 
CHY ••• A. A ••••• A •• • J\.. T ••••• T. GAT •••• A ••• C. T ••••••••• GGT •••• CT ••••••••••• Q ••••• or ••• A. A •• A •••••••• T'l'. A •••• 
FHV •• '1' •• 0 •••••••• TACA •• C ••• CGAT •••• A •• C •• G •• or •• CG.O •• A •••••••• G •••••••• 'l'C.C •• A ••• A.AC •••••••••••••••• G, 
101 200 
PBB4 AGGCTGATTATATTCGCAATAATTACGAGTTTACTGCATTTGATAAAGAT~GACCCCAGAGAAATGCATTTAAAACCCT~TTTAATACAcceGG 
CKV .A •••••••••••••• '1' •••••••• '1' •• A •••• ,C, ••••••••• ,G ••••••••••••••••• • G.T •••••••• G •• '1' ••••• G ••••••••••• A •• 
FHV .J\. • ••••••• Co •••• '1' •• c ••••• TO.A ••••• Q •• C •••••• CO ••• C •• a . . '1' ••••••••• c ••• c. C. Q •••••••• C •• G •• C •• C •• T •• A. A 
.01 300 
PBS4 'HCTCQTGGATGGCATACGACMATGA'l'ACGTATACMMA'rTG<OGAGTCC'l'GGH'HTATCGTACGGGAACA'l'C'l'GTAMTTGTAT'rGTCGAAGAAGTT 
CHY A. ,C, ••••••••••••• AGTT •••••••• '1' •• C ••••••••••• • a . . '1' •••• A ••••••• 11..'1'.'1' •••••••••••••••••••• A •• '1' ••••••••• 
FKV a •• C ••••••••••• C •• C •• C ••••• A •• 11. •• C •••• • a . . C •• TOC.a •••• A ••• C.C.AC'1'.'1' •• G •• C ••••••••••• C •• C •• A •• G ••••• G 
301 '00 
PBB4 QATOCCAGA'1'C'1'GTATATCCATATGATTCC'1"1'TGGCAT'1"1'CAACTGGAGATA'1'AAT'l'CATA~C'l'CCAT'1"1"1'TTGGT'1'TACG'1'GA'1'GGAGCTCATACAG 
CKV •••••••••••••• '1' •••••••••••••• A •••• C'1' •• C •• C •• C •• 0 ••••••••••••••••• C •• '1' •••••••• A ••••• 11. ••••• '1' •••••••• '1'. 
FHV ••••• 11. •••••••••••••••••••• C •• 11. •••• CT •• C •• C ••••• '1' •• CG. G •••• • 0 . ••••••••• • 0 . ..•• GC.GA.G •••••••• C ••• G'1' •• 
'01 500 
PBB4 AACATACTAGC'1'AT'lCAAATGA'1'CGATT'l'CAACAAAT'1'GAGGGT'l'AT'l'A'l'CC'l'A'1'TGAT'H'GGA'1'ACCAGACTACAAGTTGGGQGACCAG'l"l'TCCAGAAA 
CKV •• '1' ••• '1' ••• '1' ••••••• C •••• 11. ••••••••••••• 11. •• 11. •••••••••••••• C •• C •• A ••••• '1' •••••••• GC •••• CTC ••••••••• '1' • • G •• 
FKV •••••••••• '1' ••••• TTCA •• CA ••••••••••••• C ••••• 11. •• c ••••• A •• 11. •• c •••••••• GC •• '1' ••••• c.o •••• C ••••••••• TC .C •• 
B 
i'BB4 
Ja/PB94 
550/H8193 
A92-10/4 
CHV 
FHV 
PB84 
Ja/PB94 
550/H8193 
A92-10/4 
CHV 
FHV 
PBB4 
Ja/PB94 
550/H8193 
A92-10/4 
CHV 
FHV 
1 100 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• '1' 
T ••••• '1' •• C ••••••• A •••••••••••• G •••••• 11.. T •••••••••••••••••••••••••• a ••••••••••• GC .A •• G ••••••• T ••• C •• T 
• •• A. '1'G • •• '1' ••••••• G ••••• G •• A •• G •• A •• A ••••• GO ••••••• CG •••• '1' ••• CG ••• C •• 11. ••• - --C •• TC. C •••••••• ACA •••••• 
101 .00 
GC'1'TCGCT'1'AGTTGG'rTTAAAG'1''1'GQAGA'1'G1t.T'lG'1'ACATATCCllATATAC'1''1'MT'l'AAA'1'A'1'TTTAAT'l'GCGATCC'fCAAMAGAGTTTGGTATATGCT 
.•.....•..••••••• : ••••••••••••••••••••••.... 0 •.•.•...•••••..••••••••••••••••....•••••••••••••..•••• · 
.................................................................................................... 
• .A •• '1' •••••••••••••••••••••••••••••••••••••••••••• '1' •••••• C •••••••• G •••• T •••••••••• G ••• A ••••• C ••••• '1'. 
• • GA. TA.A ••••••••••• G •• MCCC. O. G •••• GA ••• C •• T •• G. '1"1'C. '1' •• GO. TATGAGAC'l' ••• T •••••• 11. •• CGG •• A ••••• 11. ••••• TG 
'01 .56 
TAAAAAGAACACCCGAT'lATTGGAAACCA'1'CATTGATTGGTTATTCTTTTTTAACA 
........................................................ 
· ........................................ ~ ............. . 
• ••••••• '1'. '1' •• A •••• '1' •••••••••••• G •• AG ••••••• CA. A •••••••• '1' 
CTT'l'. C. GT. G •• TTCA •••••• TTGOA. C. T •• A. CAMG ••• ATG •• CC ••••• 
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Amplification. cloning and sequencing of a 290 bp gD gene fragment 
of PhHV-l 
Amplification of a 290 bp fragment from the gO gene equivalent of PhHV-l, CHV and FHV, 
but not from PhHV-2, was achieved using primers gO, - gO" employing conditions identical 
to those used for the gB·fragment. Southern blotting using the gO fragment of PhHV-l 
PB84 as a probe revealed that under low stringent conditions significant hybridization was 
achieved only with PhHV-l isolates and CHV (Fig. 2B). 
Amplificates of four PhHV-l isolates (PB84, 550jHel93, JajPB94 and A92-10j4) were 
cloned and sequenced to detect possible strain differences. The PhHV-l isolates, regardless 
of their geographic or host origin, were highly conserved with only single nucleotide variations 
in the analysed region (JajPB94, 550jHeI93). The sequences of PB84 and A92-10j4 were 
identical. An alignment of these sequences with corresponding regions of FHV and CHV 
gO genes is presented in Fig. 3B and shows that in this gene fragment, PhHV-l shares 
considerable nucleotide identity with CHV (86%) and to a lesser degree with FHV (61%). 
Cloning and sequencing of EcoRI fragments of the PhHV-2 genome 
The nucleotide and deduced amino acid sequences of two EcoRI fragments of 788 (A) and 
315 bp (B), respectively, are presented in Fig. 4. Full-length open reading frames (ORFs) 
extending beyond the cloned fragments were identified using the option 'Frames' included 
in the GCG software package. A 'FastA' (GCG) database search employing the deduced 
protein products revealed significant homologies to proteins of 'Y-herpesviruses (Table 3). 
The ORF identified in fragment A was shown to be equivalent to the product of the Ul52' 
gene family of herpesviruses which encodes a part of the helicase-primase complex (Crute et 
al., 1989). This gene is conserved between all herpesvirus subfamilies. Its representative in 
'Y-herpesviruses is embedded in a gene cluster (referred to as block V) which is conserved 
between the herpesvirus subfamilies with respect to the collinear arrangement of the ORFs 
(Albrecht et al., 1992). 
The ORF identified in clone A mapped to a different region of the 'Y-herpesvirus genome, 
namely the BTRFl gene of Epstein-Barr virus and its equivalents in EHV-2 and herpesvirus 
saimiri type-2 (Table 3). This gene is interspersed between blocks II and III and appears to 
have no counterpart in Q- or Ii-herpesviruses (Albrecht et al., 1992). 
When comparing the similarity and identity values of the deduced amino acid sequences, 
highest scores were generally found between PhHV-2 and EHV-2 (Table 3). 
Figure 4 (opposite page). Nucleotide and deduced amino acid sequences of a 788 (A) and a 315 
bp (B) EcoRI fragment of the PhHV-2 (isolate 7848) genome. Open reading frames were identified 
using the option 'Frames' included in the GCG software. package (release 8.0) (Devereux et al., 
1984). 
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A 
B 
1 NSESPNLMLQEELQGLLDFA 20 
1 GAATTCGGAATCTCCAAACCTGATGCTACAAGAGGAGCTCCAGCGCCTCTTGGATTTTGC 60 
21 A TAP DOG R NeT K G D I F P T V H 40 
61 AGCCACTGCGCCAGATGA'rGGCAGAAACTGCACTAAAGGTQATATCTTTCCTACAGTGCA 120 
41 I N P V F R C Q F L N K N Y F V I V N A 60 
121 CATCAACCCCGTGTTCAGATGCCAGTTCCTAAA~CTACTTTGTGATTGTTAATGC 180 
61 0 I L T Q V W K S T V L L P Q T P N W A 80 
181 AGACATATTAACTCAGGTAT~GCACTGTGCTCCTACCGCAAACTCCCAACTGGGC 240 
81 TTL T D H Q I T E R I F Y K E T F F S 100 
241 TACAACTCTAACAGATATGCAGATAACTGAGCGCATTTTTTACAAAGAGACATTTTTC'rC 300 
101 L N N I K D Q L Q I S R H E ":i F N V R V 120 
301 CTTAAACAACATCAAGGATCAGCTTCAGATATCAAGGCACGAGTACTTTAATGTGAGGGT 360 
121 P V F N L V L D F D L P L G V K G L T L 140 
361 GCCAGTTTTCAACCTGGTGTTAGACTTTGACCTGCCCCTTGGTGTGAAAGGTCTCACTCT 420 
141 fI Q I ":i D VeL A L RED V I Q I L Q L 160 
421 CCATCAAATTTACGATGTGTGCTTGGCTCTCCGAGAGGACGTCATACAGATTTTGCAGCT 480 
161 L G D V D P Q THO V Y F F K sse P p 180 
481 ATTGGGTGATGTTGATCCCCAGACACACCAGGTGTATTTTTT'l'AAG'l'CA'l'CG'l'GCCCCCC 540 
181 LEW D L D E it M FeN C S E it L G L R 200 
541 'l'CTAGAGTGGGACTTGGAT~TGTTCTGCAACTGCTCT~GC'l'AGGACTCAG 600 
201 V V T N L P R G T A I V G S E P LIT L 220 
601 GGTTGTGACAAACCTTCCGAGAGGTACTGCTATTGT'l'GGATCAGAGCCTCTGATCACTCT 660 
221 V K I L N R M V K M N P L F L H L CPT 240 
661 AGTAAAGATTTTAAACAGGATGGTCAAAATGAATCCTCTATTTTTACATCTCTGCCCCAC 720 
241 L L D S E G L L I L EFT IRE R it C V 260 
721 ACTCCTAGATAGCGAAGGCCTTTTGATTCTGGAATTTACCATAA~GGAAGTGTGT 780 
261 R I 262 
181 CAGAATTC 188 
N S T L '1' P I Q T L F I K H V L L K K H 20 
GAATTCTACAC'l'CACCCCAATACAAACACTCTTTAT~CATGTGTTGTTAAAGAAAAT 60 
21 G LEN CIT D F Q N L Y N P H L S T I 40 
61 GGGGCTTGAGAATTGCATTACAGATTTT~CCTCTACAACCCTCACCTCTCCACAAT 120 
41 S E S Q L L E F G K L V A E A K G R V E 60 
121 ATCTGAGAGCCAGTTGCTGGAGTTTGGAAAGCTGGTAGCAGAAGCCAAGGGCCGTGTGGA 180 
61 0 I H F A L N SIS QAT F S K P V L P 80 
181 AGATATCATGTTTGCTCTAAATTCAATATCACAAGCCACA'l'TT'l'CAAAGCCTGTGTTGCC 240 
81 G T D V Q C V H H M E K r F W H F P P V 100 
241 AGGAACAGACGTGCAATGTGTTATGATGATGGAGAAGTACTTTTGGATGTTCCCACCCGT 300 
101 D P H N 105 
301 TGATCCCATGAATTC 315 
Ghapter 2 
Table 3: Relationships of amino acid sequences predicted from two fcoRI fragments of the 
PhHV-2 isolate 7848. 
PhHV-2 fragment Virus species Gene equivalenta. Comparison of ORFs b 
%Similarity %Identity Gaps 
fcoRI 788 bp Equine herpesvirus-2 ORF 56 63.6 47.9 4 
(262 aa) Herpesvirus saimiri-2 EDRF4 67.7 46.5 3 
Epstein-Barr virus BSLF1 60.0 36.5 5 
Human cytomegalovirus UI70 54.0 33.2 9 
Equine herpesvirus-! ORF 7 55.0 29.2 13 
Varicella zoster virus ORF 6 49.8 28.6 11 
fcoRI 315 bp Equine herpesvirus-2 ORF 23 69.2 44.2 1 
(105 aa) Epstein-Barr virus BTRF1 62.5 42.3 1 
Herpesvirus saimiri-2 ORF 23 54.8 35.6 1 
<l Sequences for comparisons were extracted from the SwissProt or the GenBank databases: EHV-
2 #U20824; HVS-2 #QOlO06, #P14346; EBV #P30119, #P03193; HCMV #Pl7149; EHV-1 
#P28962; VZV #P09270. 
b Deduced amino acid sequences were compared by using the 'Gap' program of the GCG software 
package, setting gap weight and gap extension values to 3.0 and 0.1, respectively. The calculation 
of similarity values is based on the Dayhoff matrices (Dayhoff et al., 1983). 
Discussion 
Herpesvirus isolates obtained during the last decade from different pinniped species in widely 
separated populations were analysed. Two types of pinniped herpesviruses could be readily 
distinguished by means of their antigenic and genetic properties. As all but one of the isolates 
were retrieved from species of the family Phocidae their designation as phocid herpesvirus 
(PhHV) type-1 and type-2 seems to be justified. Both types were isolated from seals ranging 
in European waters as well as in coastal United States waters. While no antigenic differences 
between American and European PhHV-1 isolates were observed, the European PhHV-2 
isolate 7848/Han88 differed in at least one epitope from the American PhHV-2 viruses. The 
PhHV-2 isolate Zalo/CaI86, retrieved from a captive Californian sea lion, a member of the 
family Otariidae, was not distinguishable from other American PhHV-2 isolates of harbour 
seal origin by means of MAb typing. Interspecies transmission from clinically healthy harbour 
seals, which were housed in the immediate vicinity of the sea lion could not be excluded. 
However, PhHV-2 has so far only been isolated from cultivated leucocytes (lebich et al., 
1994; this study) or explant lung tissue cultures (Kennedy-Stoskopf et al., 1986), which 
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together with its replication kinetics in CrFK cells indicates that its infectivity is highly cell-
associated. This does not favour interspecies transmission as a likely cause of infection of the 
sea lion. The significance of the fact that PhHV-1 has mainly been isolated from European 
seals while all but one of the American isolates have been identified as PhHV-2 cannot 
be readily explained at present. Type-specific serosurveys could be performed to gain more 
insight in the prevalences of the different pinniped herpesvirus types. 
The use of partially degenerated primers selected from conserved regions of the gB and gO 
homologous genes of CHV, FHV, and EHV-1 enabled the amplification of gB and gO specific 
sequences from PhHV-1 by PCR. No fragments were amplified from PhHV-2. This emphasizes 
once more the more distant relationship of PhHV-2 to these viruses. We have taken advantage 
of the PhHV-1 gO PCR amplification for diagnostic purposes, by showing that it was more 
sensitive in diagnosing acute PhHV-l infections than virus isolation procedures, carried out 
with clinical samples from harbour seals during an acute outbreak of respiratory disease. 
This newly developed PCR analysis may also be useful for the diagnosis of CHV and FHV 
infections (T.Harder and others, unpUblished). Sequencing of a 290 bp fragment of the 
gO gene of several PhHV-1 isolates showed that, in spite of their different geographic and 
host origins, these viruses were identical except for a single nucleotide in that fragment. By 
comparison with gO genes of a number of herpesviruses, PhHV-1 was shown to share a high 
degree of homology with members of the genus Varicellovirus and CHV in particular. Similar 
results were found with gB specific sequences of the PhHV-1 isolate PB84. These results 
confirm earlier studies on the serological characterization of PhHV-1 as a putative member 
of the genus Varicellovirus (Osterhaus et al., 1985; Frey et al., 1989; Harder et al., 1991a; 
Stenvers et al., 1992b; lebich et al., 1994). 
The taxonomic status of PhHV-2 was elucidated by sequence analysis of two EcoRI frag-
ments. A clear clustering with ,-herpesviruses was found on the basis of a database search 
using the deduced amino acid sequences of single ORFs identified in each fragment. The se-
quences obtained proved to be unique when compared to other ,-herpesvirus species where 
equivalent sequence data were available (Epstein-Barr virus, herpesvirus saimiri type-2 and 
EHV-2). PhHV-2, therefore, could represent a hitherto undescribed ,-herpesvirus. On the ba-
sis of the limited sequence data, the closest relative of PhHV-2 amongst the 1'-herpesviruses 
could not be unambiguously identified, although the highest similarity/identity scores were 
mainly encountered with EHV-2. Additional sequence data from different genome parts will 
be required for a definite taxonomic grouping. A clinical correlate of PhHV-2 infection in 
seals has not been identified so far. 
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2.3 - PhHV-1: Disease and diagnosis 
Abstract - The prevalence and clinical signs of phocid herpesvirus type-l (PhHV-1) infections 
amongst harbour seals (Phoca vitulina) in a seal rehabilitation center in the Netherlands were 
monitored between June and September 1993 and 1994 when 34 and 36 seals, respectively, were 
rehabilitated. In both years PhHV-l related disease outbreaks occurred in the pupping season. 
PhHV-l infections were diagnosed by demonstration of a more than four-fold increase in virus 
neutralizating serum antibodies in paired serum samples, by the isolation of the virus from swab 
samples in primary seal kidney cells, and by the detection of PhHV-l DNA with a polymerase chain 
reaction (peR) assay in swab samples. This assay targets a 290 bp fragment of the glycoprotein 
D (gD) gene equivalent of PhHV-1. The PCR assay when combined with Southern blotting (PCR-
SB) was approximately thousand times more sensitive than virus isolation when tested with serially 
diluted samples from PhHV-l infected cell cultures. In contrast with virus isolation, the peR-S8 
scored as positive all the animals with serological evidence of PhHV-l infection. The majority of 
seals present in the center during the outbreaks contracted the infection and developed benign 
upper respiratory disease. However, the severity of PhHV-l related disease was inversely correlated 
with age and fatal generalized infections occurred only in neonates. 
Introduction 
Two types of pinniped herpesviruses have been distinguished. They were recovered from 
members of the Phocidae family and are referred to as phocid herpesviruses type-1 and 
type-2 (PhHV-l, -2) (Osterhaus et al., 1985; Frey et al., 1989; Lebich et al., 1994). PhHV-l 
was shown to be antigenicafly closely related to felid and canid herpesviruses (Osterhaus 
et al., 1985; Lebich et al., 1994), whereas PhHV-2 appeared to be more distantly related 
to both PhHV-l and herpesviruses of terrestrial carnivores: Recently, nucleotide sequence 
data have been obtained for PhHV-l and PhHV-2 which suggest a taxonomic clustering of 
these viruses within the Varicellovirus genus of the a-Herpesvirinae subfamily and within the 
,,/-Herpesvirinae, respectively (Harder et al., 1996a). 
Infections with PhHV-1 in harbour seals (Phoca vitulina) have been associated predomi-
nantly with benign upper respiratory disease, but an enzootic outbreak with high mortality 
among newborn seals has been described in the population present at a seal rehabilitation 
and research center (Osterhaus et al., 1985; Borst et al., 1986). During the 1988 seal mass 
mortality in north west Europe, caused by phocid distemper virus (PDV), generalized PhHV-l 
infections were frequently detected in fatafly diseased, PDV-infected adult seals (Osterhaus 
& Vedder, 1988; Frey et al., 1989; Zhang et al., 1989). Upon experimental inoculation with 
a tissue culture-propagated PhHV-l isolate subadult harbour seals seroconverted, but apart 
from a moderate temperature rise no overt clinical symptoms developed (Horvat et al., 
1989). No association of PhHV-2 infection with disease in pinniped populations has so far 
been reported. 
The paper describes investigations of the prevalence and clinical signs of PhHV-l infec-
tion among harbour seals of different ages at the seal rehabilitation and research center of 
Pieterburen in 1993 and 1994, and compares the result of different diagnostic methods. 
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Materials and methods 
Seals - The center aims to rehabilitate weakened, orphaned or diseased seals which are found 
along the Dutch coast. The majority of the animals rehabilitated at the center are newborn harbour 
seals or grey seals (Halichoerus grypus), which are admitted during pupping seasons in June/July 
and December, respectively. During the present study, an additional group of 22 adult harbour 
seals, all seropositive for PhHV-l, was kept at the center, for immunotoxicological investigations 
(De Swart et al., 1994). However, animals of this group were physically separated from the seals 
housed for rehabilitation. The survey was restricted to 52 harbour seals and one ringed seal (Pusa 
hispida). Thirty-three harbour seals were present at the center between June and October 1993 and 
19 during the same period of 1994. From each animal a complete set of samples (swabs [eyes, nose 
and throat], a heparin blood sample and paired serum samples) was available. The total numbers 
of seals present at the center at these times were 34 and 36, respectively. 
Detection of PhHV infection by virus isolation and serological assays - Virus isolation pro-
cedures were applied to swab samples using primary harbour seal kidney cells (SeKC) as described 
by Osterhaus et al. (1985). Isolates were subsequently antigenically characterized using a recently 
established panel of murine monoclonal antibodies (MAbs) in an immune-peroxidase monolayer 
assay (IPMA) (Lebich et al .• 1994). 
Virus neutralizing (VN) antibody titers against the PhHV-1 isolate PB84 were measured in paired 
serum samples as described (Osterhaus et al., 1985). A more than four-fold rise of PhHV VN titer 
Was scored as evidence for active PhHV-1 infection. 
All swab samples were also checked for evidence of morbillivirus infections as previously described 
by Visser et al. (1989). 
Origin of clinical specimens for the evaluation of a peR assay - Nose, throat or eye swabs were 
collected from six harbour seals and one ringed seal, which were hospitalized in 1993 or 1994, during 
outbreaks of upper respiratory disease. Retrospectively, these seals were shown to have experienced 
active PhHV-l infection on basis of seroconversion and/or virus isolation. In addition, throat swabs 
from ten harbour seals which proved to be negative in virus isolation assays and did not seroconvert 
to PhHV-1 during the outbreaks were included. As controls, nasal and throat swab samples of six 
clinically healthy grey seal pups were sampled in 1995 when no signs of PhHV-1 related disease 
were observed in the seal population at the center. These grey seals did not seroconvert to PhHV-1 
durin'g their stay at the center. 
The swabs were kept refrigerated in 4 ml of DMEM supplemented with penicillin (300 i.u ml- I ) 
and streptomycin (300 I'g ml- I ). An aliquot (1.0 ml) was inoculated into SeKC and Vero cell 
cultures for virus isolation within four days after sampling. The remaining fluid was frozen at _800 ( 
for up to fifteen months until used for DNA isolation as described below. 
Preparation of DNA for peR assay - DNA was recovered from diagnostic swab samples of seals 
by adapting a silica-based technique as described by Boom et al. (1990). Briefly, 100 I" of a sample 
were mixed with 1 ml of lysis buffer (120 g guanidine isothiocyanate in 100 ml 0.1 M Tris HCI 
[pH 6.4]. to which 22 ml 0.2 M EDTA [pH 8]. 2.6 g Triton X 100 and 40 1'1 acidified Celite silica 
(Janssen Chimica) were added. After incubation for 10 minutes at room temperature the silica was 
pelleted and washed twice in lysis buffer lacking EDTA and Triton. Additional washing steps in 70% 
ethanol, and acetone, were carried out, after which the silica pellet was vacuum-dried. DNA was 
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released by adding of 10011i of TE-buffer (10mM Tris HCI pH 8.0, 1mM EDTA) and incubating at 
56°( for ten minutes. For the peR, aliquots of 20 III were used. 
As a control, PhHV-l DNA (reference isolate P884) was prepared from infected Crandell Rees 
f~line kidney (CrFK) cell cultures as described by Harder et al. (1996a). 
Primer selection and polymerase chain amplification - Primers were selected from conserved 
regions of the gO equivalent genes of felid and canid herpesvirus (Limbach et al., 1994; Maeda et 
al., 1994), which were found to be the closest relatives of PhHV-1 at the antigenic level (Lebich et 
al., 1994). The DNA PCR, using primers gD, (5'- gAA gTT Cgg TAT gT[A/T] AC - 3') and gD, 
(3'- gA[C/T] gAT gAA TT g ggA TT - 5') was essentially as described (Harder et al., 1996a), and 
produced specific amplificates of 290 bp from PhHV-l but not from PhHV-2 templates. 
The products were separated on agarose gels and visualized after staining with ethidium bromide. 
Non-radioactive Southern blotting was used to confirm the specificity of the amplificates (Harder 
et al., 1996a). A cloned gO fragment of the PhHV-1 reference isolate was used as a probe in 
chemoluminiscent assays (Eel, Amersham). 
Measures to minimize the risk of carry-over contaminations consisted of physical separation of 
pre- and post-peR procedures, the preparation of templates in a laminar flow cabinet, and the 
use of master mixes and aerosol-resistant tips. Negative controls (bidistilled water or tissue culture 
medium) were routinely run in parallel. 
Clinical scoring of PhHV-l related disease - The serological results obtained from an exami-
nation of paired serum samples were used as a 'golden standard' for diagnosis of active PhHV-I 
infection. Seals with a serologically confirmed PhHV-1 infection during the 1993 and 1994 outbreaks 
were grouped arbitrarily according to the severity of the disease. Group 0 seals showed no clinical 
signs. Seals of group 1 showed mild clinical signs consisting of anorexia, mucous nasal and/or ocular 
discharge and rectal temperatures of up to 38.5°C. These seals recovered" completely within one 
week at most. Group 2 animals suffered more severe signs of disease, including mucupurulent nasal 
and ocular discharge, epistaxis, lower respiratory disease (dyspnoe, coughing), and in some cases 
gastrointestinal symptoms such as vomiting and diarrhea. Their rectal temperatures frequently ex-
ceeded 38.5°C. They recovered completely with palliative antibiotic treatment within two weeks. 
The seals which succumbed to the infection were classified in group 3. 
Results 
Virus isolation and serology 
Outbreaks of an apparently contagious disease, mainly characterized by upper respiratory 
symptoms, were noticed among the harbour seal pups during the summer months of both 
years. In 1993 an active PhHV-1 infection was confirmed by seroconversion in 24 of 34 seals 
of all age groups (Tab. 1). 
Nineteen of these animals developed overt clinical symptoms. Ten seals were apparently 
not infected during their stay at the center and did not show clinical symptoms suggestive 
of the infection. Most of the PhHV-1 isolates were recovered from swab samples. In some 
animals swabs from eyes, nose and throat proved virus isolation positive, but in others only 
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Table 1. Detection of active PhHV-I infection in captive harbour seal populations. 
Season 
June-August '93 
August-September '94 
PhHV-1 isolation 
10"/34' 
14/19 
Seroconversion 
24/34 
19/19 
Disease 
19/24' 
18/19 
a Number of positive animals; b Number of animals examined; C Number of animals with serologically 
confirmed active PhHV-l infection. 
one swab sample was positive with no clear preference for the location. Leukocyte-associated 
viremia could not be detected in any of the animals studied. However, in three newborn seals 
which succumbed to the disease in 1993, generalized PhHV-I infection was demonstrated by 
virus isolation from different tissue specimens including lung, kidney, liver or CNS. 
Within the group of 22 PhHV-I seropositive adult seals kept separate from other seals, no 
clinical signs indicative of PhHV-I infection were observed during the outbreaks. However, in 
seven adult seals more than four-fold increases in PhHV-I VN titer coincided with PhHV-I 
related disease outbreaks in the groups of seal pups. 
The patterns of reaction of the panel of 32 MAbs with the PhHV-I isolates obtained in 
1993 and 1994 were identical to those obtained with the strains isolated in 1984 (Osterhaus 
et al., 1985) and during the mass mortality of seals in 1988 (Lebich et al., 1994; data not 
shown). 
No morbilliviruses were isolated from the materials used for PhHV-I isolation. 
Diagnosis of PhHV-l infection by peR 
To determine the sensitivity of the Ph HV-I PCR assay, serial ten-fold dilutions of supernatant 
from a CrFK cell culture infected with PhHV-I PB84 were examined. As shown in Fig. I, 
a positive signal was still obtained in the 10-5.0 diluted sample. Titration of the same serial 
ten-fold dilutions in CrFK cells revealed a titer of 101.9 TCID50 per 20 1'1 of the undiluted 
stock. Thus, the detection limit of the PCR assay with Southern blotting (PCR-SB) was 
10-3 .0 TClD50 • 
The suitability of this PCR assay for the detection of PhHV-I DNA in clinical specimens 
was investigated with swab samples from the eye, nose or throat of six harbour seals and 
one ringed seal which had all seroconverted to PhHV-I (Fig. 2, panel A). The gO fragment 
was detected in all the samples from which PhHV-I had been isolated. Furthermore, six 
samples which were virus isolation negative were positive in PCR-SB. All seals, except the 
adult harbour seal PB93-Cath. and the subadult ringed seal of this group showed signs of 
respiratory disease at the time of sampling. indicating that they were asymptomatic virus 
shedders. 
PhHV-l DNA was not detected by PCR-SB in swabs taken from six clinically healthy grey 
seal pups sampled as controls when no evidence for a PhHV-I infection was found (Fig. 2, 
panel B). Swab samples from ten further clinically healthy harbour seals of the 1993 season 
which remained negative in virus isolation assays and did not seroconvert to PhHV-l also 
scored negative in the PCR-SB (not shown). 
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Figure 1. Detection limits of a PCR targeting a 290 bp fragment of the gO gene of PhHV-1 
combined with Southern blotting. Template DNA was purified from 20 III of serial tenfold dilutions 
of a supernatant from a CrFK cell culture infected by PhHV-l PB84. A parallel titration of viral 
infectivity (bottom line) revealed a titer of 101.9 TCIDso per 20 I" of the undiluted stock. W: cell 
culture medium control, +: corresponding gD fragment of PhHV-l isolate PB84 amplified in a 
separate peR reaction. Non-radioactive Southern blotting was carried out with a probe prepared 
from the cloned gO fragment of PhHV-1 PB84. 
a Number of virus-positive/total wells in a microtitration assay based on the development of cyto-
pathic alterations. 
Correlation of PhHV-l disease severity with age 
In Fig. 3 the seals with serologically confirmed active PhHV-l infection are grouped according 
to their age and the severity of their clinical symptoms. Pups up to one month old were 
distinguished from juveniles aged one to twelve months and subadults or adults more than 
twelve months old. The severity of PhHV-l related disease appeared to be inversely correlated 
with age. The fatal cases were restricted to three newborn animals. 
Figure 2. peR amplification and non~radioactive Southern· blot detection of a 290 bp fragment 
of the gO gene equivalent of PhHV~ 1 from diagnostic swab samples obtained from from harbour 
seals (Phoca vitulina) and a ringed seal (Pusa hispida) during outbreaks of respiratory symptoms 
in a seal sanctuary in 1993/1994 (panel A). Clinically healthy grey seal pups (Halichoerus grypus) 
were sampled as controls in 1995 when no evidence of PhHV-l related disease was noticed in the 
sanctuary's seal population (panel B). DNA was prepared from 100 Jd of swab fluid. An equivalent 
of 20 JlI was used for peR. The results of virus isolation attempts on SeKC cultures using 1 ml of 
fresh swab fluids is indicated in the bottom line. Before use in PCR, samples of panel A had been 
stored at -BO°C for up to 15 months while other samples were processed within four days after 
sampling. (Continued overleaf ... ) 
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Figure 2 (continued from previous page): 
Panel A: 1,2 - Pusa hispida PB94-15 (throat, eye); 3 - 7: samples from Phoca vitu/ina: 3 - PB94-22 
(nose); 4 - PB94-23 (throat); 5 - PB94-24 (nose); 6 - PB94-40 (nose); 7,8 PB93-Jac. (nose, eye); 
9,10,11 PB93-Cath. (nose, throat, eye); W - Swab medium control. 
Panel B: All swab samples (throat, nose) from Halichoerus grypus: 1,2 - PB95-27; 3,4 - PB95-12; 
5,6 - PB95-04; 7,8 - PB95-02; 9,10 - PB95-30; 11,12 - PB95-07; W - Swab medium control; + -
DNA sample extracted from CrFK cells infected by PhHV-l isolate PB84. 
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Figure 3. Disease symptoms associated with PhHV-l infection in harbour seals of different age 
groups. Clustering according to the disease symptoms is described in Materials and methods. Three 
age groups were distinguished: A - neonates: up to one month, B - juveniles: one to twelve months 
and C - subadults and adults older than twelve months. 
Discussion 
Three different methods for the laboratory diagnosis of PhHV-l infections in pinnipeds have 
been compared in animals in which the clinical signs were largely dependent on the age. 
During the two pupping seasons studied PhHV-l was by far the most frequently detected 
viral agent in this population, which is routinely vaccinated against PDV (Visser et al., 
1989). The inverse correlation between PhHV-l associated disease and age is reminiscent of 
a-herpesvirus infections of terrestrial carnivores, for example canid herpesvirus (Appel 1987). 
The results are also in line with earlier studies in which the experimental PhHV-l inoculation 
of susceptible juvenile harbour seals resulted in no apparent infection (Horvat et al., 1989). 
The asymptomatic PhHV-l infections observed in the adult seals were most probably due 
to the reactivation of latent virus. During the 1993 outbreak three newborn pups (12.5% 
of actively PhHV-l infected seals) died in the course of the infection. This mortality rate is 
low when compared to the first recognized PhHV-l enzootic in 1984, when up to 50% of 
the diseased neonates died (Osterhaus et al., 1985). Although it cannot be excluded that 
PhHV-l strains with different pathogenic potentials may have been co-circulating and that 
the recent outbreaks may have been caused by milder strains, no significant differences in 
the antigenic make-up between the isolates obtained in 1984 and in 1993/94 were detected. 
Howver, since 1984 knowledge of and experience with quarantine measures, veterinary care 
and nursing of seal pups have greatly improved, and the changes may have contributed to 
the reduction in losses. They may also explain why in 1993 10 out of 34 seals did not become 
infected during their stay at the center. 
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The origin of the PhHV-1 strains responsible for the outbreaks could not be identified. As 
in herpesvirus infections of terrestrial carnivores (Appel 1987), pups may be infected directly 
after birth and thus may have carried the virus when they were admitted to the center. 
Although experimental evidence for latency of PhHV-1 in seals is lacking, the epidemiological 
importance of seals which are seropositive to PhHV-1 after loss of maternal antibodies, should 
not be underestimated, because these animals may be latent virus carriers and shed the virus 
after reactivation. 
The accurate etiological diagnosis of herpesvirus infections in marine mammals by virus 
isol.ation procedures is often hampered by the unsuitability of many diagnostic samples as 
a result of advanced decay and bacterial contamination. The PhHV-1 gO-specific PCR-SB 
was approximately thousand-fold more sensitive than virus isolation. This factor may even 
be higher when clinical specimens are analysed after storage at suboptimal conditions, which 
would be expected to affect herpesviral infectivity more than the integrity of template DNA. 
Indeed, the PCR-SB was more sensitive than virus isolation procedures in SeKC cultures 
for detection of PhHV-1 infection in archived clinical specimens from seals. The limited 
accessibility of permissive cell cultures is another reason why PCR-SB may be favoured for 
the rapid diagnosis of active PhHV-1 infection in individual seals. The reported inability to 
diagnose PhHV-2 infections in this way (Harder et a/., 1996a) is of less clinical relevance, 
because infection with this virus has so far not been associated with disease in seals. For 
studies of PhHV-1 infections in seal populations, the testing of paired serum samples for 
specific antibodies will probably remain the method of choice. 
Newborn seals were especially at risk of fatal PhHV-1 infection. Harbour seal pups orphaned 
before uptake of colostrum may be particularly threatened because the maternal antibodies 
confering temporary protection are mainly transmitted through the colostrum (Ross et a/., 
1994). As a result, passive immunization with convalescent seal sera can be useful to prevent 
serious disease during the first weeks of life in a rehabilitation setting. Active immunization 
with a non-replicating vaccine could also be considered at an early age, since harbour seals 
have been shown to be immunocompetent from birth (Ross et al., 1994). In light of their 
close antigenic relationship with herpesviruses of terrestrial carnivores (Lebich et a/., 1994), 
inactivated or subunit vaccines derived from canid or felid herpesviruses might be of value 
until a homologous PhHV-1 vaccine become available. 
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2.4 - Phocid herpesvirus-l glycoprotein B 
Abstract - A glycoprotein B (g8) gene homologue was identified in a 5A-kB BamHI genomic 
fragment of the phocid herpesvirus type-! (PhHV-l) which represents a widespread and important 
pathogen of pinnipeds. Sequence analysis revealed a gB-specific open-reading frame comprising 
881 amino acids. Phylogenetic analysis gave evidence for a close evolutionary relationship between 
PhHV-l and members of the VariceJ/ov;ru5 genus of the o'-Herpesvirinae and canid herpesvirus in 
particular. In PhHV-l infected Crandell feline kidney cells gB is expressed as a 113-kDa glycosy-
lated molecule which is proteolytically cleaved into at least two fragments of 67 and 53-59 kDa 
apparently forming disulfide-linked heterodimers of 140~kOa. Cell surface expression of PhHV-l 
gB was confirmed by FACS analysis. Thus, synthesis and processing of the gB protein of PhHV-l 
follows a pattern also observed in other Varicelloviruses. Since the gB protein of herpesviruses, 
expressed in the baculovirus system, has been shown to be a suitable target for vaccine design, 
we used this system for expression of PhHV-l gB. Recombinant (rec), baculovirus-expressed gB 
was identified as a l05-kOa glycosylated molecule. Proteolytic cleavage into fragments of 62 and 
52 kDa was markedly delayed as compared to wild-type (wt) gB. Wt and rec gB harboured endo-
glycosidase H (precursor)- as well as N-glycosidase F-sensitive N-glycans (proteolytic fragments). 
Baculovirus-expressed gB appeared to be antigenically authentic, since it was recognized in ra-
dioimmunopredpitation and immune peroxidase monolayer assays by PhHV-l-neutralizing seal sera 
and by gB-spedfic neutralizing murine monoclonal antibodies. Furthermore, PhHV-l neutralizing 
antibodies were induced in mice following immunization with baculovirus-expressed gB, indicating 
its suitability for incorporation in a candidate vaccine for seals. 
Introduction 
Two species of authentic herpesviruses of pinnipeds, designated 'phocid herpesvirus type-l 
and type-2, (PhHV-l, -2) have been described (Osterhaus et al., 1985; Lebich et al., 1994; 
Harder et al., 1996a). On the basis of partial sequence analysis, PhHV-l was tentatively 
associated with the Varicellovirus genus of the a-Herpesvirinae whereas PhHV-2 clustered 
with ,-Herpesvirinae (Harder et al., 1996a). 
While PhHV-2 infections have not been associated with disease in seals, PhHV-l represents 
an important pathogen: Following primary infection, self-limiting upper respiratory disease 
is most frequently observed. Neonate seals and immunocompromised animals, however, are 
prone to fatal generalization of the infection (Osterhaus et al., 1985, Frey et al., 1989). Se-
rosurveys indicated high prevalences of PhHV-l or other closely related herpesviruses among 
different seal species worldwide (Vedder et al., 1987; Harder et al., 1991a; Stenvers et 
al., 1992b; Stuen et al., 1994). In seal rehabilitation centers recurrent annual outbreaks of 
PhHV-l infections causing losses of pups pose a severe problem and raise demands for a 
vaccine conferring protection against disease (Osterhaus et al., 1985; Borst et al., 1986; 
Harder et al., 1997). 
Herpesvirus membrane glycoproteins (gps) mediate essential functions during the replicati-
on cycle and are important determinants of viral pathogenesis (Spear, 1993). Among several 
gps which proved to be indispensable for viral replication of a-herpesviruses in vitro, the 
glycoprotein B (gB), in concert with other gps, plays an essential role during the penetration 
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process of virus into the host cell cytoplasm by a fusion event between the virion envelope 
and the host cell membrane as well as for virus spread by cell-to-cell fusion (Cai et al., 1988; 
Pereira, 1994). Representatives of the gB family are expressed by members of all herpesvirus 
subfamilies and show considerable sequence and structural homologies (Gong et al., 1987; 
Griffin, 1991; Niikura et al., 1992; Maeda et al., 1992; Ellinger et al., 1993; Goltz et al., 
1994; Limbach et al., 1994). Therefore, gB has also become an interesting tool for studies 
on herpesvirus evolution (Karlin et al., 1994a; McGeoch & Cook, 1994). Furthermore, gB 
represents a prominent target of both humoral and cellular immune responses particularly 
against a-herpesvirus infections, and in the mouse model of herpes simplex virus-l (HSV-l) 
infection immunity solely to gB has been shown to confer protection against lethal challenge 
(Ling Chan et aI., 1985; Cantin et aI., 1987; Blacklaws & Nash, 1990; Ghiasi et aI., 1992; 
Eis-Hubinger et aI., 1993). Thus, gB is considered a major constituent in the development 
of herpesviral subunit vaccines (Inglis, 1995). 
Here we present the nucleotide and deduced amino acid sequences of the gene encoding 
the gB equivalent of PhHV-l and show that it can be expressed in a baculovirus system as 
an antigenetically and immunogenically intact protein. 
Materials and methods 
Virus and cells - Crandell feline kidney cells (CrFK), maintained in Dulbecco's modified Eagle's 
medium supplemented with 10% fetal calf serum, were used for culturing PhHV-l (isolate PB84). 
A modified Autographa californica multiple nuclear polyhedrosis virus (AcMNPV-BacPAK 6) ex-
pressing f3-glucuronidase (Kitts and Possee, 1993; obtained from Cion tech) and other recombinant 
baculoviruses were grown and assayed in Spodoptera rrug;percla clone 9 (Sf 9) monolayer cultures 
according to standard procedures (O'Reilly et al., 1992). 
Purification and restriction endonuclease digestion of PhHV-l DNA - PhHV-l viral DNA 
was extracted from mature extracellular virions enriched by ultracentrifugation through a sucrose 
cushion as described previously (lebich et al., 1994). Recovery of DNA followed the protocol of 
Engels et al. (1983). Aliquots of approximately 1 ,'g of viral DNA were endonuclease-digested, 
separation of fragments was by electrophoresis in 0.7% agarose slab gels at 1.0 V Icm overnight, 
and fragments were visualized after ethidiumbromide staining. 
Southern blot hybridization - Restriction fragments of PhHV-l DNA were separated in 0.7% aga-
rose gels and blotted using standard procedures (Sambrook ef al., 1989). A 1.6-kB PCR amplificate 
derived from the PhHV-l (isolate PB84) gB equivalent gene served as a probe in non-radioactive 
hybridizations (ECl, Amersham). Selection of degenerate primers (upstream: 5'- ACA ACT gTA 
Tgg TCT gg ; downstream: 5' - ggT AgA AAT TCA CgA TC[C/T] TC) from conserved parts of 
the canid and felid herpesvirus (CHV and FHV) gB genes as well as PCR conditions were exactly 
as described previously (Harder ef al., 1996a). 
Cloning and DNA sequencing - A 5.4-kB BamHI restriction fragment of the PhHV-I PB84 
genome hybridized to the gB specific probe and was cloned into pBluescript SK+ phagemid (Stra-
tagene). Nested sets of deletions Were generated from the 5'- end of the insert using an exonuclease 
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III system (Erase-a-BaseR, Promega). Deletion mutants were cycle-sequenced using dye-dideoxy ter-
minator reactions (PRISMR, Applied Biosystems) and analyzed on an automatic sequencer (373A, 
Applied Biosystems). Specific primers (17mers) were then selected to sequence the complement 
strand. Sequences were finally assembled and further analyzed using the GCG software package, 
Release 8.0 (Devereux e/ al., 1984). 
Construction of transfer vectors and recombinant baculoviruses - The entire ORF encoding 
the PhHV-1 gB gene was amplified by PCR from full-length viral DNA. Primers were selected ac-
cording to the newly established sequences (upstream: 5'- CgC ggA Tee AgT TAT gTA TTT AAT 
TAC; downstream: 5'- Cgg eTe gAg TTA gTT ATT AAA CCT CAT C). Italics indicate BamHI 
and Xhol restriction sites enabling directional cloning of the amplificate into baculovirus transfer 
plasmid pBacPak8 (Cion tech) downstream of the polyhedrin promoter (plasmid pBacPBgB). PCR 
was performed employing a modified polymerase (Expand High FidelityR, Boehringer Mannheim) 
to improve the fidelity of the reaction (Barnes, 1994). Sequence integrity of the BamHI-Xhol gB 
insert was confirmed using specific 17~mer primers. Liposome-mediated co~transfection of Sf 9 in~ 
sect cells with linearized baculovirus BacPAK 6 DNA (lacking a Bsu36 I fragment) and pBacPBgB 
according to the manufacturer's recommendations (Cion tech) yielded recombinants which were 
plaque-purified. Recombinants were screened for the 2.7-kB gB ORF by PCR using primers Bac 
1 (5'-ACC ATC TCg CAA ATA AAT AAg) and Bac 2 (5'-ACA ACg CAC AgA ATC TAg Cg) 
(Cion tech) located in the polyhedrin promoter and terminator regions, respectively. Selected re-
combinants were further plaque-purified and expanded for expression analysis. 
Northern blot hybridizations - The full length 2.7-kB PCR amplificate of the PhHV-1 gB was 
used as a probe in a non-radioactive Northern blot assay (ECL, Amersham). Total RNA was ex-
tracted from mock-infected and PhHV-1 (PB84) infected CrFK cells (24 hr post inoculation, p.i.). 
Hybridization at 42"C was allowed for 16 hr. Subsequent washing steps were carried out under high 
stringency conditions. 
Immune peroxidase monolayer assay (IPMA) - Semiconfluent Sf 9 cell cultures were infected 
with recombinant BacPBgB or BacPAK 6, or were mock-infected. CrFK cell cultures, infected with 
wt PhHV~l PB84 or mock-infected, were prepared in paraltel. After 3 days of incubation confluent 
monolayers were heat-fixed at 80"( for 2 hr. Serial twofold dilutions in PBS containing 0.05% 
(v/v) Tween 20 of PhHV-l-specific convalescent seal sera or monoclonal antibodies (MAbs) raised 
against PhHV-1 (Lebich e/ al., 1994) were applied to the wells and incubated at 20·C for 2 hr. 
Wells to which seal sera had been added were processed with protein A-peroxidase conjugates 
while goat anti·murine IgG peroxidase conjugates were used to detect bound MAbs. 3~amino-9-
ethyicarbazole served as a chromogene. Between all incubation steps plates were washed extensively 
with double-distilled water. Results were read by light microscopy. 
Radioimmunoprecipitation assay (RIPA) - CrFK cells either mock-infected or infected with wt 
PhHV-1 (M.O.I. = 1), and Sf 9 cells infected with BacPBgB or BacPAK 6 (M.O.I. = 4) were me-
tabolically labelled with L - ["51-methionine/cysteine (Promix, Amersham: 400 pCi per 107.cells) 
for 4 hr at 24 and 48 hr p.L, respectively. A parallel set of cultures was maintained in the presence 
of tunicamycin (10 pg ml- i ), added when cultures were starved for 1 hr in methionine/cysteine-
deficient medium. Cell lysis and immunoprecipitations were exactly as described (Barrett et al., 
1989). For precipitations MAbs l.lH3, 2.2F2, and 3.4B3 raised against PhHV-J by Lebich e/ al. 
67 
Chapter 2 - Herpesviruses of seals, dogs and cats 
(1994) were used since these MAbs were found to react to BacPBgB-infected SF 9 cells in IPMA. 
MAbs l.lH3 and 2.2F2 were also known to neutralize PhHV-1 isolates. Additionally, precipitations 
were performed with various pinniped sera obtained from seals of different species with or without 
virus-neutralizing (VN) antibodies to PhHV-l. For pulse-chase studies CrFK cells infected for 24 
hr with wt PhHV-1 and Sf 9 cells infected for 48 hr with BacPBgB cultures were pulsed with 
L - [3'SI-methionine/cysteine (400 I,Ci per 106 cells) for 15 min and chased for various times with 
cold methionine/cysteine. All immunoprecipi'tates were analyzed in 12.5% 50S-PAGE gels. 
Endoglycosidase treatment of immunoprecipitated proteins - Lysates of [35 S]-radiolabeled 
CrFK cells infected with PhHV-1 PB84 or Sf 9 cells infected with BacPBgB, were immunoprecipi-
t3ted with MAb 3.4B3. Extracted proteins were eluted from protein A-Sepharose beads by boiling 
in Endo H/F buffer (10 mM Tris pH 8.0, 0.5% SDS, 0.1% 2-mercaptoethanol) for 3 min: Digestion 
with 2 mU endoglycosidase H (cleaves high mannose and hybrid N-linked oligosacharides) or 100 
mU N-glycosydase F (removes all N-glycans except those with ,,-1,3 linked core fucose residu-
es) proceeded- at 37° C overnight in the presence of protease inhibitors (CompleteR, Boehringer 
Mannheim). Digests were analyzed by SDS-PAGE in 12.5% gels. 
Immunization of mice - Sf9 cells infected with BacPBgB or wild-type BacPAK6 for 72 hr were 
washed twice in PBS and resuspended at 107 cells per ml PBS. Mice were injected subcutaneously 
with 0.1 ml (equivalent to 106 cells). Injections were repeated 14 and 28 days later. Sera were 
recovered five days after the final injection. 
Herpesvirus neutralization assay - VN antibodies to PhHV-l, CHV, and FHV in seal and mi-
ce sera were measured by means of a complement-enhanced virus micro neutralization assay as 
described (Harder et al., 1991a). 
FACS analysis - Native CrFK and Sf 9 cells infected at high M.O.1. with PhHV-1 (20 hr) or 
BacPBgB (72 hr), respectively, were labeled with MAb 3.4B3 for 1 hr on ice in PBS supplemented 
with ~% (w/v) BSA (B-PBS). Cell viability exceeded 90% on basis of trypan blue dye exclusion. 
FIlC-labeled goat anti-murine IgG was used as a second antibody. Between all incubation steps cells 
were washed gently in B-PBS. Mock-infected controls were treated identically. Cells were analyzed 
in a FACScan (Becton-Dickinson). 
GenBank accession - The nucl~otide sequence of the PhHV-l gB gene has been assigned Acces-
sion No. Z68147. 
Results 
Identification and nucleotide sequence analysis of the PhHV-l gB 
equivalent gene. 
Southern blot hybridizations using a 1.6-kB gB-specific PCR amplificate of the PhHV-l iso-
late PB84 as a probe led to the identification of gB-specific sequences in a 5.4-kB BamHI 
fragment of the PhHV-l genome (not shown). Fig. 1 presents the nucleotide and dedu-
ced amino acid (aa) sequences of open reading frames identified within a 3-kB pa(t of the 
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OOATCCMTACMCTGTGATATACGACAGT'GATATTTt'tTCTCT'rCTTTATACGGTTCTACAAMGCTAGCf'CCTOOTCTTM'fATMA.CtAGTl''fMGAAAATM'tTATG'rATTTMTT 
End let> 18.5 holltoloque 
G S N T T V I Y D S D I F 5 L L Y T V L Q K L II P G L N I N 
Start 9B 
M '( L I 
121 ACHTAGTATT'M'TATTMTATTTTGGTTATACMTGCGtTCCMCMCACAACCTAC"i'GAATCTACACCACc.u.TT'-'CTCCfAG'fCCACCA.CCGMMACTCATCTTCGMCACTGAG 
5 T L V F FIN I L V I Q C V P T T Q P T £ S T P PIT P S P P P KIN S sis N T E 
241 T1'GMTGATGATATOAGAGAAATTTTGGGCOAATCACACA'l"WAATCTGA'1'GJITACAGC».CATTTTTTA'tGTGTCCGCCACCA'I'CTGGA'ICAACGTTGGTACGTT"TGGMCCGCCTCGO 
45 L N DOH REI L G E S Q I E SOD TAT F F H C P P P S 0 S T L V R L E P P R 
361 GC'I'TG'OCCTMTTACAAACTTGGTMAMCTTTACAOMOOTA'HGCTGTMTATTTAAAGAAAATATATCT'CCATATAMTTTMGGCfAATATTTACTATMOAATATTATTATMCA 
85 II C P N '{ K L 0 K ~ E G I A V I F KEN I S P 'i K F )( A N I 'i 'i K N I I T 
481 ACTGTATOO'rCTGGMGC'fCGTATGCCGTAGTCACTMCATGCATACTGATAGAGTACCTATAMGGT'ICAAGM.ATTACAOAATTGATCGATCGTAGGOOTATGTGCCTCTCAAAGGCT 
125 T V W S G S S Y II V V T N M H T D R V P I K V Q E I TEL I D R R G MeL S K II 
601 GATTATATTCGCAATMTT ... CGAGTT1 .... CTGCATTTGATAMGATGAAGACCCCAGAGAAATGCATTTMMCCC'tC.1t»tA'tTTM't ... CACCCOOHCTCGTGO.1.TGGCAT ... CGACAMT 
165 0 y I R N N Y EFT ... F 0 K 0 f! D PRE H H L K P S K F N T P G S R G W H T l' ~ 
121 GAT"'CG't",T ... CAIIAIIJ>.T'tGGGAGTCCTGGTTTTTATCGTACGGGAACATCTGTMATT01'ATTGTCOAAGAAGTTGATGCCAGATCTGTA1'ATCCATATGATTCC'tTl'GGCATT'l'CMC1' 
205 ~Y l' K lOS P G F Y R l' G '1 S V N C I VEE V 0 ... R S V Y P Y 0 S F 0 1ST 
841 GGAGATATMTTCATATGTCttCATTTTHGGTTTACGTGATGGAGCTCA'l''''CAGAACATACT'''GC'tAT'tCMATGATCOA1'TTCAACAMTTGAG<:GT-TAHATCC'l' ... TTGATTTGG"'T 
245 G 0 I H H S P F F 0 L R 0 G A H T f! H T S Y S NOR F Q Q lEG Y Y P I 0 L 0 
961 ... CCAGACT ... CAAGT'tGGGGGACCAGTTTCCAGMACTTTCtcACMCACMCATGTTACCGTTGCATGQAACTGGQTTCCAIIAIIJ>.TTCGTGAGGTGTGT ... CATTGGCTMATGGCGGGAA 
285 T R L Q V G G P V S R NFL l' T Q H V T V AWN W V P K IRE veT L A K W R E 
1081 ATTOATGAGAT'l'ATTCGTGATOAG'tA'tMGGGG1.'CT1'A1'AGATTTACAGCAAAATCMT'I"t'CAGCTACCTTTATH'CGGACGCAACACAGHTGATATCMCCGTG'l'MMCTMGTGAT 
325 I 0 f! I I ROE Y K G S Y R F T A K SIS A T F ISO A 'l' Q F 0 I N R V K LSD 
1201 TG'l'GC'tMACGTGAAGCAACAGAGGCTATCGATMGA'tA'tATM».ATAMTATMCAAMCCCATATCCAMCAGGAGAACTTGAMCGTATCTAGCTAGGGGGGGOTTTATTATTGCA 
365 C A K REA T f! A 10K I Y K N K yiN K TIH I Q T G f! L f! T Y L A ROO F I I A 
1321 T'l't ... GACCAATGATTAGCAATGAGCT"'GCAAMT1'",T",TATTMCGAAT1'GQCAAGATCTGAACGTATTGTTGATCTMATGCACT-TCTTMTCCATCACA'l'TCAGTTGO.1.GGOAGQ.MA 
405 F R PHI S N f! L A K L YIN E L A R S E R I VOL N ALL N P S H S V GaR K 
1441 MAAGG'l'CMTTOAOACAGAMCCCT'tGGGAGGtCAAMCGTGATGTTGACGGTGGTGTTCAAAATGTCMTAATGCAACTCTGATTMAACMCATC1'TCTATTCAT1'TTGC1 ... TGCTT 
445 K R S lET E T L G R S K R 0 V 0 G G V Q N V NIN A TIL I K T T S S I H FA H L 
= 
1561 CAG'tT'tGCGT ... CGATCAT ... TTCMTCGCATGTCMTGAAA'l'GCTT ... GTAGAAT1'GCAACCOCATGGTGTMTCTCCAAMTAMGAGAGAACTCTA'1'GGAATOAGGTT"'TGAAACTTMC 
485 Q F ... Y 0 II I Q S H V N E H L SRI A TAW C N L Q N K E R T L W N E V H K L N 
11581 CCTACAAGCATCACATCMCAAT1'ATGG"'TCAAAMGTTTCTGCMGAC'l'GCTGGGTOATGTMTCGCAGTT"'CACAATGTGTCMTA'1'TTCAGGTTCTMcqTT'lTT"'TTCAAM'lTCT 
525 P l' S I '1 S T I H 0 Q K V S ... R L L G 0 V I ... V T Q C V ~ G S, N " FlO N S 
1601 ATGCGTGTTACCGGATCT ... CAACTACATGTTACAGTCGCCCTTTQAT ... TCTTTTAMGCGCTTGAAMCTCMCAGATT ... TAT ... GAGGGTCMCTGGGGQMMTMCGAGTTG'l'tGGTA 
565 H R V l' G S T l' T C Y B R P LIS F K A L EIN S TID Y lEG Q L G I: NNE L L V 
1921 GACCGTAAACTMT'lO ... GCCGTGT ... CAGCTMTAATAAGAOOTATTTTAMTTTGGTGTGGATTA'lOT"'T",TTTro.v.AATT ... TGHT'"T ... TCCGTAAAOT ... CCCCTAMTGAAATTGAA 
605 D R K LIE P C TAN N K R Y F K F 0 V 0 Y V Y FEN Y V Y IRK V P L N E I E 
2041 AT(lATT ... OT ... CATATGTTGATCTCMCATCACACTGCTTGAAGATCGAGAATTTTT",CCATTGGAAOroT ... TACACGAGCAGAATTGGMGATACTGGCCTGCTAGACTAT ... GTGAMTT 
645 HIS '1' Y VOL I N I 1'1 L LED REF L P L f! V Y '1' R ... ELf! 0 T 0 L LOY S E I 
2161 CAACGGAGAAACCAACTCCACGCTCTCAAAT1'TT"'T(lA1''''T'''GACAG'lOTTGTTAAAG'lTGATAACMCCTT'''TM'l'T ... 'tGCGTGG'l'''''OOC'l'AACTTTTTTCCMGGAC'l'TGGAGA'lOT1' 
685 0 R R N Q L H ... L K F Y 0 IDS V V K VON N L I r H R G H L '1' F F Q G L G D V 
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2281 GGAGCTGGTT't1'GGGAAAGTTQTATTGGGTGC-TGCAAACGCGGT1'ATTTCAACTGt'U'C'I"G(lQATATCATCTTTCC'n'MCMCCCATTTGGAGCACTGGCTGl'TOO'rH'GHGAT't'tTA 
725 GAG F G K V V L G A A N A V 1ST V S GIS S F L N N P F G A L A V G L L I L 
2401 GCTGGCCTGTTTGCAGCATTTTTGGCC'l'ACCGATA'OO'tHCTMACTTMATCGAATCCAATGMAGCTT'tGTACCC'I'GTAACAACGCGAAACC'roAMQAAAGTTCAJ\N\.GA».AlIATT 
765 A G L F A A F LAY R Y V S K L K S N P H K A L Y P Y T T R N L K & S 8 K E K I 
2521 GGAGATGGTOATGAAGATGGTGATGMtT"IGATGAGGATAAACTCTCTCAGGCAAAGGAGATGATTMGTATATGACGTTAATCTCTGCtATGGAAAAACAAGAGCA'tMGGCAATGAAA 
80S GOG D E D G D E FOE 0 K L S Q A X E H I K 'i H T LIS A H E K Q E H K A H K 
2641 AAGAATAGCGGACCAGCCA'l'TTTGGCTAATCOTG'tl'GC.AMCCTCGCCCTCMGCACCt;CGGACCAAAATATMGCGTCTTMAAACATGGACGATGAAAATQATGAOOTTTMTAACTA 
= 845 K N S G P A I LAN R V A N L A L K H R G P K Y K R L K N HOD END E V 
2761 ATAAAAT-TTAAATATTACGrM'r-TTTAOTTGTGTGtcCtGCCTAC'ttTTCTMTATAAATACa::CCTAACoI.CCCMGCAT'rTTATTCTCT'l'ATCTTAGAGAGTTCTCTACAAGATCCTeT 
2881 CTTGATT»i'tCNACtA'1'OAG'rCTTTCTGCAGTn:cAOTATA'rCCAAGTGATATGGATATGMMTTGAGA'roAAACA'roAAACCCAGCAAACTTGTTCTACAGCACTOATGTCTOOAGAT 
3001 TATOATCtlTCCAC'tAGCACCMCMCGAACCCGMTTTGAAGAAGTTAACCT'fGOAGATAACTCl'OAA 
Figure 1. Nucleotide sequence of a part of a 5.4-kB BamHI fragment of PhHV-l (isolate PB84) 
and deduced amino acid sequences of open reading frames. A polyadenylation signal is indicated 
by dashed lines (2760-2765). Putative N~linked glycosylation sites are boxed. Regions of prima-
rily hydrophobic amino acids capable of spanning membranes are underlined. Subtilisin-like serine 
endoprotease motifs (-R-X-KjR-R-) are double underlined. 
respective BamHI fragment which comprises the entire gB gene homologue of PhHV-1 
capable of encoding 881 aa. The sequence context according to Kozak's rule (Kozak, 1991) 
around the putative gB initiation codon (ATT ATG T) is well conserved at position -3, but 
not at +4, which is similar to the gB gene of CHV (Limbach et al., 1994) and other members 
of the Varicellovirus genus. Analysis of sequences upstream of the putative gB ORF revealed 
homology to members of the UL28 gene family of a-herpesviruses which encodes the ICP18.5 
(Pellett et al., 1986). 
An overlap of ICP18.5 and gB ORFs as described for several members of the Varicellovirus 
genus including FHV, bovid herpesvirus-1 (BHV-1), pseudorabies virus (PRV) and equine 
herpesvirus-1 and -4 (EHV-1 and -4) was not found. Thus, PhHV-1 gene arrangements in 
this region again resemble those of CHV (Limbach et al., 1994). Downstream of the gB ORF 
several potential initiation codons were located. However, homologies to herpesviral proteins 
were not found for products translated from any of the putative start codons. 
Northern blot analysis gave evidence for at least two gB-specific mRNA species of 3.6 
and 2.8 kB in infected CrFK cells at 24 hr p.i. (not shown). Similar gB transcript patterns 
have been detected in FHV-infected cells (Maeda et al., 1992). A polyadenylation signal 
(McLauchlan et al., 1985) is present just downstream of the gB termination codon (Fig. 1). 
Possible gB promoter regions were not identified in this study. 
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Figure 2. Inferred evolutionary relationships of PhHVwl based on gB aa sequences. Alignments 
were computed by 'Pileup' included in the GCG software package (Version 8.0) setting gap creation 
weights to 3.0 and gap extension weights to 0.1. Further editing included the removal of stretches 
which could not be unambiguously aligned. Distances were calculated by the Kimura method on 
the basis of 645 residues and used to construct trees according to the neighbor-joining method. 
Branches are drawn in proportion to distances as indicated by the bar. Numbers at tree branchings 
represent bootstrap P values after 200 replications. Values?: 95% indicate a statistically significant 
separation of the respective cluster from the rest of the tree. Calculations were carried out using 
the 'Phylip' software package (Felsenstein, 1989). Sequences were extracted from the GenBank 
database (Accession No. indicated) or from recent publications (CHV, Limbach et al., 1994). VZV. 
varicella zoster virus. 
Predicted PhHV-l gB amino acid sequence and phylogenetic infe-
rences. 
Secondary structure analysis of the deduced amino acid sequence of PhHV-l gB revealed 
characteristics of a type-I transmembrane glycoprotein featuring three C-terminal clusters of 
hydrophobic amino acids (Fig. 1). The most N-terminal stretch of these, however, harbours 
an arginine residue in a central position and, therefore, is highly unlikely to function as a 
membrane anchor. Though an N-terminal hydrophobic translocation signal was identified, a 
possible signal cleavage site was not unambiguously predicted (Nakai & Kaneshisa, 1992) 
using either the Van Heijne matrix (Van Heijne. 1987) or the method of McGeoch (1985). 
Within the putative extra cytoplasmic domaine eight potential N-linked glycosylation sites 
are predicted. A motif of subtilisin-like serine endoproteases (-R-X-KjR-R-; Garten et al .. 
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1994) is found at aa positions 443 - 446 and 455 - 458. Cleavage at or near either of these sites 
would yield two fragments of approximately 51/49 or 52/48 kDa from a 100-kDa precursor 
(molecular masses calculated for full-length unglycosylated forms). 
To study evolutionary relationships of PhHV-l, deduced aa sequences of gB equivalents 
of several herpesvirus species were aligned using 'Pileup' (GCG). Stretches which could not 
be unambiguously aligned were removed and phenetic analysis finally was based on 645 
aa residues. Inferences were performed by use of the neighbor-joining principle (NJ) based 
on distance matrices calculated by Kimura's method and by use of maximum parsimony 
(PARS) employing a branch and bound approach. The best trees computed by these methods 
(Phylip software package; Felsenstein, 1989) displayed similar topologies plaeing PhHV-l 
among the members of the Varicellovirus genus (NJ: Fig. 2; PARS: not shown). HSV-l, 
an a-herpesvirus of the Simplexvirus genus was chosen as an outgroup. According to the 
distances calculated and confirmed by the high bootstrap values, CHV was identified as the 
closest relative of PhHV-l (Fig. 2). 
Synthesis and processing of authentic and baculovirus-expressed 
PhHV-l gB. 
Baculoviruses carrying the complete gB ORF of PhHV-l were constructed, and the recom-
binant BacPBgB was selected for expression studies. Several MAbs (including !.lH3, 2.2F2, 
3.4B3), and all five PhHV-l-neutralizing pinniped sera strongly reacted in IPMA with Sf 9 
cells infected by BacPBgB, but not with control cells (BacPAK6 expressing fJ-glucuronidase, 
mock-infected Sf 9 cells) (data not shown). 
Synthesis and processing of authentic and rec gB were analyzed by RIPA. MAb 3.4B3 
specificallY coprecipitated proteins of 53-59, 67, and 113 kDa from CrFK cells infected with 
the parent PhHV-l isolate (PB84) and proteins of 52, 60-62 and 105 kDa from Sf 9 cells 
infected with BacPBgB when precipitates were analyzed under reducing conditions (Fig. 3a). 
Under nonredueing conditions, proteins of approximately 113 and 140 kDa (wt gB) and 105 
kDa (rec gB) were depicted (Fig. 3b). MAbs l.lH3 and 2.2F2 known to neutralize PhHV-l 
isolates (Lebich et al., 1994), showed identical reactivities (data not shown). Sera collected 
from free-ranging pinnipeds reacted to a 105-kDa protein expressed in BacPBgB infected 
Sf 9 cells only when containing neutralizing antibodies (titers exceeding 1/20 NDso) against 
PhHV-l (Fig. 3a). All seal sera tested also reacted weakly to a 135-kDa protein in Sf 9 cells 
infected with BacPAK 6. 
Possible relationships of gB-specific proteins coprecipitated by single MAbs from PhHV-
I-infected CrFK cells were investigated in pulse-chase experiments which gave evidence that 
the 53 to 59, and 67-kDa protein species are generated by proteolytic cleavage from a 
113 kDa precursor (Fig. 4a). Cleavage products were demonstrated already after a IS-min 
chase. However, processing was incomplete since after a 6~hr chase at least 50% of precursor 
molecules still remained uncleaved. In addition, a 62-kDa protein was weakly copreeipitated 
from PhHV-l-infected cell Iysates by gB-speeific MAbs; the intensity of this band decreased 
during the chase (Fig. 4a). 
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Figure 3. Detection of wt and rec PhHV-l gB by RIPA. [35SJ-methionine/cysteine labeled Iysates 
of CrFK cell5 infecled with PhHV-I PB84 (+) or mock-infected (-) and Sf 9 cells infecled with 
BacPBgB (+) or BacPAK6 (-) were precipitated using the PhHV-I specific MAb 3.4B3 (4B3) 
or various pinniped sera obtained from different species worldwide. Selection of sera was based 
on presence of neutralizing antibodies to PhHV-l (titer exceeded 1/20 NDso): Pv4 and Pv48 
(common harbour seal, Phoca vitulina, US Atlantic coast and Dutch Wadden Sea), Or53 (walrus. 
Odobenus rosmarus, Bering Sea), Pf42 (ribbon 5eal, Phoca fasciata, Bering Sea), Lw88 (Weddell 
seal, Leptonychaetes weddellii, Antarctica). Sera from Pf57 (ribbon seal, Phoca fasciata, Bering Sea) 
and B79 (bearded seal, Erignathus barbatus, Norton Sound) had no detectable VN antibodies to 
PhHV-l. Separation was by 50S-PAGE (12.5% polyacrylamide) under reducing (A) or nonreducing 
(B) conditions. The apparent AIr of precipitates is indicated. 
Pulse-chase studies performed with BacPBgB infected Sf 9 cells likewise revealed pro-
teolytic processing of the 105-kDa baculovirus-expressed PhHV-l gB precursor (Fig. 4b). 
Significant amounts of fragments of 52 and 60-62 kDa, however, were present only after 6 
hr of chase and even after 24 hr at least 50% remained unprocessed. 
To examine glycosylation of wt and rec PhHV-l gB, immunoprecipitates obtained with 
MAb 3.4B3 from BacPBgB-infected Sf 9 cells and wt PhHV-l-infected CrFK cells were di-
gested overnight with endoglycosidase H, N-glycosidase F or were left untreated. In parallel, 
precipitates from PhHV-l-infected CrFK cells labeled in the presence of tunicamycin to shut 
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Figure 4: Synthesis and processing of PhHV-l gB. CrFK cells infected with wt PhHV-l (A) or 
Sf 9 cells infected with BacPBgB (B) were pulse-labeled at 24 and 48 hr p.i, respectively, with 
p5S]~methionine/cysteine at 400 /lCi per 106 cells for 15 min and then chased for the indicated 
time periods. Cell Iysates were precipitated using MAb PhHV-I 3.4B3. Mock-infected CrFK cells 
or BacPAK6 infected Sf 9 cells served as controls (-). Separation was by SOS-PAGE (12.5% 
polyacrylamide) under reducing conditions. The apparent AIr of precipitates are indicated. 
off N-linked glycosylation were analyzed. As shown in Fig. 5, proteins of 47/49, 59, and 98 
kOa were precipitated from tunicamycin-treated PhHV-l infected ceillysates. Both wt and 
rec gB were sensitive to Endo Hand Endo F digestion. The shifts observed in molecular 
masses after digestion were similar in wt and recombinant gB and indicated that the gB 
precursor molecules were particularly sensitive to Endo H. The fragments, at least, of wt 
gB were fully sensitive to Endo F, but only partially to Endo H. The smallest wt gB frag-
ment generally migrated as a broad band of 53 - 59 kOa. Following treatment with Endo H, 
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Figure 5: Glycosylation of wt and baculovirus-expressed gB of PhHV-l. PhHV-l-infected CrFK cells 
or Sf 9 insect cells infected with BacPBgB were metabolically labeled with [3551-methionineJcysteine 
at 24 and 48 hr p.i., respectively. for 4 hr. Lysates were reacted with MAb 3.4B3. Precipitates were 
either left untreated (0) or digested with endoglycosidase H (H) or N-Glycosidase F (F). In addition, 
precipitates were obtained from infected CrFK cells which were grown in the presence of tunicamycin 
(T). Mock-infected CrFK cells or BacPAK6-infected Sf 9 cells served as controls (-). Separation 
was by 50S-PAGE (12.5% polyacrylamide) under reducing conditions. The l\rlr of marker proteins 
are indicated. 
however, a single protein of approximately 53 kOa was depicted (Fig. 5), indicating that 
different levels of Endo H-sensitive glycosylation may account for the varying molecular 
weights. 
Cell surface expression of PhHV-l gB was further examined by FACS analysis of CrFK 
and Sf 9 cells using MAb 3.4B3. As shown in Fig. 6, expression of the protein was much 
more pronounced in the CrFK cells than in the Sf 9 cells when analyzed 24 and 48 hr after 
infection, respectively. 
Immunogenicity of recombinant PhHV-l gB in mice. 
Mice immunized with BacPBgB infected Sf 9 cells developed neutralizing antibodies against 
PhHV-l with titers ranging from 8 to 22 (reciprocal of NO,o). No reactivities in neutralization 
assays were detected with sera of control mice (immunized with BacPAK6-infected Sf 9 cells). 
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Discussion 
In the present paper we have molecularly characterized the gB of PhHV-l and expressed 
it in a baculovirus system. Sequence analysis revealed greatest homology to a-herpesvirus 
species of the Varicellovirus genus which encode a proteolytically cleavable gB. Taxonomic 
clustering of PhHV-l was confirmed by phylogenetic inference indicating that the genuine 
a-herpesviruses of carnivores (FHV, CHV and PhHV-l), like the equine <l-herpesviruses, 
form a separate cluster within this genus. In line with our previous data concerning cross-
neutralization and B cell epitope patterns (Osterhaus et a/., 1985; Harder et a/., 1991a; 
Lebich et a/., 1994), CHV was identified as the closest relative of PhHV-1. Considering 
recent evidence for a monophyletic origin of pinnipeds from a caniforrn carnivore ancestor 
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(Lento et al., 1995), the phylogenetic tree of a-herpesviruses from carnivores overlaps with 
the phylogeny of their natural hosts. These findings may contribute to the cospeciation 
hypothesis of a-herpesvirus evolution (McGeoch & Cook, 1994). 
Biochemical characterization of PhHV-l gB confirmed several features predicted from its 
sequence analysis: In infected CrFK cells the protein is synthesized as a 98-kDa transmem-
brane molecule which is cotranslationally glycosylated to yield a 113-kDa, Endo H-sensitive 
product. Further processing involves proteolytic cleavage into at least two, probably disulfide-
linked fragments of 53 to 59, and 67 kDa which oligomerize to forms of approximately 140 
kDa. PhHV-l gB cleavage products were already present 15 min after chase in contrast to 
the gB of PRV which is cleaved after translocation into the Golgi apparatus, requiring at 
least 60 to 90 min (Whealy et al., 1990). Similar, however, to PRV gB, the gB of PhHV-l 
was incompletely processed and at least 50% of the precursor molecules still remained intact 
after 6 hr of chase. The proteolytic fragments of PhHV-l gB predominantly contain complex, 
Endo H-resistant N-glycans. The identity of an additional 62-kDa molecule which was weak-
ly coprecipitated from PhHV-l infected cells remains to be elucidated. In PhHV-l infected 
CrFK cells gB molecules follow the exocytic pathway and are expressed at the cell surface. 
Synthesis of PhHV-l gB is, therefore, very similar to other members of the Varicellovirus 
genus, e.g., EHV-l (Sullivan et al., 1989). 
A signal cleavage site as well as the site of cleavage of the fragments of PhHV-l gB 
was not unambiguously identified in this study. Most of the endoproteolytically cleavable 
gB molecules of the different herpesvirus species harbour a single motif (-R-X-K/R-R-) of 
subtilisin-like serine endoproteases located close to the middle of the primary sequence. The 
gB of genuine herpesviruses of carnivores, in contrast, contains this motif twice, separated by 
eight (FHV, PhHV-l) and six (CHV) aa, respectively (Maeda et al., 1992; Spatz & Maes, 
1993; Limbach et al., 1994). Whether both sites actually are used and an endoproteolytic 
fragment is removed during maturation of these gB molecules, as has been suggested for 
equine herpesvirus-l gB (Wellington et al., 1996), remains to be investigated. 
Synthesis and posttranslational processing of recombinant PhHV-l gB expressed in baculo-
virus-infected Sf 9 insect cells resulted in products of slightly lower molecular weight (105, 
62,52 kDa) compared to wt gB, which may be due to differences in N-linked glycosilation in 
insect cells (Davidson & Castelli no, 1990; Kretzschmar et al., 1994). The markedly delayed 
kinetics of endoproteolytic cleavage of ree gB into at least two fragments in comparison to wt 
gB·cannot be explained by lack of endoproteases with 'R-X-K/R-R' substrate specificity in Sf 
9 cells (Du et al., 1994), but probably is at the bottom of the absence of oligomerized forms 
of rec gB after a 4-hr labeling period. Trafficking of ree gB toward the cell surface seemed to. 
be impaired as enly small amounts were detected in the cell membrane ef BacPBgB-infected 
Sf 9 cells in cemparisen to. PhHV-l-infected CrFK cells. Since eligemerization appears to. 
influence cerrect trafficking ef gB molecules via the execytic pathway (Claessen-Welsh & 
Spear, 1986; Navarre et al., 1993), the slow fermation ef the 52/62-kDa fragments of 
baculovirus-expressed PhHV-l gB may be related to. its lew cencentration at the Sf 9 cell 
surface. 
Though certain biochemical differences were observed between baculovirus~expressed and 
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authentic PhHV-1 gB, apparently they did not have a major impact on the antigenicity and 
immunogenicity of the recombinant protein. Possible protective effects of the PhHV-1 gB 
specific immunity induced in mice could not be evaluated since a challenge system has not 
been established. It should be noted, however, that the induced immune responses were 
comparable to those of mice vaccinated with baculovirus-expressed gB of HSV-1: These 
mice were shown to be fully protected from lethal intraperitoneal HSV-1 challenge and from 
induction of latency (Ghiasi et al., 1992). The suitability of baculovirus-expressed gB as a 
compound of a future PhHV-1 subunit vaccine will be the subject of further studies. 
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Abstract - Immunogenic proteins in cells infected with the 0"- or the ,-herpesvirus of seals, 
phocid herpesvirus-! and -2 (PhHV-I, -2), were examined in radioimmunopredpitation assays as 
a further step toward a PhHV-l vaccine. Using convalescent sera obtained from different seal 
species or murine monoclonal antibodies (MAbs), at least seven virus-induced glycoproteins (gps) 
were detected in Iysates of PhHV-l infected CrFK cells. A presumably disulfide-linked complex 
composed of gps of 59, 67 and 113/120 kDa, expressed on the surface of infected cells, was 
characterized as a major immunogenic infected cell protein (ICP) of PhHV-l. This gp complex 
has previously been identified as the proteolytically cleavable glycoprotein B (gB) homologue of 
PhHV-l (Harder & Osterhaus, 1997, Virology 227, 343-352). Using MAbs at least three distinct 
neutralization-relevant epitopes have operationally been mapped on the gB of PhHV-l. Among the 
ICPs of the antigenically closely related felid and canid herpesvirus, the gB equivalent proved to 
be the most highly conserved gpo Sera obtained from different seal species from Arctic, Antarctic 
and European habita,ts did not precipitate uniform ICP patterns from PhHV-l-infected cell Iysates 
although similar titers of neutralizing antibodies were displayed. Thus, antigenic differences of the 
n-herpesvirus species prevalent in the different pinniped populations cannot be excluded. PhHV-2 
displayed a different lep pattern, and only limited cross reactivity to PhHV-I at the protein level 
was detected which is in line with its previous classification as a distinct species, based on nucleotide 
sequence analysis, of the I-herpesvirus lineage. A MAb raised against PhHV-2 and specific for a 
major gp of 117 kDa, cross reacted with the gB of PhHV-l. The 117-kDa gp could represent the 
uncleaved PhHV-2 gB homologue. 
Introduction 
During the last decade, herpesvirus infections have been recognized in a growing number 
of aquatic mammal species. Herpesvirus infections of pinnipeds were mainly linked to re-
spiratory disease although generalized, fatal herpesvirus infections have been described in 
free-ranging European harbour seals (Phoca vitulina) with concurrent phocid distemper virus 
infections (Zhang et al., 1989) and as a monoinfection in captive neonate seals (Osterhaus 
et al., 1985; Borst et al., 1986; Harder et al., 1997a). Herpesvirus isolates from a Cali-
fornia sea lion (Zalophus californianus) and from several European and American harbour 
seals showing respiratory or generalized forms of disease have been adapted to cell cultures 
(Osterhaus et al., 1985; Frey et al., 1989; Lebich et al., 1994; Harder et al., 1996a). On basis 
of cross neutralization, typing with monoclonal antibodies (MAbs) and nucleotide sequence 
analysis, two species of seal herpesviruses have been distinguished and were associated with 
the a-Herpesvirinae (phocid herpesvirus-1, PhHV-1) and the ,-herpesvirus lineage (phocid 
herpesvirus-2, PhHV-2), respectively (Lebich et al., 1994; Harder et al., 1996a). 
Serological evidence points toward a moderate prevalence of PhHV-1 or other closely 
related herpesviruses in various pinniped species, including seals of Arctic and Antarctic 
habitats (Vedder et al., 1987; Harder et al., 1991a; Stenvers et al., 1992b; Stuen et al., 
1994; Zarnke et al., submitted). Disease associated with herpesvirus infection in seals, has 
so far only been attributed to PhHV-1-like isolates. While firm data on the incidence of 
PhHV-1 infection in free-ranging pinniped populations are lacking, significant problems arising 
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from enzootic PhHV-l outbreaks have been noticed in seal rehabilitation and conservation 
centers, and raised concern for protection of seals in captivity against PhHV-l associated 
disorders (Osterhaus et al., 1985; Harder et al., 1997a). As a first step toward a PhHV-l 
subunit vaccine, the glycoprotein B (gB) encoding gene of PhHV-l has been molecularly 
cloned, sequenced and successfully expressed in insect cells (Harder & Osterhaus, 1997). In 
infected mammalian cell cultures, the authentic PhHV-l gB has been identified as a 113 kDa 
glycosylated precursor molecule Which is proteolytic ally processed to give two disulfide-linked 
fragments of 53-59 and 67 kDa (Harder & Osterhaus, 1997). Under non-reducing conditions, 
heterodimers of 140 kDa are formed. 
Here we focuss on the identification of major immunogenic (particularly glycosylated) 
proteins WhiCh are expressed in cells infected with different PhHV-l isolates and a strain of 
PhHV-2. At the protein level we confirm and extend previous evidence to distinguish PhHV-
1 and -2 as different viral species. Among at least seven glycosilated viral protein species 
detected in infected ceillysates, the putative PhHV-l gB is identified as a major immungenic 
gp WhiCh is antigenically highly conserved compared with the gB equivalents of canid and 
felid herpesvirus (CHV and FHV). 
Materials and methods, 
Virus and cells - The origin of PhHV-isolates used in this study has been specified elsewhere 
(Osterhaus et al., 1985; Frey et al., 1989; Lebich et al., 1994). The FHV vaccine strain FVR 605 
(Povey, 1975) as well as the PhHV-l isolates PB84, PB85, 2501jHan88, 2010jHan90, and the 
PhHV-2 isolate 7848jHan90 were propagated in Crandell Rees feline kidney (CrFK) cells (Crandell 
et al., 1973). Madin-Darby canine kidney (MOCK) cells (Gaush et al., 1966) were used to grow the 
CHV isolate 5105/Han89 (Harder et al., 1991a). Experiments were performed using virus material 
which had undergone at least three plaque purification cycles. 
Sera - Titers of herpesvirus-neutralizing (VN) antibodies in sera obtained from seals of different 
species Were determined by a complement-enhanced microneutralization assay as described (Lebich 
et al., 1994). 
Monoclonal antibodies (MAbs) - Production and partial characterization of MAbs raised against 
PhHV-l (1.1H3, 2.2F2, 3.103, 3.3H5, 3.4Gl) and PhHV-2 (2.6E5) has been specified by Lebich 
et al., 1994. For use in radioimmunoprecipitations, immune-affinity purified preparations of these 
MAbs were employed. 
Definition of operational epitopes- MAbs raised against PhHV-l were biotinylated according to 
standard protocols for use in ELISA competition assays. ELISA antigen was produced from PhHV-
I-infected CrFK cells which were lysed when at least 80% of the culture showed viral cytopathic 
alterations. Lysis buffer consisted of 150 mM NaCl, 50 mM TRIS base (pH 8.7) and 20 mM 
p·octylthioglucopyranoside. Unsoluble residues were pelleted and the supernatant was extensively 
dialysed against 150 mM NaC!, 50 mM TRIS base (pH 8.7). Antigen-coating of ELISA plates 
proceeded overnight at 4°C. The optimal antigen dilution in PBS was determined by checker board 
tit rations using unlabeled MAbs. Competetion reactions between biotinylated and unlabeled MAbs 
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were carried out according to standard protocols. Streptavidin-peroxidase conjugate was used to 
detect biotinylated MAbs. ABTS served as a chromogene. 
Metabolic radiolabeling and immunoprecipitation (RIPA) - MDCK or CrFK cell cultures 
infected with the various herpesvirus species and showing early stages of viral cytopathic destruction 
were starved for one hour in methionine (met)- or glucose/pyruvate-deficient medium. Labeling 
using D-[U-14CJ-glucosamine HCL (Amersham 2: 200 mCi/mmol) at 5 JlCi/ml or L-[3SSJ-met 
(Amersham 2: 1000 Ci/mmol) at 50 JlCi/ml proceeded for 16 hr. Labeled cells were lysed on ice in 
RIPA-buffer (10 mM Tris Base pH 7.8, 150 mM NaCl, 600 mM KCI, 5 mM EDTA, 2%[v/vJ Triton 
X 100,0.1% [w/vJ sodium desoxycholate, and 2.5 mM iodoacetamide), supplemented with 0.5% 
(w/v) aprotenine. Insoluble residues were removed by centrifugation at 15.000 x G for 15 minutes. 
RIPAs were carried out following exactly the protocol of Barrett et al. (1989). Immunoextracts were 
separated by 5DS-PAGE using 10% or 5 - 15% gradient gels. Fluorographs were scanned and the 
molecular weight (M,) of proteins calculated (Ultroscan XL, Gelscan XL, Pharmacia LKB). 
Detection of viral gp cell surface expression by fluorescence analysis (FACS) - MOCK or 
CrFK cell cultures infected with the various herpesvirus species were incubated until the' majority of 
cells had detached due to viral replication, Unfixed, native cells (lOO.OOOjreaction; ;::: 90 % viable on 
basis of trypan blue dye exclusion) were incubated with either PhHV-1- or PhHV-2-specific MAbs 
for one hour on ice. MAb F 3.5, specific for the fusion glycoprotein of canine distemper virus, 
was used as a negative control. Cells were washed thrice in PBS containing 0.1% of bovine serum 
albumine and then incubated with goat FITC-Iabeled anti-murine IgG for one hour. Flowcytometry 
was carried out on a FACScan (Becton Dickenson) and data were analysed using the Consort 
software package (Version 3.0). 
Table 1. Cross neutralization of herpesviruses of pinnipeds and terrestrial carnivores by seal 
sera selected for use in RIPA. 
T estviruses2 
PhHV-l PhHV-2 FHV CHV 
SerumjYear l Host 2557 7848 FVR 605 5101 
Pv 26/88 Ph, vitulina 230 :52 8 130 
Pv 35/92 Ph. vitulina 450 3 130 130 
Pv 48/90 Ph. vitulina 450 45 45 180 
Pgr/93 Ph. groenlandica 75 :52 23 45 
Lw/91 Lept. weddel/ii 64 <2 56 70 
1 Designation and origin of sera: Pv 26 was obtained from a subadult harbour seal after recovery 
from experimental infection with the PhHV-1 isolate 2501/Han88 (Horvat et al., 1989). Other seal 
sera were sampled from free-ranging, spontaneously infected individuals: Pv 35 and Pv 48 originated 
from harbour seals of the North Sea; PhHV-2 7848/Han90 was isolated from lymphocytes of Pv 
48 (Lebich et al., 1994). In addition, sera of an Arctic harp seal (Pgr) from the Russian White Sea 
and of an Antarctic Weddell seal (Lw) were included. 
2 T estviruses employed in complement-enhanced micro neutralization assays, Reciprocal titers of 
neutralizing dose 50% endpoint tit rations are indicated. 
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Results 
Major infected cell proteins induced by PhHV-l and PhHV-2. 
Phocid serum PV 26 which was raised against the PhHV-1 isolate 2501 following experimental 
infection (Horvat et a/., 1989). precipitated abundant proteins of 28, 39,56, 67, 113, 125, 
135 and 172 kDa from met-labeled cells (Fig. 1, lanes 3-7). Polypeptides of 41 and 45 kDa 
were precipitated also from mock-infected CrFK cells (Fig. 1, lane 1). No overt differences 
of ICP patterns were detected between five European PhHV-1 isolates obtained between 
1984 and 1990 from diseased harbour seals ranging in the Dutch and German Wadden sea. 
For further experiments, therefore isolate 2557/Han88 was used as a PhHV-1 representative. 
PhHV-2 showed a different ICP pattern with major species of 33,37,44,83, 117 and 135 
kDa when precipitated using the autologous phocid serum Pv 48 (Fig. 1, lane 8). 
Serum Pv 26, raise against PhHV-1 in a seal, cross reacted efficiently with ICPs induced 
in FHV and CHV infected cells (not shown), but only marginally with PhHV-2 proteins (Fig. 
1, lane 9). 
45_ 
41-
Mock 
2 
PhHV·1 PhHV·2 
3 4 5 6 7 8 9 
Figure 1. RIPA and 50S-PAGE in 10% polyacrylamide (reducing conditions) of viral proteins in 
CrFK cells infected with five PhHV-1 isolates (PB84, PB85, 2501, 2557, 2010) or with a PhHV-
2 isola1e (7848). Lysates were prepared from cells metabolically labeled with L.[35SJ-methionine. 
Precipitations were carried out using phocid sera Pv 26 (lanes 1, 3 -7 and 9) or Pv 48 (lanes 2 
and 8). See Tab. 1 for origin and properties of these sera. The apparent A1r of major virus-induced 
proteins is indicated. U - non-specific precipitates. 
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Antibody specificities to ICPs of PhHV-l in seal sera from Arctic, 
Antarctic and European habitats. 
Origin and cross neutralizing properties of pinniped sera selected for use in RIPA are presented 
in Tab. 1. PhHV-l proteins of 113 and 135 kDa were abundantly precipitated by all pinniped 
sera which displayed titers of VN antibodies to PhHV-l (Fig. 2). A serum obtained from 
a spontaneously infected, free-ranging European harbour seal (Pv 35) which exhibited the 
highest VN titer, reacted most efficiently to ICPs of 39, 56, 113, 125, 135, and 172 kDa, 
similar to serum Pv 26. Differences in reactivity patterns were evident when using serum 
Pgr which had been obtained from an Arctic harp seal (Phoca groenlandica) and serum 
Lw, originating from an Antarctic Weddell seal (Leptonychaetes weddell;'). While both sera 
efficiently precipitated the 113 and 135 kDa ICPs, little, if any, reactivity to the 172 kDa 
protein of PhHV-l was detected. Although these two sera displayed similar VN titers, serum 
Lw, in contrast with serum Pgr, did not react to the 28, 39 kDa ICPs and only weakly to 
ICPs 56, 67 and 125 kDa. 
Pv35 Lw Pv26 Pgr Figure 2, RIPA and 5D5-PAGE in 
+ + + + 
10% polyacrylamide (reducing con~ 
ditions) of viral proteins in PhHV-
1 infected CrFK cells emplyoing se-
-
fa from seals of different, geogra-
I phically widely separated populati-172- II ons (Tab. 1). Lysates were prepa-135_ t I a red from cells metabolically labeled 125- with L-["51-methionine which we-113- re either mock-infected (-) or infec-
ted with PhHV-l 2557 fHanSS (+). 
.. The apparent lVlr of major virus-~~fi> ~ induced proteins is indicated. U -67- 1ff: non-specific precipitates . 
56- ,~ • • u_ ,o;-J,~. 
-i ";,,w, u- 'Aji{ 39- .. • ;i!!* 
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-
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Immunogenic glycoproteins expressed by PhHV-l and PhHV-2, 
Employing D-[U-14C]-glucosamine HCL for metabolic labeling, at least seven viral induced 
gps of 59,67,75,83, 113, 120 and 154 kDa were detected in PhHV-1 infected cells by use of 
serum Pv 26 when separated under reducing conditions (Fig. 3a, lane 1). Under non-reducing 
conditions, two major gps of 140/160 kDa and a minor species of 83 kDa were demonstrated 
(Fig. 3a, lane 3). Serum Pv 26 reacted also strongly with a 70 kDa gp of presumably cellular 
origin in mock-infected CrFK cells which was only depicted when non-reducing conditions 
were applied for separation (Fig. 3a, lane 4, marked 'c'). In PhHV-1 infected CrFK cells, 
reactivity against this cellular gp is absent, suggesting that the 70 kDa gp is efficiently 
down-regulated as a result of the herpesvirus infection (Fig. 3a, lane 3). 
Table 2. Properties of gB-specific MAbs raised against PhHV-1 and -2. 
Reactivity in 
MAb l FACS' PA3 RIPA4 
PhHV-1 l.lH3 PhHV-1, CHV 100 gp 59-67-113/120 
PhHV-12.2F2 PhHV-1, CHV 100 gp 59-67-113/120 
PhHV-1 3.103 PhHV-1, CHV S 20 gp 59-67-113/120 
PhHV-1 3.4G1 PhHV-1, CHV, FHV 60-90 gp 59-67-113/120 
PhHV-1 3.3H5 PhHV-1, CHV, FHV < 20 gp 59-67-113/120 
PhHV-2 2.6E5 PhHV-2, PhHV-1 < 20 gp (88)-117 
I MAbs were raised against the indicated herpesviruses by Lebich et al., 1994. 
2 Cross reactivity of MAbs as measured by FACS analysis. 
Epitope' 
I 
II 
lila 
IIlb 
II Ie 
n.d. 
3 Percentage of plaque reduction (against 50 pfu) at a MAb concen~ration of 100 Jlg/ml (Lebich 
et al., 1994). 
4 Molecular weights (kDa) of gps precipitated from Iysates of cells infected with the homologous 
virus species. 
5 Determined in competition assays (Fig. 4). 
n.d. not determined. 
PhHV-1-induced gps were also detected by use of MAbs raised against PhHV-l. Properties 
of these MAbs are listed in Tab. 2. It should be noted that MAbs l.lH3, 2.2F2 and 3.4G1, 
raised against PhHV-1, neutralized the infectivity of PhHV-1 isolates. In addition, all MAbs 
listed in Tab. 2 reacted to native infected cells in FACS analysis indicating that they are 
specific for a cell surface-expressed viral protein (FACS data not shown). MAb 1.1H3 co-
precipitated major viral gps of 59, 67 and 113 kDa and a minor species of 120 kDa (Fig. 
3a, lane 5); non-reducing separation conditions revealed two gps of 140 and 160 kDa (Fig. 
3a, lane 7). Identical precipitate patterns were obtained with all other MAbs listed in Tab. 2 
(MAb 3.3H5: Fig. 3a, lane 9; other MAbs: data not shown). The 59-67-113 kDa gp complex 
of PhHV-1 has previously been identified as the gB equivalent (Harder & Osterhaus, 1997). 
Competition assays showed that the PhHV-1 gB-specific MAbs listed in Tab. 2 defined at 
least five distinct operational epitopes of which at least three proved to be neutralization-
relevant (Fig. 4). 
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Figure 3, RIPA and SDS·PAGE in 5·15% polyacrylamide gradients of immunogenic gps of PhHV·l 
(panel A) and PhHV·2 (panel B), Metabolic labeling of virus·infected (+) or mock·infected (.) 
CrFK cells was done with D-[U_14 C]_glucosamine-HCI. Immunoprecipitates were separated under 
reducing (r) or non-reducing (nr) conditions. The apparent AIr of major virus-induced proteins is 
indicated. U - non-specific precipitates. 
In PhHV-2 infected celis, three gps migrating at 88,117 and 130 kDa (reducing conditions) 
or 140/160 kDa (non·reducing conditions) were precipitated using serum Pv 48 (Fig. 3b, lanes 
1, 3), MAb 2,6E5, which has been raised against PhHV·2, reacted to a PhHV-2 gp of 117 
kDa; in addition, the 88-kDa gp was weakly co-precipitated (Fig, 3b, lane 5), When separated 
under non-reducing conditions, these precipitates migrated as a double band of 140/160 kDa 
(Fig, 3b, lane 7), 
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Biotinylated mAbs 
1,1H3 .OO~O 
2.2F2 0.000 
3.103 00 ••• 
3.4G1 ~O ••• 
3.3H5 0 0 [[ill]] [[ill]] • 
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II 
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Figure 4. Operational epitope pat~erns of the glycoprotein B equivalent of PhHV-l. Results were 
obtained in ELISA competition assays using biotinylated and unlabeled MAbs .• Complete com-
petition (2: 80% inhibition), IIlI partial competition (inhibition 40 - 60%), ?J enhancement, 0 no 
. competition (5 20% inhibition). 
Conserved B cell epitopes on gps expressed by PhHV-l, CHV and 
FHV. 
B cell epitopes. conserved between gps of PhHV-1, FHV. and CHV, were detected by use 
of serum Pv 26. Strong cross-reactivity to FHV-induced gps of 62, 67 and 115 kDa and gps 
of 60,67, 80, 95 and 115/120 kDa specified by CHV could be demonstrated (Fig. 5a, lanes 
4, 5). No gps were cross-precipitated from PhHV-2 infected cells (Fig. 5a, lane 3). Epitope 
conservation was further explored by use of the broadly cross reactive MAb 3.3H5, raised 
against the PhHV-1 gB (Tab. 2). This MAb precipitated gB equivalents of 62-67-115/120 
kDa and 60-67-115/120 kDa from FHV- and CHV-infected ceillysates (Fig. 5b, lanes 5, 6), 
Although no cross-reactivities between gps of Ph HV-1 and -2 were detected using serum 
Pv 26, MAb 2.6E5, specific for a 117 kDa gp of PhHV-2, proved to cross react in FACS with 
PhHV-1 (Tab. 2). In RIPA, it could be shown that this property is due to reactivity with the 
gB of PhHV-1 (Fig. 5b, lane 9). 
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Figure 5. RIPA and SDS-PAGE in 
10% polyacrylamide (reducing con-
ditions) of gps antigenically con-
served between PhHV, CHV and 
FHV as detected by polyclonal (pa-
nel A) and monoclonal antibodies 
(panel B). Lysates of mock-infected 
or virus-infected cells, respectively, 
were prepared after metabolic la-
beling with D-[U_I'IC}_glucosamine-
Hel (open lane numbers) or with 
L-[35SJ-methionine (bold-face lane 
numbers). U - non-specific precipi-
tates. 
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Discussion 
As a further step towards the development of a homologous PhHV-1 vaccine, we have iden-
tified viral proteins in cells infected by PhHV-1 and PhHV-2 which represent major targets 
of the humoral immune system of naturally infected pinnipeds. 
Five PhHV-1 isolates obtained between 1984 - 1990 exhibited similar ICP patterns. In 
comparison, the PhHV-2 isolate 7848/Han90 differed markedly and cross reactivities between 
PhHV-1 and PhHV-2 were harshly limited. At the protein level, these results confirm and 
extend our previous data, based on typing with MAbs and on nucleotide sequence analysis, 
to classify two distinct species of phocid herpesviruses (Lebich et al., 1994; Harder et al., 
1996a). 
Sera from European and Arctic seals, naturally infected by PhHV-1, displayed comparable 
PhHV-1 ICP reactivity patterns. A serum from an Antarctic Weddell seal, however, revealed 
limited specificity to ICPs of an European PhHV-1 isolate despite similar VN titers compared 
to an Arctic seal's serum. While a high prevalence of VN antibodies against PhHV-1 has 
been detected in both Antarctic Weddell seals (Harder et al., 1991a; Stenvers et al., 1992b) 
and Arctic seal species (Stuen et al., 1995), it cannot be excluded that different, yet closely 
related, a-herpesvirus species circulate in these populations. 
While aiming at the detection of major immunogenic proteins of PhHV-1, we demonstrated 
more than 20 proteins specifically expressed in PhHV-1-infected CrFK cells of which at 
least seven were glycosilated. The identification of most of these ICPs, however, remains 
speculative since up to now only the PhHV-1 gB gene and its products have been molecularly 
characterized (Harder & Osterhaus, 1997). Among the non-glycosilated ICPs a 135 kOa 
species was conspicuously precipitated from PhHV-1, PhHV-2, CHV and FHV cell Iysates 
using serum Pv26; by analogy to previously published data, the apparent molecular weight, 
the relative abundance and the seemingly conserved antigenic structure of this ICP would be 
compatible with the major capsid protein of herpesviruses (Fargeaud et al., 1984; Manning 
et al., 1988). 
With regard .to the development of herpesvirus vaccines, envelope gps attract particular 
attention because many of them are prominent targets of both the humoral and cellular 
immune response (Mettenleiter, 1991; Spear, 1993). Especially, the glycoproteins B (gB) 
and 0 (gO) of ,,-herpesvirus species have been shown to elicit high titers of VN antibodies 
(Para et al" 1985; Backlaws et al.,.1990; Ghiasi et al., 1994), and are important targets of 
cytotoxic T cells (Witmer et al., 1990). 
Among the seven gps detected in PhHV-1-infected cells only the 59, 67 and 113(120 kOa 
species are unambiguously identified, namely as products of the gB gene. We have shown 
that among the gps expressed by PhHV-1, FHV, and CHV, the gB complex is antigenically 
highly conserved which has already been predicted by analysis of the deduced amino acid 
sequences (Harder & Osterhaus, 1997). Cross reactive gB-specific antibodies were also pro-
minent in sera of spontaneously and experimentally infected natural hosts of PhHV-l. Using 
gB-specific MAbs, at least three distinct neutralization-relevant epitopes were defined. The 
gB of a-herpesviruses is expected to migrate as a single species or as oligomerized forms 
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when analysed under non-reducing conditions (Highlander et a/., 1991; Maeda et al., 1995). 
In this study, however, the native gB of PhHV-1 migrated as double band at 140/160 kDa. 
The identity of the 160 kDa gp, not detected in a previous study of PhHV-1 gB expression 
(Harder & Osterhaus, 1997) remains to be elucidated. As a possible explanation for this di-
sagreement different labeling periods of 16 hr (this study) versus 4 hr (Harder & Osterhaus, 
1997) should be considered. Complex formation involving further viral or cellular proteins 
during the prolonged labeling period cannot be excluded. In this context, the identification of 
a 25 kDa protein, coprecipitated by gB-specific MAbs and by polyclonal antibodies (e.g. Fig. 
4b, lanes 1 and 9) and likewise not detected in the previous study, will be of special interest. 
Members of the ,-Herpesvirinae subfamily also express gB equivalents which were shown to 
share a high degree of sequence and structural homology to those of a-herpesviruses (Pellett 
et al., 1985; Agius et al., 1994; Stewart et al., 1994). MAb 2.6E5 which was raised against 
the pinniped ,-herpesvirus PhHV-2 cross reacted with the gB of PhHV-1 and precipitated 
a major 117 kDa gp from PhHV-2 infected cells. It is tempting to speculate that the 117 
kDa gp might represent the un cleaved gB equivalent of PhHV-2. 
The overall pattern and the molecular weights of further gps preciptated from PhHV-1-
infected cell Iysates corresponded closely to those described for CHV and FHV, except for 
a 154 kDa gp which appeared to be unique to PhHV-l. (Fargeaud et al., 1984; Burgener 
& Maes, 1988; Compton, 1989; Limcumpao et al., 1990; Rota & Maes, 1990; Xuan et al., 
1992; Spatz & Maes, 1993, 1994; Maeda et aI., 1994, 1995). In addition to the 154 kDa gp, 
a 83 kDa gp of PhHV-1 was abundantly precipitated by immune seal sera. A putative gD 
homologue of PhHV-1, by analogy to CHV and FHV (Limbach et al., 1994; Maeda et al., 
1994) expected to migrate as a single gp of 55 - 65 kDa, was not identified in this study. 
In conclusion, at the protein level we confirmed the existence of two distinct species of 
phocid herpesviruses. The gB of PhHV-1 was shown to be a major immunogenic gp in 
the course of natural PhHV-l infections of pinnipeds and harbours neutralization-relevant 
epitopes which further justifies considerations to include gB as a component of a future 
PhHV-1 subunit vaccine. Currently, studies on the identification of further gp-encoding genes 
of PhHV-1 are in progress. 
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2.6 - Seroprevalences of PhHV-1, -2 in the North Pacific 
Abstract - Blood samples were collected from 1042 marine mammals off the coast of Alaska 
and Russia during the period 1978 to 1994. Eight species of pinnipeds were represented. Sera were 
tested for presence of neutralizing antibodies to both the PB84 isolate of phocid herpesvirus~l 
(PhHV-l) and the 7848/Han90 strain of phocid herpesvirus-2 (PhHV-2). Species-specific antibody 
prevalences ranged from 22% to 77% for PhHV-l and 17% to 42% for PhHV-2. Species-specific 
antibody prevalences for PhHV-l were greater than or equal to prevalences for PhHV-2. For both 
viruses and each host species, differences in antibody prevalences were not related to: 1. location of 
capture, or 2. year of collection. Antibody prevalence of PhHV-l in walruses (Odobenus rosmarus) 
could be quantitatively predicted as a function of age. In sea lions (Eumetopias jubatus) and harbour 
seals (Phoca vitulina) females showed a significantly higher PhHV-l antibody prevalence. The two 
authentic herpesviruses of pinnipeds have distinct biological properties. The current data indicates 
that the epizootiology of the two viruses is different, as well. No evidence of herpesvirus-induced 
mortality has been detected in areas included in this survey. Based on results of this survey, neither 
PhHV-l nor PhHV-2 are considered significant mortality factors in mammals which inhabit the 
marine environment off the coast of Alaska or Russia. 
Introduction 
Phocid herpesvirus-1 (PhHV-1) is an a-herpesvirus (Harder et a/., 1996). It was first identi-
fied in 1984 when it caused the deaths of 11 harbour seals (Phoca vitulina) pups in a nursery 
in the Netherlands (Osterhaus et al., 1985). Twelve additional pups which were ill during 
that epizootic subsequently recovered over the course of a 2-month period (Borst et a/., 
1986). Mortality due to PhHV-1 infection has only been observed in 1. neonates or 2. seals 
acutely infected with phocid distemper virus (PDV) or 3. seals which have been otherwise 
immunocompromised (A.D.M.E. Osterhaus, unpublished). 
Clinical signs of PhHV-1 disease included: 1. elevated body temperature, 2. inflammation 
of the oral mucosa, 3. nasal discharge, 4. coughing, 5. vomiting, 6. diarrhea, 7. anorexia and 8. 
lethargy (Visser et a/., 1991). Duration of illness ranged from 1 to 6 days (Borst et a/., 1986). 
Interstitial pneumonia and necrosis of hepatic parenchyma were the primary histologic lesions. 
Less significant changes were also observed in kidneys, spleen and lymph nodes (Borst et a/., 
1986). Experimental evidence indicates that: 1. harbour seals can be infected by means of 
intranasal instillation of PhHV-1 or direct contact with infected animals, and 2. virus is shed 
in nasal and ocular discharge from naturally- and experimentally-infected animals (Horvat et 
al., 1989; Harder et a/., 1997). Presumably, natural transmission occurs by means of aerosols 
or direct contact, as in other a-herpesvirus infections. 
Based on serology, approximately 50% out of 49 free-ranging harbour seals which were 
involved in the 1988 PDV epizootic in the North Atlantic, had been exposed to PhHV-1 (Frey 
et a/., 1989). Despite this high antibody prevalence, PhHV-l was isolated from only four of 
112 harbour seals which had died during the 1988 PDV epizootic (Frey et a/., 1989). Serum 
antibody prevalence for PhHV-1 was 100% in 25 apparently healthy Weddell seals (Lept-
onychotes weddellil) and three apparently healthy crab eater seals (Lobodon carcinophagus) 
from the eastern Weddell Sea (Harder et al., 1991). 
95 
Chapter 2 - Herpesviruses of seals, dogs and cats 
A second seal herpesvirus type has been isolated from: 1. a captive California sea lion 
(Zalophus californian us) (Kennedy-Stoskopf et al., 1986), 2. free-ranging adult harbour seals 
from the North Sea (Lebich et al., 1994), and 3. free-ranging harbour seals from the North 
Atlantic offshore the United States (Harder et aI., 1996). These isolates are collectively 
known as phocid herpesvirus-2 (PhHV-2). Nucleotide sequence data indicate that PhHV-2 
is a 'l'-herpesvirus (Harder et aI., 1996). There is no evidence that PhHV-2 causes clinical 
disease in pinnipeds. Neutralizing antibodies against PhHV-2 have been detected in a small 
cohort or harbour seals of the North Sea but not in Weddell seals of Antarctica. 
Herpesviruses have been implicated in recent fatal and nonfatal infections of harbour seals 
in the North Pacific. Twenty-six harbour seals were collected during the investigation of the 
1989 Exxon Valdez oil spill in Prince William Sound. One male had lesions on the penis and 
prepuce. Intranuclear inclusion bodies typical of herpesvirus were observed during histologic 
examination of the lesions (Spraker et al., 1994). The death of a single harbour seals off 
the coast of Washington State in 1990 was attributed to a herpesvirus. This diagnosis was 
based upon gross lesions, light microssopy, and electron microscopy (G.M. Zaucha, pers. 
comm.). Hepatic and adrenal necrosis were found in 12 harbour seal pups which died at a 
rehabilitation center in Sausalito, California, during 1990. Herpesvirus virions were detected 
in these necrotic areas by use of electron microscopy (Lowenstine et al., 1992). 
Herpesviruses have also been detected in other northern hemisphere marine mammals spe-
cies including: 1. harbour porpoise (Phocoena phocoena) (Kennedy et al., 1992), California 
sea lion (Kenndy-Stoskopf et al., 1986), and sea otter (Enhydra lutris) (Harris et al., 1990). 
The purpose of the current project was to determine the serum antibody prevalence of 
PhHV-l in marine mammal populations off the coast of Alaska and Russia. 
Materials and methods 
Collection of samples - Animals were collected by various investigators during studies of marine 
mammal population biology and ecology. Collection areas included portions of southeastern Alaska, 
the Gulf of Alaska, eastern and western Bering Sea, Chukchi Sea, and Beaufort Sea (Fig. 1). The 
following descriptive data were recorded for each animal: 1. sex, 2. date and 3. location. Age data 
were collected only for walruses (Odobenus rosmarus). Age determination for walruses was based 
on: 1. body conformation, 2. tusk size, and 3. facial characteristics (Fay, 1982). For the purpose 
of comparison, samples were grouped by year of collection. Year of collection does not neccessarily 
reflect year of exposure. 
Blood was routinely drawn from the extradural vein, caudal gluteal vein, or rear flipper. Samples 
were allowed to clot and then centrifuged. Serum was transferred to sterile vials. Sera were initially 
stored at -12°C for several months and then transferred to -40 to -46°C for periods lasting from 
several months to several years until the time of testing. 
Serology - Similar microneutralization assays were used to detect antibodies against both PhHV-
1 and PhHV-2 (Osterhaus et al., 1985: Lebich e/ al., 1994). The PB84 isolate of PhHV-l was 
grown in seal kidney cells (Osterhaus e/ al., 1985). The 7848/Han90 strain of PhHV-2 was pro-
pageted in Crandell Rees feline kidney (CrFK) cells (Harder e/ a/., 1996). Both isolates were obtained 
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Figure 1. location of collection sites for marine mammals included in PhHV-l, -2 serologic sur-
veys. A, Southeast Alaska (134'W, 56'N); B, Prince William Sound (14rW, 61'N); C. Cook Inlet 
(152'W, 60'N); 0, Kodiak Island (153'W, 57"N); E, Alaska Peninsula (160'W, 56'N); F, Kus-
kokwim Bay (163'W, 59'N); G, Pribilof Islands (170'W, 57'N); H, Bering Sea (174'W, 62'N); I, 
Bering Strait (169'W, 66'N); J, Northwest Alaska (164'W, 70 0 N); K, Barrow (157'W, 71'N); L, 
Prudhoe Bay (148'W, 7l'N); M, Chukchi Sea (172°W, 69°N); N, Karaginsky Gulf (164'E, 58'N); 
0, Southeast Kamchatka Peninsula (160'E, 53'N); P, Kuril Islands ()50'E, 46'N). 
from harbour seals of the North Sea. One hundred mean tissue culture infective doses (TCID50 of 
virus were used in each test. Results were evaluated by development of viral cytopathic effect after 
3 days for PhHV-l and 7 days for PhHV-2. 
Under normal test protocol, samples which neutralize PhHV-l or PhHV-2 at a serum dilution of 
1:5 or greater are considered indicative of previous natural exposure to the virus (Osterhaus et al., 
1985; Lebich et al., 1994). For the current study a higher threshold dilution of 1:20 was selected. 
Samples that met or exceeded a titer of 20 will be referred to as positive. All others will be referred 
to as negative. This change in threshold was implemented in order to reduce the impacts of potential 
nonspecifc neutralizing or cytotoxic substances on test interpretation. The higher threshold may 
lead to an underestimation of actual antibody prevalences. 
Statistics - For walrus, a generalized linear model with a logit link (McCullagh & Neider, 1989) 
was used to determine if there was a significant dependence of serum antibody prevalences on the 
following variables: 1. age, 2. sex, and ~. year of collection. Antibody response is a binary response 
variable. Age was treated as a continuous variable. Sex and year of collection were categorical. 
Geographic location was not included in any logit model for predicting antibody status of walruses. 
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With one exception, samples were collected from unique locations each year. Therefore, year of 
collection is confounded with location in the modelling process. All main and interaction effects of 
these variables were evaluated. During the modelling process, all higher order terms were removed 
from the model if they did not substantially (P " 0.05) increase the fit of the model based on the 
deviance function compared to a Chi*squared value (McCullagh & Neider, 1989). The SAS statistical 
software package was used to fit the model with maximum likelihood parameter estimates. 
Sex and year-of-collection data for harbour seals, sea lion, and spotted seal were also subjected to 
the logit modelling process for PhHV-l. Ages were not available for these species. The Chi-square 
test was used to determine if PhHV-2 antibody prevalence for ribbon seals, spotted seals, or harbour 
seals was related to sex of the animal. 
Results 
Serum antibody prevalences for PhHV-1 ranged from 22% to 77% (Tab. 1). Serum antibody 
prevalences for PhHV-2 ranged from 17% to 42%. In most species, prevalence for PhHV-1 
was higher than for PhHV-2. From 11% to 34% of each species had been exposed to both 
viruses. 
For walruses, neither sex nor year of collection had a significant effect on antibody preva-
lence for PhHV-1 (P" 0.05). The only factor retained in the model was age 
(P = 0.04). Age is a continuous variable. Therefore, the final model is equivalent to lo-
gistic regression. The model predicts the probability of a positive test result as a function of 
age (Fig. 2): 
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Figure 2. Relationship between walrus (Odobenus rosmarus) age and predicted probability of a 
walrus serum sample exceeding threshold titer (2: 20) for phocid herpesvirus-I. 
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For harbour seal, spotted seal, and sea lion the only factor which had an effect on prevalence 
was sex. Sex is a categorical variable. Therefore, the final model is equivalent to a Chi-square 
contingency table. Prevalence was higher in females for all three species (103/138 for female 
harbour seals versus 90/151 for males; 13/25 versus 2/23 for sea lions; and 17/22 versus 
19/31 for spotted seals. These sex-specific differences were statistically significant only for 
harbour seals (P = 0.007) and sea lions (P = 0.001). 
Antibody prevalences of PhHV-2 in all species was not related to: 1. sex, 2. age and 3. 
year of collection. Antibody prevalence of PhHV-2 for walruses was not a function of age. 
Discussion 
Cross reactivity is a common problem in serologic surveys. Antibodies produced as a result 
of exposure to one disease agent may react with a closely-related agent. These circumstan-
ces can produce false positive results. Cross neutralization, however, is negligible for most 
o-/"",-herpesvirus pairs such as equine herpesviruses-l and -2, bovid herpesviruses-l and-4 
or varicella zoster virus and Epstein Barr viruses (Plummer et al., 1973; Honess & Watson, 
1977; Levings, 1984). In the current study, many sera had titers against either PhHV-l or 
PhHV-2. These results concur with a previous study of marine mammals from European 
waters (Lebich et al., 1994). Therefore, sera with siginifcant titers against either PhHV-l or 
PhHV-2 are believed to represent prior natural exposure to the individual virus. Sera with 
titers against both PhHV-l and PhHV-2 are believed to represent natural exposure to both 
viruses. 
No phocid herpesvirus isolates are available from the area included in the current survey. 
Therefore, isolates of European origin were used. Pinnipeds in the current study area may 
be exposed to viruses which are closely related and yet, antigenically distinct from those 
found in European waters. Antibody produced in response to these hypothetical viruses may 
neutralize European strains of PhHV-l or PhHV-2 less efficiently. These circumstances could 
yield false negative results. There are minor variations between European isolates of PhHV-l 
(Frey et al., 1989). However, there were no significant antigenic differences between isolates 
of European and United States origin (Harder et al., 1996). Therefore, all positive serologic 
test results are considered indicative of PhHV-l and/or PhHV-2 exposure. 
Two general taxonomic groups were represented in the survey: 1. phocids - ringed seal 
(Pusa hispida), spotted seal (Phoca largha), harbour seals, bearded seal (frignathus barba-
tus) and ribbon seal (Histriophoca (asciata); and 2. odobenids and otariids - walrus, Steller 
sea lions (fumetopias jubatus) and northern fur seal (Callorhinus ursinus). Prevalences for 
PhHV-l ranged from 22% to 77% for the phocids and 34% to 54% for the odobenids and 
otariids. The three highest prevalences were seen in phocid seals. However, there was no clear-
cut patterns among or between the two groups. Current antibody prevalences for PhHV-l are 
in the range previously reported for hooded seals (Cytophora cristata) and harp seals (Phoca 
groenlandica) from the White Sea (Stuen et al., 1994) and for European harbour seals (Frey 
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Table 1. Serum anti boy prevalences of phocid herpesvirus-1 (PhHV-1) and phocid herpesvirus-2 (PhHV-2) in selected marine 
mammal species sampled off the coast of Alaska and Russia, 1978 - 1994. 
1 PhHV_1 2 Species Years of Locations PhHV-2 PhHV-1 and Negative 
collection sampled PhHV-2 
Ringed seal 
(Pusa hispida) 
1978-1992 H,K,L 10113 (77%) 214 1/4 0/4 
Spotted seal 1978-1993 H,J,K,N,O,P 
(Phoca largha) 
73197 (75%) 5/32 (16"10) 5/32 (16%) 9/32 (28%) 
Harbour seal 
(Phoca vitulina) 
1978-1994 A,B,C,D,E,G 161/219 (73%) 521124 (42"10) 421124 (34%) 19/124 (15%) 
Walrus 1981-1987 F,I,M 
(Odobenus rosmarus) 
2081384 (54%) 98/341 (29%) 611341 (18%) 115/341 (34%) 
Steller sea lion 1978-1993 A,B,C,D,E,G 41/88 (46%) 5/22 (23"10) 4122 (18%) 10/22 (46%) 
(Eumetopias jubatus) 
Bearded seal 1978-1990 H,K 
(Erignathus barbatus) 
11/24 (45%) 3118 (17%) 2118 (11%) 6/18 (33%) 
Northem fur seal 1980 G 
(Callominus ursinus) 
631185 (34%) 621154 (40%) 22/154 (14"10) 61/154 (40%) 
Ribbon seal 1978-1979 H 
(Histriophoca Fasciala) 
7/32 (22%) 7/24 (29%) 5124 (21%) 15/24 (63%) 
1 A, Southeast Alaska; B, Prince William Sound; C, Cook Inlet; D, Kodiak Island; E, Alaska Peninsula; F, Kuskokwim Bay; G, Pribilof Islands; 
H, Bering Sea; I, Bering Stratt; J, Northwest Alaska; K, Barrow; L, Prudhoe Bay; M, Chukchi Sea; N, Karaginsky GuH; 0, Southeast Kamchatka 
Peninsula; P, Kurillslands. 
2 
Number of samples with significant levels of antibody/total number of samples tested, 
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et al., 1989). Prevalences for PhHV-2 ranged from 17% to 42% for the phocids and 23% to 
40% for the odobenids and otariids. 
The highest prevalence value was seen in phocids. 
Antibody prevalences for PhHV-l were generally higher than for PhHV-2 (Tab. 1). Trans-
mission of the highly contagious PhHV-l is primarily via the respiratory route (Osterhaus et 
al., 1985; Harder et,a/., 1997). Routes of transmission for PhHV-2 are unknown. The most 
effective method of isolating PhHV-2 is ~ia cocultivation of leucocytes (Lebich et al., 1994). 
Apparently, the virus is highly cell-associated under natural conditions. This conclusion is sup-
ported by cell culture under laboratory conditions (Lebich et al., 1994). The cell-associated 
nature of PhHV-2 makes airborne transmission unlikely. Alternate routes of transmission for 
PhHV-2 may produce lower transmission rates than for PhHV-1. These lower rates of trans-
mission may be reflected in the lower antibody prevalences observed in the current survey. 
Harbour seals and Steller sea lions live primarily in the subarctic and temperate regions. 
In contrast, walrus and the remainder of the seal species live primarily in the arctic. There 
was no discernible pattern of prevalences between these two groups. Apparently, exposure 
of marine mammals to PhHV-l, PhHV-2, or related herpesviruses has been: 1. common, 2. 
geographically widespread, and 3. long term. 
The logit model quantitatively predicts antibody prevalence of PhHV-l as a function of 
age for walruses (Fig. 2). This model apparently reflects: 1. moderate exposure rates at an 
early age, and 2. continual opportunity for exposure throughout life. 
Differential sex-specific mortality rates could contribute to the higher sex-specific antibody 
prevalence in female harbour seals, spotted seals, and sea lions. If mortality is higher in males 
than in females, then females would constitute a greater proportion of the older age cohorts. 
The age effect observed in walrus (Fig. 2) suggests that prevalence would also be higher in 
older age harbour seals, spotted seals, and sea lions. Unfortunately, age data is not available 
for these three species. 
During the sample collection period, populations of the following species have declined: 
1. Steller sea lion (Merrick et al., 1987), 2. northern fur seal (Fowler, 1990), and 3. harbour 
seal (Pitcher, 1990). No cases with clinical signs of PhHV-l infection have been reported 
for either Steller sea lions or northern fur seals. A single case of fatal PhHV-l infection in 
a harbour seal was recently reported from the coast of Washington State (G.M. Zaucha, 
pers. comm.). Thus, there is no apparent relationship between declines of these species and 
exposure to PhHV-l or a related herpesvirus. 
Based on census data, populations of both walrus (Gilbert, 1989) and polar bear (Amstrup 
et al., 1986) seem stable. The geographic range of sea otters in Alaskan waters has expanded 
in recent decades (Rotterman & Simon-Jackson, 1988). Population status for other species 
is unkown. 
Based upon serum antibody prevalences reported here, marine mammals in the waters 
of Alaska and Russia are commonly exposed to PhHV-l, PhHV-2, or related herpesviruses. 
Apparently, herpesviruses have become enzootic in these waters. There have been no do-
cumented herpesvirus epizootics in these host populations. However, PhHV-l is capable of 
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causing morbidity and mortality in non immunocompetent seals. Therefore, future outbreaks 
of clinical disease are possible. 
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3.1 - Antigenic relationships of PDV and CDV 
Abstract - Inter typic antigenic differences and the intratypic variability of the canine and phocid 
distemper viruses were examined using a molecular (monoclonal antibodies specific for the H- and 
F-glycoproteins) and a functional (kinetic neutralization, KN) approach, KN studies were performed 
by using a novel immunoplaque technique which combined conventional plaque assay and antigen-
specific enzyme-immunostaining techniques. Morbillivirus isolates of canine and phocid origin clearly 
formed two separate groups. Minor antigenic differences were also evident within each cluster. A 
distemper isolate of mustelid origin was distinguishable from both CDV- and PDV-like prototype 
viruses by KN studies, 
Introduction 
Previously undescribed morbilliviruses have been identified as causative agents of a distemper-
like disease in sever~1 marine mammal species (Osterhaus et a/.,1988; Kennedy et a/. 1988a,b; 
Domingo et a/., 1991). Data on viral antigenic and genetic properties suggested that at least 
isolates derived from harbour seals (Phoca vitu/ina), now referred to as phocid distemper 
virus (PDV), can be regarded as a new species in the morbillivirus genus. Canine distemper 
virus (CDV) appears to represent the most closely related of the well-known members of the 
genus (Mahy et a/., 1988; Cosby et a/., 1988; Orvell et a/., 1990; Haas et a/., 1991; Kovamees 
et a/., 1991; Blixenkrone-M¢lIer et a/., 1992; Curran et a/., 1992). Candidate morbilliviruses 
obtained from cetacean species such as porpoises (Phocoena phocoena) and striped dolphins 
(Stenella coeruloalba) are awaiting a more detailed characterization, The origin of morbillivi-
ruses obtained from marine mammals remained speculative. So far, no isolates linking PDV-
and CDV-prototype viruses epizootiologically have been described. 
Morbilliviruses form a genus of enveloped negative-strand RNA viruses which are taxono-
mically placed in the Paramyxoviridae family (Pringle, 1992). These viruses are composed 
of six structural polypeptides of which two are glycosilated and anchored within the lipid 
envelope (for a review see: Rima, 1983, Morrison, 1988). The H- (haemagglutinin) glycopro-
tein interacts with membrane receptors of permissive host cells and mediates the attachment 
between viral and cellular membranes. Following attachment, the F- (fusion) glycoprotein, 
consisting of two disulfide-linked subunits, initiates the release of the viral nucleocapsid into 
the host cell cytoplasm by fusion of the attached membranes. The majority of neutralization-
relevant epitopes is found on the H-protein whereas the F-protein apparantly carries only 
a few epitopes which are critical in inactivation of viral infectivity by antibodies (Orvell et 
a/. 1985; Sheshberadaran & Norrby, 1986; Malvoisin & Wild, 1990). An immune response 
directed against both glycoproteins has been shown to play an important role in recovery and 
protection from morbillivirus infections (Miele & Krakowka, 1983; Varsanyi et a/., 1987; De 
Vries et a/., 1988; Rima et a/., 1991; Taylor et a/., 1991). 
A classification of morbilliviruses as PDV- or CDV-like can't be based on host origin 
of an isolate alone, since PDV- and CDV-like morbilli viruses display a broad and widely 
overlapping host range both in natural and experimental infection. It is of interest to note 
that morbillivirus isolates of the CDV-type were recovered from distemper-diseased Baikal 
seals (Phoca sibirica) and, conversely, an outbreak of distemper-like disease in a mink farm 
was caused by a natural infection with a morbillivirus which was antigenically indistinguishable 
from a PDV-prototype virus (Visser et a/., 1990; Blixenkrone-M¢lIer et a/., 1990). 
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Kinetic neutralization (KN) represents a sensitive method for the differentiation of closely 
related viruses and intratypic neutralization-variants, respectively (McBride, 1959; Mandel, 
1978; Gould & Butler, 1980). The applicability of this technique to members of the morbil-
livirus genus has formerly met dilliculties due to the slow growth and poor plaque-inducing 
properties of these viruses, especially with regard to wild-type isolates. Nevertheless, Rossiter 
et al. (1989) were able to characterize intratypic neutralization variants of rinderpest virus. 
In order to circumvent problems encountered with the detection of native plaques Rapp et 
a/. (1959) established an immunofluorescence-plaque assay which enabled the detection of 
measles virus-induced foci by an indirect immunofluorescence technique. 
Here we report on the intertypic differentiation and detection of intratypic variants among 
recent isolates derived from distemper-diseased terrestrial carnivores and harbour seals by a 
kinetic neutralization technique. The examination of low-passage morbillivirus field isolates 
was feasible by the development of an immunoplaque assay which combined classical plaque 
methods and immunocytochemical staining techniques. The isolates were further characte-
rized by typing of antigenic sites of the H- and F-glycoproteins employing a large panel of 
recently established monoclonal antibodies. 
Materials and methods 
Cells and virus - Vero cells were maintained i~ DMEM (Serva Inc.) supplemented with 2% fetal 
calf serum (FCS). Tab. 1 summarizes the different morbilliviruses (COV, POV, MV) used in this 
study. All strains and field isolates were previously adapted to Vero cells by five to ten serial dilute 
passages. Stock virus was produced in glass roller bottles (Schott, Germany). A multiplicity of 
infection (M.O.I) of 0.01 to 0.1 was chosen for the inoculation of subconfluent Vera cell layers in 
glass roller bottles. Medium was replaced every second day. The cultures were harvested by one 
freeze/thaw-cycle when at least 80% of the cell layer showed cytopathic changes suggestive of 
morbillivirus replication. After removal of cellular debris by centrifugation (5000 xG, 15 minutes) 
the virus suspension was aliquoted and stored at - 80°(, 
Sera and monoclonal antibodies - Sera against PDV (isolate 2558/Han88) were raised in 
two piglets within 31 weeks following intranasal inoculation of virus suspensions (approx. 105.0 
TClD5o/animal) at days 1, 131 and 196. Normal porcine serum was obtained from piglets prior to 
inoculation. The production of a porcine serum against canine distemper virus (strain Rockborn) 
has been reported previously (Zaghawa et al., 1990). 
The production and characterization of murine monoclonal antibodies (MAbs) raised against 
isolates of PDV (2558/Han88; OK 88 4a) and a vaccine strain of CDV (Convac) was described 
elsewhere (Orvell et al., 1985; Orvell et al., 1990; Harder et al., 1991b; Blixenkrone-M¢lIer et al., 
1992). Exclusively, MAbs specific for the attachment (H) or fusion (F) glycoproteins were selec-
ted for this study. The reactivity of each MAb against various morbilliviruses was determined by a 
peroxidase-linked antibody assay as described below. Selected MAbs were further examined for neu-
tralizing capacities against POV 2558/Han88 and COV strain Rockborn (ROC) by a conventional 
micro neutralization assay (see below). 
Peroxidase-linked antibody assay (PLA) - Vero cells simultaneously infected with a morbillivirus 
(M.O.1. 0.01) were grown in microtitre plates (Nunc, Denmark) until a few distinct foci of viral 
cytopathic alterations within a confluent layer of cells became evident. After being washed once 
with PBS (diluted to 30% (v/v) in Aq. bidest.) the cell layer was heat-fixed for four hours at 80'(' 
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Table 1. Origin of viruses. 
Strain/Isolate 
Canine distemper 
'Rockborn' (ROC)' 
'Onderstepoort' (ONST) 
5804/Han90 
1493/Han89 
Phocid distemper 
1970/Han88 
2135/Han88 
2558/Han88 
2953/Han88 
Measles 
'More' (att. Enders)' 
3.1 - Antigenic relationships of PDV and CDV 
Origin 
(Host/cellular source) 
vaccine strain 
vaccine strain 
canine/kidney tissue culture 
mustelidflung tissue 
phocid/lung tissue 
phocidJlung tissue 
pnocid/leucocytes 
phocid/lung tissue 
vaccine strain 
Reference 
Rockborn (1958) 
Haig (1948) 
F 
F 
liess ef al. (1989b) 
liess ef al. (1989b) 
liess ef al. (1989b) 
liess ef al. (1989b) 
a Provided by Dr. G. Rockbarn, Biomedical Center, Uppsala, Sweden; b provided by Dr. M. Drescher, 
Hannover Med. School, Hannover, Germany; F - recent isolates obtained from diseased animals. 
100/tl of serial twofold dilutions (starting dilution 1 : 20) of each MAb in PBS containing 0.005% 
Tween 20 (PBST) were added per we.!! and incubated for two hours at room temperature. Appro-
priately diluted HRPO-conjugated caprine anti-murine IgG was applied to the cavities for another 
hour at 20'C. 3-amino-9-ethylcarbazole (2 mg dissolved in 300,,1 dimethylformamid, Sigma Che-
micals) diluted in 5 ml of 50 mM acetate buffer (pH 5.0, 0.005% H20 2) was used to visualize the 
reaction. Between each step the plates were washed extensively with PBST. Results were read by 
light microscopy. The highest dilution of a MAb still mediating an easily visible staining of antigen 
was recorded as its PLA-titre. For the detection of morbilli virus antigen in neutralization and focus 
forming assays the MAb PD/TC 4-2 raised against PDV 2558/Han88 was used throughout. This 
antibody was previously shown to react with a highly conserved epitope located on the nucleocapsid 
protein (N) of all members of the morbillivirus genus (Harder ef al., 1991b). 
Focus forming assay (immunoplaque assay) - Vero cells were seeded into Petri dishes (diameter 
6 em, Nunc, Denmark) at a concentration of 1.6 x 106 cells/dish forming a confluent monolayer 
within 16 hours. Medium was decanted and the cell layer rinsed once with PBS in order to remove 
loosely attached cells and small aggregates. Virus was diluted in /0910 steps in OMEM without 
serum and 1 ml of each dilution was inoculated per petri dish. Virus adsorption was allowed for 
one hour at 37°e. Subsequently, the inoculum was removed and the cell layer rinsed carefully twice 
with PBS. Residual fluid was fully drained prior to addition of 7 ml of a semisolid overlay. The 
overlay medium consisted of a 1% (w/v) solution of Noble agar (Difco Laboratories) in OM EM. 
supplemented with 5% (v/v) FCS. Following an incubation period of 72 hours the overlay (soaked 
in PBS for ten minutes) was mechanically removed using a scalpel blade. The cells were briefly 
rinsed with PBS, air-dried and heat-fixed for 4 hours at 80°e. Staining of morbillivirus antigen 
was achieved by the peroxidase-linked antibody assay using MAb PO/TC 4-2 as a first layer as 
described above. 
The results were read microscopically at a magnification of 32x. Foci of antigen-positive cells 
(referred to as immunoplaques) were counted in twenty non-overlapping visual fields ~Iong a line 
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corresponding to the diameter of the Petri dish. The relative concentration of focus-forming units 
referring to an inoculum of 1 ml was expressed as focus forming units in 20 visual fields per dish 
(FFUx20VF). 
Conventional microneutralization assay - Heat-inactivated sera and selected monoclonal antibo-
dies were assayed for morbilli virus neutralizing properties by a peroxidase-linked microneutralization 
assay as described in detail by Liess et ai, (1989a,b). Briefly, 50p' of serial twofold dilutions of test 
sera or MAbs prepared in quadruplicate were reacted with 50pi of the respective virus suspensi-
onadjusted to 100 TCIDso/50ILi for one hour at 37'C. Subsequently, Vero cells were added at a 
concentration of 6 x 103 cells/well. The cultures were maintained for four 'days until heat-fixation. 
Morbillivirus antigen was identified immunocytochemically as described above. Wells containing 
at least a single antigen-bearing cell were regarded ·non~protected'. The neutralizing dose (50% 
endpoint) was calculated according to Karber (1931). 
Kinetic neutralization assay - Neutralization profiles of several morbillivirus strains against two 
porcine immune sera raised against PDV 2558/Han88 (serum 254/8) and CDV ROC (serum 253/8) 
were determined by kinetic neutralization tests (McBride, 1959) employing a focus reduction tech-
nique. Additionally, profiles were also measured against the MAb PO/Te 6-2 which recognized an 
epitope located on the H-protein of PDV isolates (Harder et al., 1991b; Tab. 2). 
Virus suspensions were adjusted to 6-8 x 103 FFUx20VF /ml. 1.5 ml of this suspension were 
mixed and incubated at 3rC with an equal volume of diluted immune serum or MAb, respectively. 
At various times (0, 3, 6, 9, 12, 15, 20, 25, 30, 45, 60 minutes) aliquots of 200 1'1 were removed, 
diluted 10-1 in chilled PBS and immediately inoculated in duplicate onto accurately prepared Vero 
cell monolayers in Petri dishes (1 mlfdish). Virus adsorption proceeded for one hour at 3rc. The 
following steps were carried out essentially as described for the focus~forming assay. Sera and MAb 
employed in kinetic neutralization were used at a previously determined working dilution capable of 
reducing the relative concentration of the homologous virus expressed as FFUx20VS by one /0910 
step within 15 minutes (253/8: 1/400, 254/8: 1/40 and MAb 6-2: 1/20). As a control of physical 
(thermal) inactivation of infectivity kinetic experiments were performed in parallel using a normal 
porcine serum (morbillivirus-neutralizing titre NOsD ~ 1:5) at a dilution of 1 : 80 (final). 
Arithmetic means of FFUx20VS-values calculated for each virus-serum pair from two separate 
experiments were subjected to regression and correlation analysis by standard statistical methods. 
The gradient of each regression curve (b) was recorded as an equivalent of the neutralization con~ 
stant of the respective virus-serum pair. In order to enable a comparison of the different experiments 
regression gradients were normalised (Nb) by the formula: 
10gb, 
Nb = --100 10gb, 
bl ~ regressiQf! gradient of homologous virus-serum pairs 
b2 ~ regression gradient of heterologous or heterotypic virus-serum pairs. 
Results 
Production of an immune serum against PDV in swine 
Upon repeated intranasal inoculation of the PDV-isolate 2558/Han88 into two piglets morbilli-
virus-neutralizing antibodies were induced. During the whole period no symptoms attributa-
ble to inoculation of PDV were observed. Titres of homologous PDV-neutralizing antibodies 
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Table 2, Development of morbillivirus-neutralizing antibodies in pigs intranasally inoculated 
with PDV 2558/Han88. 
Animals Weeks post inoculation 
1 3 7 13 21 25 28 30 31 
254 ::; 5a 40 25 15 520 730 460 920 970 
::; 5' ::;5 23 26 65 53 53 80 65 
255 ::;5 65 30 15 1460 640 530 1600 1400 
<5 <5 26 92 110 80 92 80 110 
The animals were inoculated intranasally each with approx. 105.0 TCIDso in 5 ml DMEM with 2% 
FCS at days I, 133 (week 19) and 196 (week 28). 
" Test virus PDV 2558jHan88 (100 TClDso); , Test virus CDV Rockborn (100 TClDso); titre, are 
expressed as reciprocals of NDso. 
assayed by conventional neutralization techniques reached about 1/1000 (NDso). Heterotypic 
CDV-neutralizing tit res were also measurable, but paralleled those against PDV on avarage 1 
/oglO step lower. The development of morbillivirus-specific antibodies is summarized in Tab. 
2. In kinetic neutralization studies the serum exhibited a high avidity for its homologous virus 
(see below). 
Development of an immunoplaque assay 
The various morbillivirus field isolates obtained from clinical cases of canine, mustelid and 
phocid distemper did not induce overt viral cpe within 72 hours of incubation in cultures of 
Vero cells under a semisolid agar overlay. In cultures infected by the vaccine strains CDV 
Onderstepoort (ONST) and MV MORE occasionally large multinucleated cells became cells 
became microscopically detectable. Macroscopically visible native plaques could not be ob-
served at all. However, subsequent to immunocytochemical staining solitary redish foci of 
antigen-bearing cells became evident. In case of CDV ONST and MV MORE these foci 
reached a diameter of 0.5 to 1.0 mm. Microscopic examination of cultures infected with 
field isolates revealed small (:'0 0.1 mm) immunoplaques of approximately equal size ran-
domly distributed throughout the culture. Thus, for accuracy of enumeration microscopic 
evaluation was indispensable. Areas of antigen-positive cells were sharply separated from 
uninfected cells which facilitated the enumeration of foci considerably. The morphology of 
immunoplaques varied amongst the isolates. Foci induced by field isolates usually consisted 
of 5 to 20 infected cells. Immunoplaques induced by MV and CDV ONST were characterized 
by larger syncytia containing sometimes more than 50 nuclei. Generally, cytoplasmic antigen 
of all viruses examined was stained with equal intensity. However, mononuclear infected cells 
gave a more intensive signal compared to the cytoplasm of large multinucleated syncytia. 
No staining appeared in uninfected cultures. The suitability of the immunoplaque assay for 
quantitative analysis of virus concentrations was evaluated by repeated titration of various 
virus suspensions. In all cases a reproducible linear correlation existed between the dilution 
of the virus suspension and the number of FFUx20VS per dish (data not shown). 
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Table 3. Clustering of morbilliviruses according to normalized neutralization constants (N,) 
measured against two porcine morbillivirus-immune sera and a monoclonal antibody. 
Cluster 
I (N, :0 70) 
II (25:0 N, :0 70) 
III(N, :0 25) 
Porcine sera 
253/8' 
CDV ROC (100) 
CDV ONST (89) 
CDV 5804 (73) 
CDV 1493 (33) 
PDV 1970 (33) 
PDV 2135 (40) 
PDV 2558 (36) 
PDV 2953 (33) 
MV MORE (27) 
254/8' 
PDV 2558 (100) 
PDV 1970 (97) 
PDV 2135 (89) 
PDV 2935 (105) 
CDV 1493 (29) 
CDV ROC (10) 
CDV ONST (14) 
CDV 5804 (17) 
MV MORE (11) 
MAb 
PD/TC 6-2' 
PDV 2558 (100) 
PDV 1970 (97) 
PDV 2135 (115) 
PDV 2953 (72) 
CDV 5804 (22) 
CDV 1493 (20) 
" raised against CDV Rockborn. NDso against CDV ROC: 1/5000; against PDV 2558: 1/1000. 
, raised against PDV 2558/Han 88. NDso against PDV 2558: 1/970; against CDV ROC: 1/65. 
, produced against PDV 2558/Han88 (H-protein-specific). NDso against PDV 2558: 1/1280; 
against CDV ROC: :0 1/5. 
Nb: normalized regression gradient-value (for details of calculation see text). Mean values of each 
strain/isolate examined are presented in brackets. 
Kinetic neutralization 
In order to distinguish loss of infectivity due to neutralizing antibodies from physical (thermal) 
inactivation, kinetic studies were carried out employing a porcine normal serum without 
morbillivirus-neutralizing tit res when checked by the conventional neutralization test (NDso :s: 
1:5). The arithmetic mean of regression gradients of all viruses (n=9) was bx = 0.96 (s = 
0.01) indicating that under the conditions of this study loss of 1 [agIO of viral infectivity 
during One hour of incubation at 37"C was expected to be attributable to non-specific 
physical factors. 
The two porcine immune sera and the MAb PD/TC 6-2 showed moderate to high neutra-
lizing titres when tested against the respective homologous virus by conventional neutraliza-
tion (253-8: 1/5000. testvirus CDV-ROC; 254-8: 1/1000. testvirus PDV 2558; PD/TC 6-2: 
1/1280. testvirus PDV 2558). When reacted with the porcine immune sera or MAb PD/TC 
6-2, respectively, the neutralization of infectivity in kinetic experiments generally followed a 
first order exponential function of the type f(,) = ab'. The arithmetic mean of correlation 
coefficients calculated for 24 regression curves (I', = 0.987) confirmed a strong and functio-
naf coherence of the measured values. For easier comparison, the gradient b (representing a 
measure of the neutralization constant) of each regression curve was normalized (Nb), giving 
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Figure 1: Kinetic neutralization (KN) profiles of different morbilliviruses against porcine immune 
sera raised against the Rockborn strain of COV (253/8; top) and the POV isolate 2558/Han88 
(254/8; bottom). KN experiments were performed by using an immunoplaque reduction techni-
que (for methodological details see text). Foci of antigen:-positive cells (immunoplaques) were 
enumerated microscopically. The relative concentration of focus-forming units was expressed as 
focus-forming units in twenty non-overlapping visual fields (FFUx20VF). <> Canine distemper virus 
(vaccine strain Rockhorn); 0 mustelid distemper virus (isolate 1493JHan89); 6 phocid distemper 
virus (isolate 2558/Han88). 
the gradient of the homologous virus-serum pair a value of 100. Thus, a Nb-value of 30 of 
a heterologous or heterotypic virus would indicate that the neutralization of infectivity by 
a certain serum is only 30% complete in relation to the homologous virus within the same 
time. 
According to their Nb-values the viruses could be grouped into three clusters (Tab. 3). 
Cluster 1 comprised viruses which were rapidly neutralized by the respective serum (Nb 2: 
70) and therefore regarded to be most closely related to the homologous virus. Cluster 2 
contained isolates being moderately neutralized (25 :0; Nb :0; 70). Viruses of cluster 3 were 
not neutralized at all (Nb :0; 25) and loss of infectivity was indistinguishable from physical 
inactivation alone. 
A clear intertypic differentiation of distemper isolates of phocid and canine origin as well 
as measles virus was achieved by both porcine sera and MAb POjTC 6-2. The mustelid 
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(ferret) distemper isolate 1493/Han89, however, took an intermediate position and clustered 
with PDV-isolates when assayed against the porcine anti-CDV serum. On the other hand, 
1493 was the only non-phocid isolate which was - though weakly - neutralized by the 
anti-PDV serum (Fig. 1). Measles virus was weakly neutralized only by the anti-CDV serum. 
MAb PD/TC 6-2 exclusively neutralized PDV-isolates. 
A marked degree of heterogeneity was uncovered among viruses of the Nb-ciuster 1 in-
dicating an intratypic variability (Tab. 3). In this respect, the CDV field isolate 5804 was 
distinguishable from the two CDV-vaccine strains ROC and ONST. A considerable variabili-
ty was also observed among PDV-isolates when tested against the neutralizing MAb PD/TC 
6-2 whereas a more homogeneous picture was obtained with the porcine anti-PDV serum. 
Epitope-typing by MAbs directed against morbillivirus glycoproteins 
Using a large panel of MAbs previously developed against the H- and F- glycoproteins of CDV 
and PDV the viruses involved in this study could be grouped into three antigenic clusters, 
consisting of canine (and mustelid) distemper viruses, distemper virus isolates of phocid 
origin and, finally, measles virus (Tab. 4a, 4b). The epitope pattern of the F-glycoprotein 
was considerably conserved among the various viruses and contrasted sharply to the broad 
intertypic variability of antigenic sites located on the attachment (H) glycoproteins. The 
majority of MAbs reacted homogeneously within each cluster Trifling intratypic variations 
could be detected by five MAbs against the H-protein and by one MAb specific for the F-
protein (Tab. 4a, 4b). Out of these six MAbs enabling intratypic differentiation only MAB 'H 
3.734', raised against the H-protein of the CDV Convac strain, defined an epitope (CDV H 
3) which was neutralization-relevant in conventional neutralization assay (data not shown). 
CDV 1493, isolated from a distemper-diseased ferret, clearly clustered with CDV-like viruses 
and - in contrast to KN-studies - could not be differentiated from canine distemper virus 
vaccine strains or a field isolate of canine origin. 
Discussion 
Since the initial studies of Dulbecco (1952) plaque assay applications are regarded the most 
precise - though laborious - technique for the quantification of infectious virus in vitro. 
The applicability of this method to members of the morbillivirus genus has been hampered 
by the poor plaque-inducing properties of morbilliviruses. Vero cells have been reported to 
be the most suitable cell line for comparative investigations of morbilliviruses (Shishido et a/., 
1967). However, even well adapted, high-passage vaccine strains required long incubation 
periods (6 to 21 days) to induce visible native plaques in Vero cell cultures. The majority 
of plaques did not exceed 1 mm in diameter and, in case of field isolates, were often only 
of pinpoint size (Gourlay, 1970; Ozawa and Nelson, 1973; Hirayama et a/., 1978 and 1986; 
Albrecht et a/., 1981; Cosby et aI., 1981). 
By combining conventional plaque assay- and enzyme-immunotechniques these problems 
could be coped with: The immunoplaque assay as used in this study did not only allow 
to abridge incubation times to three days (which deminishes the risk of secondary plaque-
formation) but also allowed the investigation of field isolates. The use of MAb PD/TC 4-2 
114 
3.1 - Antigenic relationships of PDV and CDV 
Table 4a. Reactivity of H-glycoprotein-specific MAbs with different morbilliviruses detected 
by a peroxidase-linked antibody assay. 
MAb Epi- CDV CDV CDV CDV PDV PDV PDV PDV MV 
tope ROC ONST 5804 1493 1970 2135 2558 2953 MORE 
COV Convac' 
1.347 1 + + + + + + + + 
2.267 2 + + + + 
3.734 3 + + + + + + w 
3.775 4 + + + + 
4.043 5 + + + + + + + + 
4.074 5 + + + + + + + + + 
4.275 6 (+) + (+) w (+) (+) (+) (+) 
4.941 7 + + + + 
POV OK 88.4a' 
1.062 G5 1 + + + + 
1.063 C3 1 + + + + 
1.063 E9 1 w + + + + 
1.069 D9 1 + + + + + + + + 
1.07l E5 1 + + + + 
1.067 E5 2 (+) (+) (+) (+) + + + + 
1.068 F2 3 (+) (+) (+) (+) + + + + w 
1.07085 4 + + + + 
1.072 C4 4 + + + + 
1.085 C4 5 w + + + + 
1.122 D11 6 w + + + + + + + w 
POV 2558/Han88 
6-2 n.d. + + + + 
20-2 n.d. + + + + 
22-2 n.d. + + + + 
23-2 n.d. + + + + 
I Viral antigen used to raise the specified Mabs. 
+ Strong reactivity, PLA-titre > 1/1000; (+) moderate reactivity, PLA-titre between 1/100 and 
1/1000; w weak reactivity, PLA-titre between 1/20 and 1/100; - no reaction, PLA-titre S 1/20; 
n.d. not determined. Data on epitope specificity are from Orvell et al. (1985. 1990) and Blixenkrone-
M¢lIer et al. (1992). 
which reacted with a highly conserved genus-specific epitope for the detection of antigen 
further opens the possibility to apply this technique to other strains and isolates of of the 
morbillivirus genus. Essential prerequisites of a regular plaque assay as summarized by Cooper 
(1961) could be fulfilled: No immunoplaques were detected in non-infected cultures and focus 
formation was reduced by heat-inactivated specific antisera but not by normal sera, taking 
into account physical (thermal) inactivation of infectivity. An absolute quantification of focus 
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Table 4b, Reactivity of F glycoprotein-specific MAbs with different morbilliviruses detected 
by a peroxidase-linked antibody assay. 
MAb Epi- COV COV COV CDV PDV PDV PDV PDV MV 
tope ROC ONST 5804 1493 1970 2135 2558 2953 MORE 
COV Convae' 
3.608 1 + + + + + + + + + 
3.633 1 + + + + + + + + + 
5.086 1 + + + + + + + + + 
3.551 2 + + + + + + + + w 
3.584 2 + + + + + + + + 
3.697 2 + + + + + + + + 
4.068 2 + + + + (+) w (+) w 
4.985 3 + + + + 
5.148 3 + + + + + + + + 
POV OK 88 4a' 
1.062 E2 1 + + + + + + + + 
1.068 B2 1 + + + + + + + + 
1.067 D2 2 + + + + + + + + + 
1.073 Gl0 3 + + + + + + + + + 
1.092 C3 3 + + + + + + + + + 
1 Viral antigen used to raise the specified Mabs. 
+ Strong reactivity, PLA-titre» 1/1000; (+) moderate reactivity, PLA-titre between 1/100 and 
1/1000; w weak reactivity, PLA-titre between 1/20 and 1/100; - no reaction, PLA-titre :s 1/20. 
n.d. not determined. Data on epitope specificity are from Orvell et al. (1985, 1990) and Blixenkrone-
M¢lIer et 01. (1992). 
forming units per dish by microscopic examination was not feasible. Nevertheless, the enume-
ration of randomly distributed foci in defined parts of the dish gave a consistantly reproducible 
proportional correlation between virus concentration and induced foci. 
The immunoplaque technique described here was used to study intertypic antigenic diffe-
rences and intratypic variation of distemper isolates of canine, mustelid and phocid origin by 
kinetic neutral.ization assays employing polyclonal sera and a neutralizing MAb. A CDV field 
isolate and two vaccine strains were clearly distinguishable from four PDV isolates by their 
neutralization profiles. A morbillivirus isolate obtained from a case of distemper in mustelids 
(ferret), however, took an intermediate position between CDV- and PDV-prototype strains 
in KN-studies. The characterization of antigenic sites by a large panel of MAbs raised against 
the H- the H- and and F-glycoproteins of CDV- and PDV-prototype viruses substantiated 
the interspecies differentiation. The limited degree of reciproke cross neutralization between 
PDV and CDV isolates as observed by conventional techniques (Liess et al., 1989b; Harder 
et al., 1991b) and kinetic neutralization as shown in the present study showed that only a 
few epitopes which are relevant for in vitro-neutralization are shared between the two virus 
types. This can be interpreted as a result of selection pressure on the H-protein leading to an 
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optimal adaptation to cellular receptors of different natural host species. The homology of 
the amino acid composition between the attachment proteins of CDV and PDV was shown 
to be about 75 % (Kovamees et al., 1991; Curran et aI., 1992). These significant differences 
can not be attributed simply to a recent interspecies transmission of a CDV-like virus to 
seals. 
It may be speculated whether cross neutralization between distantly related morbilliviruses 
such as CDV and RPV or MV is largely mediated by epitopes of the F-protein. The fusion pro-
tein is one of the most conserved morbillivirus proteins and neutralization-relevant epitopes 
have previously been identified on the MV F-protein by monoclonal antibodies (Malvoisin and 
Wild, 1990). The demonstration of neutralizing activities in monospecific sera raised against 
isolated F-proteins, however, proved to be difficult (Norrby & Gollmar, 1975; Varsanyi et al., 
1987; Barrett et aI., 1989; Taylor et al., 1991). 
Antigenic intratypic differences among viruses which were grouped in the same Nb-ciuster 
were evident by a remarkable heterogeneity of neutralization profiles (see Tab. 3, cluster I) 
which were substantiated by the reaction patterns of five MAbs directed against different 
epitopes of the H-protein and by one MAb specific for a F-protein epitope. The detection 
of intratypic variants which differ in biologically active antigenic sites confirm and extend 
findings findings of a previous study where the same panel of MAbs was applied to a num-
ber of different isolates of CDV and PDV (Blixenkrone-M¢lier et al., 1992). Epitope-typing, 
however, provided no explanation for the clustering of the mustelid distemper isolate 1493 
in KN-studies. Nevertheless, epitopes may be involved which are not detected by any of the 
MAbs employed. MAbs 'H 1.067 E5' and 'H 1.068 F2' directed against epitopes designa-
ted Hz and H3 of the PDV-H-pr~tein were previously found not to react with CDV-like 
strains (Blixenkrone-M¢lIer et al., 1992). In this investigation, however, both MAbs detected 
corresponding epitopes in all strains of CDV. The observed discrepancy appeared to be due 
to differences of the test methods employed; in the former study results were obtained by 
indirect immunofluorescence using acetone-fixed cell-bound antigen. When heat-fixation as 
carried out routinely in this study was replaced by acetone treatment of morbillivirus-infected 
cells, both epitopes were found to be lost in CDV-, but not in PDV-strains. Thus, epitopes 
Hz and H3 (PDV-H) are acetone-labile in CDV-like viruses. 
In addition to qualitative differences concerning the presence or absence of certain functio-
nal epitopes, quantitative variations in the concentration of neutralization-relevant epitopes 
on the surface of a virus must also be considered when interpreting the occurence of intratypic 
neutralization variants. It may be assumed that two isolates display H- (and F-) glycoproteins 
which are identical in regard to their amino acid and glycosilation patterns; however, copies of 
each of the proteins are incorporated in different numbers into the envelope of each isolate. 
For a complete neutralization of the isolate which displays lower numbers of glycoprotein 
copies and thus a lower concentration of fun'ctional (neutralization-critical) epitopes, lesser 
amounts of antibodies are needed. Consequently, this isolate will be more rapidly neutrali-
zed by equimolar amounts of antibodies compared to isolate with higher concentrations of 
neutralization-relevant epitopes. This phenomenon has recently been demonstrated among 
cell culture-variants of the Edmonston strain of MV where considerably higher tit res of neu-
tralizing antibodies in specific sera were measurable when a high-passaged, plaque-purified 
variant was used and compared to low-passage virus material (Albrecht et al., 1981). Dif-
ferences concerning the density of otherwise identical neutralization-critical epitopes could 
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contribute to the observed heterogeneity among viruses grouped within the No-cluster I of 
this study. Furthermore, none of the isolates used were plaque-purified and therefore are likely 
to represent genetically and probably also phenotypically inhomogeneous populations. 
At present, possible in vivo-effects of the occurence of intratypic neutralization variants 
of distemper viruses can not be assessed. The fact, however, that two recent CDV isolates 
appeared to be distinguishable from two commonly used vaccine strains demands further 
investigations of a larger number of recent distemper field isolates. The immunoplaque assay 
proved to be a useful alternative in quantitative virological investigations in virus-cell sy-
stems when cell culture properties of the viruses under study interfere with the performance 
of regular plaque assays which may be encountered in studies of e.g. non-cytopathogenic 
pestiviruses (Howard et al., 1987) or retroviruses (Fevereiro et al., 1991). 
Acknowledgements -This work was supported financially by the Ministry of Science and Culture, 
Federal State of Lower Saxony, F.R.G. We are grateful to Dr. G. Rockhorn, Uppsala, and Dr. M. 
Drescher, Hanover, for providing virus strains. 
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3.2 - CDV in Serengeti's lions 
Abstract - Recently an epizootic, reported to be due to a morbillivirus infection, affected the 
lion population of the Tanzanian Serengeti National Park, A morbillivirus phosphoprotein (P) gene 
fragment was amplified by peR from tissue samples of several affected lions. Sequencing of the 
amplificates and subsequent phylogenetic analyses revealed that a wild· type strain of canine di-
stemper morbillivirus (CDV) was involved. Vaccination of the local domestic dog population with 
proven safe CDV vaccines is proposed. 
Recently, a considerable proportion of the lion population of the Tanzanian Serengeti 
National Park, has succumbed to a disease that closely resembles distemper in dogs and seals, 
which are caused by the morbilliviruses canine distemper virus (CDV) and phocine distemper 
virus (PDV), respectively (Appel & Gillespie, 1972; Osterhaus et al., 1988). On basis of 
the clinical symptoms observed, a morbillivirus aetiology was suspected and subsequently 
confirmed by demonstrating immunofluorescence with morbillivirus specific antisera in organs 
of dead lions, and by showing the development of morbillivirus specific serum antibodies in 
affected animals (cited after Morell, 1994). Details of the distemper outbreak in lions in 
the Serengeti are being reported separately (Roelke et aJ.. 1996). Until recently, felids were 
not considered natural hosts of morbilliviruses. However, in 1991 and 1992 infections with 
CDV-like morbilliviruses caused enzootics amongst large felids in zoos in the USA (Appel et 
al., 1994). To acquire insight in the possible origin of the viruses involved in these outbreaks 
in large felids, we have conducted a phylogenetic analysis of the viruses involved. To this 
end we have sequenced and compared a P gene fragment of the respective morbilliviruses, 
which was previously shown to be informative for determining phylogenetic relationships of 
the presently known members of the genus Morbillivirus (Barrett et al., 1993). 
Brain and lymphoid tissues obtained from five lions which had died in the Serengeti National 
Park during the outbreak (kindly provided by Dr. Hans Lutz, Dept. of Internal Veterinary 
Medicine, University of Zurich on behalf of the Messerli Foundation of Zurich, Switzerland) 
were processed for reverse transcription of total RNA with random hexamer primers and 
subsequent PCR amplification of the relevant P gene fragment using the suitable primer set 
(Barrett et a/., 1993). The amplificates were identified as P gene derived by Southern blot 
analysis using a CDV P gene fragment. In the tissues of four out of the five lions, the relevant 
P gene fragment was detected (not shown). P gene fragments derived from brain material of 
two lions were cloned and sequenced, using standard techniques (Murphy & Kavanagh, 1988). 
The sequences were identical and were subsequently compared to corresponding recently 
determined P gene fragments of other morbilliviruses. These included CDV vaccine strains 
(Onderstepoort and Bussell), recent CDV isolates from a dog in Europe and from a seal in 
Siberia (PDV-2) as well as recent isolates from a grey fox (A92-9A) and a captive black 
leopard (A92-6) from the USA, PDV, measles virus (MV), rinderpestvirus (RPV) and two 
cetacean morbilliviruses (DMV and PMV, for review see Barrett et al., 1993; Visser et a/., 
1993a). Sequence alignments of the P gene fragment of a Vero cell adapted CDV isolate 
from a captive black leopard (A92-6; Appel et al., 1994) and a PCR amplificate obtained 
from brain material of a Serengeti lion (94-28/PLE) are shown in Fig. 1. 
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Figure 1. Sequence alignment generated by 'Pileup' of the GCG software package (version 8.0) of 
a 388 bp P gene fragment (sequences of peR primers are excluded) of the Onderstepoort (Onst) 
vaccine strain of canine distemper virus (GenBank ace. no. X51869), Vero cell-adapted CDV isolates 
of a black leopard (A92-6) from a North American zoo and of a grey fox (A92-9A) from the USA 
as well as a PCR amplificate obtained from brain material of a free-ranging lion of the Tanzanian 
Serengeti Nationalpark (94-28/PLE). Identical nucleotides are shown as dots. Non-synonymous 
mutations to the ONST sequence are shown in upper case. 
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Figure 2. Phylogenetic tree, generated by the neighbor joining method (Saitou & Nei, 1987). of 
morbilliviruses based on analysis of a 388 bp P gene fragment (excluding sequences of primers used 
for peR). The robustness of the tree was statistically analysed by the bootstrap method employing 
2000 replications (Felsenstein, 1985; Hedges, 1992). Values of ;::: 95 indicate statistic significance 
that the respective cluster is separated from the rest of the tree, Maximum parsimony analysis of 
the data gave similar results (not shown). Branch lengths are proportional to the genetic distances 
which were calculated by the Kimura-2-parameter method (Kimura, 1980). Sequences were aligned 
by using 'Pileup' of the GCG.software package (release 8.0) setting gap weights to 3.0 and gap 
length weights to 0.1. Within the compared fragment no gaps were observed. MV - measles virus 
(M89920); RPV - rinderpest virus (X68311); DMV, PMV - dolphin and porpoise morbilli viruses; 
PDV - phocid distemper virus (European harbour seal morbillivirus, DI0371); ONST (X51869), 
Bussell - canine distemper virus (CDV) vaccine strains; 5804/Han90 - CDV field isolate obtained 
from a dog in Germany; PDV-2 - phocid distemper virus type-2 (Baikal seal morbillivirus); A92-6 
- CDV isolate of a captive black leopard from the USA; A92-9A - CDV isolate of a grey fox from 
the USA; Serengeti lions 94-28/PLE and 94-36/PLE - sequence of PCR amplificates of the P gene 
fragment generated from brain material: three, respectively two, clones were sequenced, all showed 
an identical sequence. Sequences were either extracted from the GenBank data base (acc. no given 
in brackets) or from recent publications (Barrett et al., 1993; Mamaev et al., 1995, 1996). 
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From the phylogenetic tree constructed on basis of these data, it may be concluded that 
the morbillivirus that caused the epizootic amongst the Serengeti lions belongs to the CDV 
cluster of morbilliviruses (Fig. 2). The data also indicate that the viruses which caused the 
recent outbreaks amongst large felids in the U.s.A. and in Africa are no new or separate 
felid morbilliviruses but rather viruses circulating in domestic and wild carnivores that from 
time to time also cross species barriers into feline hosts. Similarly, evidence for CDV and 
PDV infections in pinniped species and for DMV and PMV infections in cetacean species 
was recently reported (Osterhaus et al., 1988; Visser et al., 1993a) which had apparently 
not been infected with these viruses in the last decades. Whether the crossing of species 
barriers is a natural phenomenon for morbilliviruses that has largely been overlooked in the 
past, or whether predisposing factors have rendered the species involved more susceptible to 
infections with 'foreign' morbilliviruses, remains to be determined. Efforts are in progress to 
isolate the CDV strain causing mortality among lions in the Serengeti and further sequence 
its Hand F glycoprotein genes for more detailed comparisons. 
Efficient control of morbillivirus infections can be achieved by vaccination measures. Ho-
wever, vaccination of wild life populations is not generally recommendable. Furthermore, use 
of live attenuated CDV vaccines in non-canid wildlife species which are highly susceptible to 
CDV infections such as the lesser panda or mustelid species like the black-footed ferret led to 
vaccine-induced fatal distemper. Therefore, in order to reduce the potential risk of recurrent 
introduction of CDV into the population of large felids and other CDV susceptible carnivores 
of the Serengeti we propose to vaccinate the local domestic dog population with proven safe 
·CDV vaccines. 
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3.3 - CDV infections in large felids 
Abstract - Specific pathogen free (SPF) domestic cats were inoculated with tissue homogenate 
obtained from a Chinese leopard (Panthera pardus japonensis) that had died in a North American 
zoo from a natural infection with canine distemper virus (CDV). The cats developed a transient 
cell-associated CDV viremia along with pronounced lymphopenia but did not show any clinical 
symptoms. Plasma neutralizing antibody titers against the homologous CDV (A92-27/4, isolated 
from the Chinese leopard) were consistently higher than against the CDV vaccine strain 'Bussell'. 
The Chinese leopard CDV isolate showed in vitro biological properties reminiscent of virulent, 
wild-type CDV strains. Sequence analysis of the H gene of two large felid COV isolates from the 
USA (A92-27/4 and A92-6) revealed up to ten percent scattered predicted amino acid changes 
including up to four additional potential N-linked glycosilation sites in the extra cytoplasmic domain 
as compared to COV vaccine strains. Phylogenetic analysis was performed using the entire coding 
region of the H gene and a 388 bp fragment of the P gene of several morbillivirus species. Evidence 
was obtained that recent COV isolates from different species in the USA (including isolates from 
large felids), Europe and Africa are significantly distinct from CDV vaccine strains. All wild-type 
CDV isolates analysed clustered according to geographical distribution rather than to host species 
origin. By sequence analysis a CDV epizootic among large felids in a Californian Safari Park was 
linked to a virus which most likely originated from feral non-felid carnivores. 
Introduction 
Within the genus Morbillivirus of the Paramyxoviridae family, seven virus species have been 
identified to date which infect humans (measles virus, MV), ruminants (rinderpest virus, 
RPV and peste des petits ruminants virus, PPRV), terrestrial carnivores (canine distemper 
virus, CDV), marine carnivores (phocine distemper virus, PDV) or cetaceans (porpoise and 
dolphin morbilliviruses, PMV and DMV) (Pringle, 1992; Visser et al., 1993a). Although most 
of these viruses may infect more than one species, susceptible animals are usually restricted 
to a single order (Appel & Gillespie, 1972). CDV has been shown to infect terrestrial and 
aquatic carnivores under natural circumstances (Mamaev et a/., 1995a). Sporadic suspect 
cases of natural CDV infection in large felids were first reported in 1981 (Cook & Wilcox, 
1981). Apparently unrelated enzootic outbreaks of CDV infections amongst Old World large 
felids (tigers, lions and leopards) have been noted in different zoos in the USA in recent 
years (Appel et al., 1994). Virus isolates from these outbreaks were identified as CDV on the 
basis of cross reactivity in virus neutralization assay and typing with a limited set of mouse 
monoclonal antibodies (MAbs) (Appel et al., 1994). Recently, an epizootic associated with 
considerable mortality among lions in the Tanzanian Serengeti National Park has also been 
attributed to CDV infection (Morell, 1994; Harder et al., 1995). 
In the large felid populations of the North American zoos, the infection probably spread 
from cat to cat although recurrent introduction from a common source of infection (e.g. 
free-ranging Procyonidae species like racoons) was not excluded. It remained elusive whether 
each outbreak was due to separate introductions of CDV or whether a cat-adapted strain of 
CDV circulated in these populations (Appel et al., 1994). 
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To date, there are no indications for naturally occurring morbillivirus infections in domestic 
cats. Experimental infection of cats with the highly virulent Snyder-Hill strain of CDV resulted 
in an asymptomatic infection and virus shedding could not be demonstrated (Appel et al., 
1974). 
Here we describe the results of experimental infection of SPF domestic cats with tissue 
homogenate from a Chinese leopard that had died recently from a CDV infection in a zoo 
in the USA (Appel et al., 1994) and the phylogenetic comparison of CDV isolates from felid 
and non-felid origin. 
Materials and methods 
Viruses and cells - Canine peripheral blood mononuclear cells (PBMC) obtained from a healthy 
SPF dog were prepared from heparinized blood samples as previously described (Visser et al .. 
1993a), stimulat'ed overnight in the presence of 20 Jig ml- I of PHA-M and maintained in Iscove's 
medium supplemented with 20% fetal calf serum (FCS) and 100 I.U. ml-1 of recombinant human 
interleukin 2 (rh IL-2). Feline PBMC and thymocytes or lion (Panthera leo) PBMC were stimulated 
for three days using Concanavalin A (Con A, 5 Jig ml- I ) and expanded in RPMI 1640 containing 
10% FCS and 100 I.U. ml- 1 rh IL-2 (Siebelink et al., 1990). Vero cells as well as CRFK cells (clone 
ID 10) were kept in Dulbecco's modified Eagle's medium (DMEM) supplemented with 4% or 10% 
FCS, respectively. 
The CDV strain 'Bussell' a Vero cell-adapted clone of the Onderstepoort vaccine strain (Bussell 
& Karzon, 1965) was used as a reference virus. The COV isolate A 92-27/4 was obtained from 
thymus material of a fata lIy diseased Chinese leopard (Panthera pardus japonensis) of the Shambala 
Wildlife Waystation, Angeles National Forest, California, using stimulated canine PBMC. CDV A92-
27/4 was passaged four times in stimulated canine PBMC and adapted to replication in Vero cells 
by cocultivation with infected canine PBMC. Stock virus was prepared from material of the third 
passage in Vero cells. CDV A92-6 originated from a black leopard (Panthera pardus) that died 
of the infection in a zoo located in Illinois (USA). The CDV isolate A92-27/14b was obtained 
from a racoon (Procyon lotor) which had been found in close vicinity of the Shambala location. 
These isolates were passaged three to five times in Vero cells following primary isolation in dog 
lymphocytes. 
Infection and sampling of cats - Two specific pathogen-free (SPF) domestic European short 
hair cats were inoculated intratracheally with 3 ml of 10% (w/v) tissue homogenates (lung, thymus, 
brain) of a Chinese leopard that had died from a morbillivirus infection and from which COV A92-
27/4 had been isolated (Appel et al., 1994). 
Blood samples and tonsillar swabs were collected at days 0, 2, 4, 7, 9, 11, 14, 17, 21 and 
36 post inoculation along with the recording of rectal temperatures. PBMC were recovered for 
virus isolation from heparinized blood samples by Iymphoprep density centrifugation as previously 
described (Siebel ink et al., 1990). Plasma was used for serological analysis. Routine hematological 
parameters were measured with EDTA blood samples. 
Animals were euthanized on day 36. Direct tissue cultures were initiated from kidneys and lympha-
tic organs (spleen and mesenteriallymphnodes) of all cats using standard procedures. In addition, 
11-2 dependent T cell lines were raised from PBMC of the day 0 blood samples of the cats by serial 
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repeats of Con-A stimulation and expansion In IL-2 containing medium as previously described 
(Siebelink et al., 1990). 
Virus isolation and identification - PBMC obtained from the inoculated cats were stimulated 
for 3 hours in the presence of 5 pg Con A and then diluted in duplicate in five 10glO steps from 
100,000 to 1 cell per ml. 1 x 105 stimulated canine PBMC were added and cocultivated for seven 
days. Plasma samples, pharyngeal swabs and tissue homogenates of various organs were directly 
inoculated into canine PBMC cultures containing approx. 1 x 105 cells ml- 1 , Following an adsorption 
period of two hours, the cells were washed twice in Iseove's medium and cultivated for seven days, 
After one freeze/thaw cycle a second passage of seven days was initiated for all isolation attempts. 
Morbillivirus antigen was detected with the monoclonal antibody (MAb) F 3.5 directed against 
a highly conserved epitope located on the fusion (F) glycoprotein employing an immune peroxidase 
monolayer assay (IPMA) described elsewhere (Harder et al., 1993b). 
Virus isolation from tissue homogenates used for the inoculation of SPF cats was also attempted 
using mitogen-stimulated PBMC of a dog, a cat and a lion, feline thymocytes as well as Vero and 
CRFK cells. ' 
Serological assays - Plasma samples were assayed for morbillivirus neutralizing antibodies against 
50 - 100 TCIDso of the Vero cell-adapted homologous CDV isolate (A 92-27/4,3. passage) and the 
Bussell strain of COV by a microneutralization assay. N05-o titers were calculated by the Kaerber 
method (Kaerber, 1931). 
Radioimmunoprecipitation assays - Vero cells infected by the respective morbilli viruses we-
re metabolically labelled for two hours with [3ssJ-methionine/cysteine (Amersham-Buchler, 100 
pCi/25cm2 tissue culture flask) when a viral-induced cytopathic effect had involved approximately 
50% of the monolayer. Preparation of cell Iysates and precipitation reactions using either MAbs 
specific for the nucleocapsid (N), phospho (P), fusion (F) and hemagglutinine (H) proteins or sera 
from experimentally infected cats were exactly as described (Barrett et al., 1989). Precipitates were 
separated by 50S-PAGE under reducing conditions in 10% gels. 
Antigenicity profiles lIsing MAbs - Reactivities of MAbs to antigens of the COV strain Bussell 
and the isolate A92-27/4 were assayed in an IPMA using heat-fixed infected Vera cell cultures 
as described previously (Harder et al., 1993b). MAbs were tested in dilutions of 1/50, 1/500 and 
1/5000. The panel of MAb's specific for the F and H glycoproteins had previously been raised against 
the Convac strain of CDV (Orvell et al., 1985). 
Amplification. cloning and sequencing of a P-gene fragment and the complete coding 
region of the H-gene - Total RNA was prepared from Vera cells infected by the different COV 
strains and used for cONA synthesis as described (Visser et al., 1993a). All PCR reactions were 
limited to 25 cycles comprising of 30" at 94°C, l' at 55°C and l' at 72°(, A final elongation phase 
of 10' at 72°C was allowed. 
Universal primers suitable for the amplification of a 429 bp fragment from the P gene of various 
morbillivirus species have been described (Barrett et al., 1993). The upstream primer (5'- TTA 
ATT GAG CTC ATG TTT ATG ATC ACA GCG GTG - 3') represents positions 400 - 419 on the 
measles virus P gene (mRNA sense) while the downstream primer (5'- TTA ATT ACT AGT ATT 
GGG TTG CAC CAC TTG TC - 3') refers to nucleotides P 828 - 808 (vRNA sense) (Bellini et 
al., 1985). The amplificate spans the RNA editing site Cattaneo et al., 1989). Amplificates were 
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cloned into pBluescript SK/+ using Sac I (upper primer) and Spe I (lower primer) restriction sites 
(shown as italics in primer sequences). 
The H gene was amplified using primers RH-3 (5'-AGG GCT CAG GTA GTC CAG C -3') 
representing nucleotides 1 - 19 of the mRNA and RH-4 (5'- AAT GCT AGA GAT GGT TTA ATT 
-3') referring to nucleotides 1937 - 1917 of the H-gene (vRNA sense), thus extending into the 
3'·UTR of the H mRNA (sequences taken from the CDV vaccine strain Onderstepoort, GenBank 
acc. no. #D00758). Amplificates of approximately 1.9 kB comprising the complete coding region 
were cloned into a BtickyT vector (peR II, Invitrogen). 
Dideoxy-sequencing of double stranded plasmid DNA was carried out using M13 universal forward 
and reverse primers (Murphy & Kavanagh, 1988) as well as sequence-specific 17mers (H gene). 
Two clones obtained from a single peR reaction were sequenced in completion. To correct for 
possible reading errors of the Taq polymerase a third clone was analysed if necessary. Sequences 
were assembled and analysed using the Genetics Computer Group (GCG) software package (release 
8.0). Computer-assisted phylogenetic analysis ('MEGA', version 1.01, [Kumar et a/., 1994]) of the 
nucleotide sequences was done by the neighbor-joining method (Saitou & Nei, 1987); distances 
were calculated according to Kimura's 2-parameter method (Kimura, 1980). Bootstrap analysis 
(Felsenstein, 1985) was performed using 2000 replications (Hedges, 1992). 
GenBank accession numbers - Sequences of the H gene of CDV A92-27/4 and CDV A92-6 
have been assigned GenBank accession numbers #254156 and #254166, respectively. 
Results 
Clinical and virological outcome of Chinese leopard CDV infection in 
SPF cats 
Within the 36 day observation period following inoculation with tissue homogenate of a 
Chinese leopard that had died from a CDV infection, no overt clinical symptoms were observed 
in the inoculated SPF cats. A transient leuko- and lymphopenia, which was most pronounced 
between days 7 to 11 was observed in both these cats (Fig. 1). 
Lymphopenia was accompanied by a PBMC associated CDV viremia which peaked about 
one week after infection and had subsided within two weeks after infection (Fig. 1). CDV was 
isolated in mitogen-stimulated canine PBMC: large multinucleated syncytia became apparent 
after four to six days of incubation. Immunocytochemically it was shown that these syncytia, 
and single mononuclear cells, contained CDV antigen. Isolation attempts were unsuccessful 
when similarly stimulated feline or lion PBMC, feline thymocytes, Vero cells and CRFK cells 
were used (not shown). CDV could not be isolated from tonsillar swabs or from cell-free 
plasma samples. 
CDV neutralizing plasma antibody titers reached higher levels and could be detected earlier 
against the homologous CDV (A92-27/4, Chinese leopard) than against the Bussell vaccine 
strain of CDV (Fig. 1). 
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Figure 1. Results of experimental inoculation of two domestic SPF cats (A, B) with tissue homo-
genate from a Chinese leopard that had died from a CDV infection. Upper panel: Peripheral blood 
lymphocyte counts (0-0) and numbers of CDV infected PBMC per 10· PBMC are shown (grey 
columns). Lower panel: Kinetics of neutralizing plasma antibody titers (iagto NOso) against the 
Chinese leopard CDV isolate A92·27/4 (0-0) and the CDV vaccine strain Bussell (a-a). 
Patterns of MAb recognition and migration in PAGE of Chinese Jeo-
pard CDV (A92-27/4) proteins 
Using a panel of MAbs specific for seven or three operationally defined non-overlapping 
epitopes of the CDV Hand F proteins respectively, no significant differences in reactivity to 
A92-27/4 or the CDV Bussell strain were seen in IPMA, except for MAb 3.775 specific for 
the epitope H-4 which did not react to A92-27/4 (data not shown). 
Similarly, migration paUerns of CDV A92-27/4 proteins immunoprecipitated by MAbs or 
convalescent cat sera from infected ceillysates were in the range found for other CDV strains 
(data not shown). The P protein of CDV A92-27/4, however, migrated at about 85 kDa which 
is considerably higher than that of previously examined CDV strains which migrate at about 
72-75 kDa (brvell, 1980; Rima et al., 1991; Shapshak et al., 1982). Also, a difference between 
the molecular weights of the H protein of the Bussell strain (72 kDa) and A92-27/4 (78/82 
kDa) was noticed (not shown). 
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Sequence comparison and phylogenetic analysis of CDV isolates using 
a P-gene fragment 
A 388 bp P gene fragment had previously been shown to be informative for infering the phy-
logenetic relationships of morbilliviruses (Barrett et al., 1993). Alignments of the respective 
fragments from the large felid morbilliviruses A92-27/4 and A92-6, recent American and Eu-
ropean CDV field isolates (Mamaev et al., 1995a) from non-felid species, a P gene sequence 
obtained from a PCR amplificate of CNS tissues of a Serengeti lion (Harder et al., 1995) 
and two CDV vaccine strains (Onderstepoort and Bussell) are presented in Fig. 2. The field 
isolates harboured up to 16 mutations when compared to the sequences of the two vaccine 
strains, which proved to be identical . 
Phylogenetic analysis of these sequences revealed a clustering within the group of canine 
distemper-like viruses (Fig. 3a). The vaccine strains are clearly separated from recent CDV 
isolates as indicated by the high bootstrap values. Wild-type CDV isolates can be subdivided 
into clusters reflecting their geographic origin as European, American or African. The two 
CDV isolates obtained from large cats in Illinois (A92-6) and California (A92-27/4) were 
quite distinct whereas a grey fox isolate (A92-9a) and a racoon isolate (A92-27 /14b) from 
California were most closely related to the Chinese leopard CDV isolate A92-27/4. It is 
interesting to note that the racoon was found in close vicinity to the Safari Park where the 
Chinese leopard was kept. 
Sequence comparison and phylogenetic analysis of the H gene of two 
CDV isolates from large felids 
A 1.9 kB product representing almost the entire H mRNA was amplified by PCR from the 
CDV isolates A92-27/4 (Chinese leopard, California) and A92-6 (black leopard, Illinois). Se-
quence analysis revealed unique sequences of both isolates which differed from each other in 
3.0 % at the nucleotide level. A single large open reading frame (ORF) was identified of which 
the amino acid composition was deduced and aligned to those of CDV vaccine strains (Fig. 
4) showing scattered predicted amino acid changes of up to 10%. While the Onderstepoort 
Figure 2. Alignment of nucleotide sequences of a P-gene fragment (mRNA sense) of CDV strains 
and isolates. Sequences of primers used for peR amplification are excluded. Line 1 shows the 
nucleotide sequence of the Onderstepoort vaccine strain of CDV (GenBank ace. no. #X51869). 
Non-synonymous mutations to this sequence are shown in upper case, Bussell: CDV vaccine strain; 
A92-27/4: Chinese leopard isolate (California, USA, 1992); A92-24/14b: racoon isolate (California, 
USA, 1992), Other sequences were taken from Harder et al. (1995): A92-9a: grey fox isolate (Cali-
fornia, USA 1992); A92-6: black leopard isolate (Illinois, USA, 1992); 94-28/PLE: Lion (Serengeti, 
Tanzania 1994) and from Mamaev et 31. (1995a), respectively: 1493/Han89: ferret isolate (Ger-
many, 1989); 5804/Han90: dog isolate (Germany, 1990); PDV-2: isolate from a Baikal seal (Phoca 
sibirica) , Siberia. Sequences were aligned with 'Pileup' included in the GCG software package. 
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Figure 3. Phylogenetic analysis of canine distemper-like virus isolates and other morbillivirus spe-
cies computed on the basis of a sequence analysis of a 388 bp P gene fragment (A) and the entire 
protein coding region of the H gene (B). Sequences of CDV Bussell, A92·27/4 (Chinese leopard, 
California 1992), A92·6 (black leopard, IIlionois 1992, H gene) and A92·27/14b (raccoon, Califor· 
nia, 1992) were generated in this study. Other sequences were extracted from GenBank database: 
CDV strain Onderstepoort (P: #X51869, H: #L13194), CDV strain Convac (H: #Z35493), PDV 
(P, H: #DI0371), MV vaccine strain Edmonston (P: #M89920, H: #U03669), RPV strain RBOK 
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H gene harbours an ORF capable of encoding 604 amino acids (Curran et al., 1991), those 
of the large felid isolates and the Convac vaccine strain (Kevamees et al., 1991) code for 607 
amino acids. Secondary structure analysis revealed that the H protein of the large cat CDV 
isolates, like all other morbillivirus attachment proteins (Morrison, 1988), represents a class II 
transmembrane glycoprotein with a putative membrane anchor sequence near its N-terminus 
(positions aa 35-55, overlined in Fig. 4). All 12 cysteine residues were completely conserved 
between the CDV isolates whereas 94 % of the proline residues of the Onderstepoort H 
protein were retained in the large cat isolates. The glycosilation pattern, however, differed 
considerably (Fig. 4). While four potential N-linked glycosilation sites were shared between 
all CDV isolates, three (Convac and A92-6), respectively four (A92-27 /4) additional sites, 
all located in the extracytoplasmic domain, proved to be present in the other sequences. 
Phylogenetic analysis of the entire protein-encoding region of the H gene (Fig. 3b) con-
firmed the clustering of the large cat isolates as CDV-like. Bootstrap P values indicate that 
they are significantly separated from CDV vaccine strains and also from current European 
and Asian CDV wild-type isolates. 
Discussion 
In the present study we have shown that SPF cats can be infected by CDV from a Chinese 
leopard, without developing overt clinical symptoms and that the CDV isolates which have 
recently caused disease outbreaks in large felids do not constitute a separate lineage within 
CDV. Tissue homogenate instead of a CDV isolate was used for this inoculation as it has 
been shown that adaptation of morbilliviruses to replication in cell culture systems may affect 
its virulence (Friedlander et a/., 1985; Appel et a/., 1992). 
The apparent lack of clinical symptoms in the SPF cats should be interpreted with cauti-
on, since we have also shown that e.g. infection with the usually highly virulent Snyder-Hill 
(P: #X68311, H: #M21513), RPV strain L (H: #M17434) or from recent publications (Barrett 
et a/., 1993): dolphin (DMV) and porpoise morbilliviruses (PMV); (Mamaev et al., 1995a, 1995b): 
1493/89 (ferret, Germany 1989), 5804/90 (dog, Germany, 1990), phocid distemper type-2 (PDV-
2, Lake Baikal seal); (Harder et al., 1995): CDV A92-6 (black leopard, P) and A92-9a (grey fox, 
California, 1992). MUltiple sequence alignments were computed by 'Pileup' included in the GCG 
software package (version 8.0) setting gap creation weights to 3.0 and gap extension weights 
to 0.1. Distances were calculated by the Kimura-2-parameter method (Kimura, 1980) and used 
to construct trees according to the neighbor-joining method (Saitou & Nei, 1987). Alignment 
gaps were ignored in pairwise distance estimations. Branches are drawn in proportion to genetic 
distances as indicated by the bar. Numbers at tree branchings represent bootstrap P values after 
2000 replications (Felsenstein, 1985; Hedges, 1992). Values ;:::. 95% indicate a statistically significant 
separation of the respective cluster from the rest of the tree. All calculations were carried out using 
the 'MEGA' PC program (Kumar et al., 1994). 
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3.3 - CDV infections in large felids 
strain of CDV only results in mild symptoms in SPF dogs (De Vries et al., 1988). Although 
domestic cats, in contrast to large felids, may have a high intrinsic resistance towards CDV 
infections, it can not be excluded that conventionally raised domestic cats may develop clinical 
symptoms upon CDV infection. So far, however, clinical and epidemiological indications for 
this assumption are lacking. In contrast, CDV-neutralizing antibodies have been detected in 
sera of healthy domestic cats from the Netherlands (Osterhaus & Vos, unpublished). 
For the isolation and amplification of large cat CDV isolates mitogen-stimulated canine 
PBMC proved to be the most suitable cells. Replication of CDV A92-27/4 in Vero cells, 
in contrast, required an adaptation of three passages of 14 days each. In accordance with 
previously published biological data (Appel et a/., 1994) these results confirm that CDV 
A92-27/4 represents a non-attenuated strain of CDV. Replication of CDV A92-27/4 in feline 
lymphoid cells, including IL-2-dependent T cell lines established from each of the SPF cats, 
could hardly be demonstrated (data not shown) and during further passaging infectivity rates 
also declined gradually. This is also in line with results of an earlier study (Appel et al., 1974), 
in which serial passage of the Snyder-Hill strain of CDV could not be accomplished in in feline 
lung macrophages, while the virus replicated fulminantly in canine lung macrophages. This 
is yet another indication that the morbillivirus isolates from large felids, are not members of 
a separate feline lineage of CDV. 
Comparison of the deduced amino acid sequences of the H protein of the CDV isola-
tes A92-27/4 and A92-6 to other CDV-like viruses revealed up to ten percent scattered 
differences, which is within the range reported for other morbillivirus species like MV and 
RPV. The number of potential N-linked glycosilation sites in the H protein of the large 
cat isolates resembles the situation of recent wild-type CDV isolates (5804, 1493) of non-
felid origin (Mamaev et al., 1995b), but is quite distinct from that in the vaccine strains. 
In the measles virus H protein, N-linked carbohydrates were found to be involved in the 
formation of conformational epitopes which appeared to be critical in eliciting neutralizing 
antibodies (Hu et al., 1994). The differences found in potential N-linked glycosilation sites 
between wild-type and vaccine strains of CDV may explain the differences in neutralization 
efficacy of sera obtained from the experimentally inoculated domestic cats towards the ho-
mologous isolate (A92-27/4) and the Bussell vaccine strain. Comparable differences in cross 
neutralization efficacies were also described for recent CDV field isolates from a dog (5804) 
Figure 4. Alignment of deduced amino acid sequences of the H-proteins the canine distemper 
virus vaccine strain Onderstepoort (#000758), tne COV vaccine strain Convac (#Z35493), recent 
CDV field isolates from a dog (5804; #Z85000) and a ferret (1493; #Z84999), and two CDV 
isolates obtained from captive large felids (A92-27/4: Chinese leopard; A92-6: black leopard). Se-
lected, sequences were aligned using 'Pileup' and secondary structure predictions were computed 
by 'PeptideStructure' and 'Motifs' included in the GCG software package '(version 8.0). A stretch 
of predominantly hydrophobic character representing the putative membrane anchor is overlined. 
Potential Asn-glycosilation sites are boxed, the site at position 19 (dotted box) is probably not used 
as it is located in the intracellular domain. 
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and a ferret (1493) using sera raised aginst the Rockborn vaccine strain of CDV in a kinetic 
neutralization assay (Harder et a/., 1993a). An explicit clustering of predicted amino acid 
changes around potential Asn-glycosilation sites, as has been described for recent MV field 
.isolates (Rota et a/., 1992), however, was neither found in the large felid CDV isolates nor 
in wild-type CDV isolates from other species (Fig. 4). 
Phylogenetic analysis of the H gene and P gene fragment sequences revealed that current 
wild-type CDV isolates and vaccine strains are clearly distinguishable. Within the group of 
recent fiel~ isolates a tendency to cluster according to geographic rather than to host species 
origin was noticed. Geographic lineages have also been described for other morbillivirus species 
(Chamberlain et al., 1993; Rota et al., 1992; Taylor et al., 1991). On basis of our data it 
can be excluded that the US large cat isolates have recently evolved from CDV vaccine 
strains. Instead they rather seem to be representatives of CDV strains presently circulating 
in North America, which was also emphasized by the close phylogenetic relationship between 
the Chinese leopard CDV and a racoon isolate from the same area. 
Taken together, the biological and sequence data we obtained so far do not indicate the 
existence of aCDV lineage adapted to feline species but rather suggest that the outbreaks 
of distemper-like disease among captive and feral large felids are most likely initiated by 
interspecies transmission of CDV from local feral (non-felid) carnivores. 
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Herpesviruses of pinnipeds: Clinical and virological implications 
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4.1 - Herpesviruses of pinnipeds 
Abstract - Harbour seals (Phoca vjtulina) are host to an 0'- and a "(~ herpesvirus, designa-
ted phocid herpesvirus type-l and type-2 (PhHV-l, -2). Serosurveys in various pinniped species 
revealed a global prevalence of PhHV-I and, in part, also of PhHV-2. PhHV-I has been shown 
to exhibit a significant pathogenic potential, particularly in hospitalized seal populations. Disease 
varies considerably from mild upper respiratory disorders to fatal generalized exacerbations and is 
inversely correlated to the age and the immunocompetence of the affected individual. Antigenic 
and molecular characterizations showed that the herpesviruses of terrestrial carnivores, felid and 
canid herpesvirus, are closely related to PhHV-l. Recent developments in the diagnosis of PhHV-l 
infections and attempts toward a subunit vaccine protecting seals from PhHV-l-associated disea-
se are discussed. As yet, no disease conditions have been ascribed to PhHV-2 infection. Previous 
antigenic and molecular studies and further nucleotide sequence analysis presented here, suggest 
a clustering of PhHV-2 together with its seemingly closest relative, the equine herpesvirus-2, as a 
third genus in the J-Herpesvirinae subfamily. 
Introduction 
Devastating epizootics among seals in northwestern European waters (1988) and among 
dolphins of the Mediterraenean Sea (1990/91), caused by previously unknown viruses of the 
Morbillivirus genus, resulted in an upsurge of general public and scientific interest in virus 
infections of aquatic mammals (Heide-J¢rgensen et al., 1992; Osterhaus et al., 1995). A 
considerable expansion in knowledge of marine ~ammal viruses has occured since. To date, 
at least thirteen virus species out of ten virus families, including, e.g., adeno-, pox-, morbilli-
and herpesviruses, have been shown to infect pinnipeds and/or cetaceans (reviewed by Visser 
et al., 1991). While morbilliviruses require a considerable critkal population size of up to 
400.000 individuals to maintain an endemis status, herpesviruses, in contrast, perpetuate 
even in small populations. Perpetuation is related to persisting latent infections induced 
by herpesviruses in susceptible hosts; infectious virus can be periodically reactivated from 
latency and is often asymptomatically shed. Diseases provoked upon primary herpesvirus 
infection vary from mild superficial mucutaneous lesions, respiratory and Iymphoproliferative 
disorders to fatal generalized infections. Severity of disease is modulated by the age and the 
immunocompetence of the infected individual. 
Pinnipeds are host of at least two distinct herpesvirus species. The a-herpesvirus of seals, 
referred to as phocid herpesvirus-I (PhHV-I), is recognized since 1985 as an important 
pathogen of free-ranging and hospitalized harbour seals (Phoca vitulina) (Osterhaus et al., 
1985; Frey et al., 1989; Stenvers et al., 1992a). We recently showed that PhHV-I is by far 
the most frequently encountered viral pathogen in hospitalized newborn and juvenile harbour 
seals (Harder et al., 1997a), where enzootic PhHV-I-related disease outbreaks can account 
for mortality rates of up to 50% (Osterhaus et al., 1985). 
A second seal herpesvirus type, biologically and antigenically markedly distinct from PhHV-
I, has been isolated from a captive California Sea lion (Za/ophus californian us) and from adult 
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harbour seals of European (North Sea) and United States (North Atlantic) waters and has 
been designated PhHV-2 (Kennedy-Stoskopf et al., 1986; Lebich et al., 1994; Harder et al., 
1996a). While previously published nucleotide sequence data of PhhV-2 suggested a classifi-
cation as a member of the ,-Herpesvirinae, the limited data did not allow an unambiguous 
clustering into one of the ,-herpesvirus genera (Harder et al., 1996a). 
Here, we review data published on the clinical impacts and the molecular properties of her-
pesviruses of pinnipeds. In addition, novel nucleotide sequence data of PhHV-2 are presented 
that enable a more precise taxonomic and phylogenetic classification. 
PhHV-l - a pathogenic alpha-herpesvirus of seals 
PhHV-1 has been first described in 1984 as an agent causing an epizootic disease that was 
associated with high mortality rates among newborn and juvenile harbour seals housed for 
rehabilitation in a Dutch seal sanctuary (Osterhaus et al" 1985). Up to now, PhHV-l con-
tinued to be the most frequent viral pathogen isolated from hospitalized seals (Harder et 
al., 1997a). Development of disease following primary PhHV-l infection depends largely on 
the age and the immunocompetence: Clinically healthy juvenile and adult seals will develop 
mild upper respiratory disease which is usually self-limiting. Inapperent infections probably 
occur frequently as has been shown by a transmission experiment using low passage cell 
culture-grown PhHV-l, which provoked only mild temperature rises in juvenile seals (Hor-
vat et a/., 1989). Whether also fertility problems and ocular disease, disorders commonly 
described for various a-herpesvirus infections, are also associated with PhHV-1 infection 
remains to be elucidated. Severe and frequently fatal PhHV-l disease is seen in immunoin-
competent (neonates) and otherwise immunocompromised seals which are prone to fulminant 
generalized infections characterized by focal necrotic hepatitis and nephritis, gastroenteritis, 
bronchopneumonia and encephalitis (Borst et al., 1986). 
The majority of PhHV-l isolates has been obtained from diseased adult seals during the 
1988 European seal mass mortality (Frey et a/., 1989; Have et al., 1991). Fatal generalized 
PhHV-l infection in these seals probably arose endogeneously from a reactivated latent 
PhHV-l status as a sequel of the concurrent phocid distemper morbillivirus (PDV) infection 
in these animals, being at the basis of a severe immunosuppression (Osterhaus & Vedder, 
1988; Osterhaus et al., 1988; Zhang et al., 1989; Haas et al., 1991). Hardly any data are 
available on the incidence of PhHV-l associated diseases in free-ranging pinniped populations, 
independent from morbillivirus epizootics. It should be noted, however, that PhHV-l has been 
repeatedly isolated since 1990 from carcasses of newborn and adult harbour seals and grey 
seals (Halichoerus grypus) which were found ashore the Baltic and the North Seas as well as 
along US Atlantic coasts (pers. comm. by M. Appel and K. Kulonen; Harder, unpublished; 
Harder et al., 1991a, 1996a). 
Diagnosis of PhHV-l infection is accomplished by demonstration of at least fourfold rises 
of virus neutralizing antibody titers, by virus isolation from swabs and tissue suspensions 
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or by PCR (Osterhaus et al., 1985; Frey et al., 1989; Harder et al., 1997a). The recently 
developed PCR assay, targeting a fragment of the gD gene equivalent of PhHV-1, has been 
shown to be surperior to virus isolation with respect to sensitivity, particularly when bacterio-
logically contaminated or degraded specimens are to be examined (Harder et al., 1997a). A 
comprehensive panel of monoclonal antibodies (mAbs) is available for the rapid identification 
and antigenic characterization of putative herpesvirus isolates from pinnipeds (Lebich et al., 
1994): 
In vitro, the host cell spectrum comprises primary seal fibroblast and epithelial cultures 
(lung/kidney) and several feline cell lines (Crandell-Rees feline kidney, Felis catuswhole fetus 
cells) as well as primary lung or kidney cultures of cats. In cell culture, PhHV-1 exhibits 
a comparatively short replication cycle and significant amounts of cell-free infectivity are 
released. Maximum infectivity titers peak at about 10'·0 TCID,o (Lebich et al., 1994). Round 
cell formation constitutes the predominant cytopathic effect induced by PhHV-l. 
Antigenically, PhHV-1 has been shown to be closely related to canid herpesvirus (CHV), 
and to a lesser extend, also to felid herpesvirus (FHV) (Osterhaus et al., 1985; Harder 
et al., 1991a; Stenvers et aI., 1992b). Immunogenic proteins expressed in infected cells by 
all authentic a-herpesviruses of carnivores (FHV, CHV and PhHV-1) exhibit comparable 
patterns and molecular weights (Harder et al., 1997b). Differentiation is possible by cross 
neutralization assays and by typing with mAbs (Lebich et al., 1994). 
Further evidence for a classification of PhHV-I as a separate species in the Varicellovirus 
genus of the a-Herpesvirinae is based on nucleotide sequence and subsequent phylogenetic 
analysis of the gene encoding the glycoprotein B (gB) which is conserved among all her-
pesvirus species (Harder & Osterhaus, 1997). On basis of this analysis, CHV represents the 
closest relative of PhHV-1 although in vitro, canine cells, in contrast to cultures of feline ori-
gin, are refractory to PhHV-1 and vice versa. In addition, gB has been demonstrated a major 
immunogenic protein of PhHV-l and carries neutralization-relevant epitopes (Lebich et aI., 
1994; Harder & Osterhaus, 1997; Harder et aI., 1997b). PhHV-l gB has been successfully 
expressed as an immunogenically and antigenically authentic molecule in insect cells (Harder 
& Osterhaus, 1997). 
According to several serosurveys, infections with PhHV-1 or other closely related a-her-
pesviruses occur globally in various pinniped species including those of Arctic and Antarctic 
habitates (Vedder et al., 1987; Frey et al., 1989; Harder et al., 1991a; Stenvers et al., 1992b; 
Stuen et al., 1994; Zarnke et aI., 1997). Seroprevalences, however, ranged widely in different 
areas and species. 
Little is known to date about the epidemiology of PhHV-l. In analogy to other a-herpes-
viruses, however, PhHV-l-seropositive seals are considered life-long carriers of latent virus 
which can be periodically reactivated and may be shed asymptomatically. Spread of infection 
is assumed to occur predominantly horizontically via aerosols and direct contact. Considering 
the close antigenic relationship between PhHV-l, CHV and FHV, a susceptibilty of terre-
strial carnivores to PhHV-1 cannot be ruled out at present, although recent attempts to 
transmit PhHV-1 experimentally to FHV-seronegative domestic cats have failed (Osterhaus 
& Soethout, unpublished). 
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Gamma-herpesvirus infections of pinnipeds 
Herpesviruses that are antigenically and biologically distinct from PhHV-1 have been isolated 
since 1986 from four harbour seals (ranging in US North Atlantic waters and in the North 
Sea, respectively) and from a hospitalized Californian sea lion (Za/ophus califarnianus) which 
suffered from a terminal, respiratory disease (Kennedy-Stospkopf et al., 1986; Lebich et al., 
1994; Harder et al., 1996a). Isolation apparently required the direct cultivation of tissues or 
peripheral mononuclear blood cells (PBMCs) and subsequent cocultivation with primary seal 
fibroblast cultures. Adaptation to growth on feline cell lines and - at least for two isolates 
- also to a simian cell line (Vero) has been achieved (Harder et al., 1996a). In contrast to 
PhHV-1, these isolates frequently induced giant cell formation, exhibited delayed replication 
kineties and their infectivity remained largely cell-associated (Lebich et al., 1994). Antigenic 
characterization by cross neutralization, typing with mAbs and analysis of viral proteins 
expressed in infected cells further confirmed their diversity from PhHV-1, CHV and FHV 
(Lebieh et a/., 1994; Harder et al., 1996a, 1997b). Since all five isolates examined so far 
reacted homogeneously with a panel of mAbs raised against the European isolate '7848', and 
all, except one, are of harbour seal origin, they are referred to as phocid herpesvirus type-2 
(PhHV-2). 
Previous analysis of nucleotide sequence data from a partial EcoRI library of the PhHV-
2 genome (isolate 7848) revealed greatest homology to members of the i-Herpesvirinae 
(Harder et a/., 1996a). In order to confirm and specify the classification of PhHV-2 as a 
I-herpesvirus, here we report on the extension of nucleotide sequence analysis from this 
library: 
Further EeaRI clones were chosen arbitrarily and various subclones, not exceeding 600 
bp in length, were constructed in pBluescript. M13 forward and reverse primers were used 
in dye-dideoxy cycle sequencing reactions (Perkin-Elmer). Semiautomated sequencing was 
performed on a A373 sequencer (Applied Biosystems). Assembly and analysis of sequence 
data were carried out with the GCG software package version 8.0 (Devereux et al., 1984). 
Sequences were generated from fragments EcaRI 78e22, 78e11a and 78e11b whieh received 
GenBank accession nos. Z83323, Z83322 and Z83324. Open reading frames (ORFs) detec-
ted in these fragments (,Frame', GCG) were translated and the deduced amino acid (aa) 
sequences used in a 'FastA' search of the SwissProt and PIR databases. Significant homolo-
gy to proteins encoded by genes 24 (minor capsid protein: 78ella), 25 (major capsid protein: 
78ellb) and 56 (part of heliease/primase complex: 78e22), respectively, of i-herpesviruses 
were revealed (Albrecht et al., 1992; Telford et al., 1995). Pairwise aligments with homo-
logous sequences of species of other herpesvirus subfamilies were compiled ('Gap', GCG). 
Identity and similarity scores between the aligned sequences are summarized in Table 1 and 
confirm that PhHV-2 displays greatest homology to members of the i-Herpesvirinae. 
Further proof to classify PhHV-2 as a i-herpesvirus Was obtained by analysing the CpG 
dinucleotide frequencies of these sequences. As an exception among viruses with a large 
genome, i-herpesviruses, capable of establishing latency in dividing (lymphoid) cells, ha-
ve been reported to be suppressed in the dinucleotide CpG which is compensated for by a 
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Table 1. Comparison of ORFs deduced from PhHV-2 specific sequences. 
PhHV-2 Virus species Gene equivalent l Comparisons 2 
fragment %Homology %Identity Gaps 
78e223 Equine herpesvirus-2 (EHV-2) ORF 56 66 52 2 
(237 aa) Herpesvirus saimiri-2 (HVS-2) ORF 56 65 52 1 
Epstein-Barr virus (EBV) BSlFI 45 29 2 
78ella4 Equine herpesvirus-2 ORF 24 47 35 2 
(269 aa) Herpesvirus saimiri-2 ORF 24 48 36 4 
Human herpesvirus-8 (HHV-8) ORF24H 49 36 4 
78ellb I;quine herpesvirus-2 ORF 25 80 67 1 
(397 aa) Herpesvirus saimiri-2 ORF 25 74 61 1 
Human herpesvirus-8 ORF 25H 74 61 1 
Epstein-Barr virus BclFI 66 54 1 
Human cytomegalovirus (HCMV) UI86 47 31 12 
Human herpesvirus-6 (HHV-6) U57 45 31 9 
Herpes simplex virus-l (HSV-l) UI19 44 29 11 
Equine ·herpesvirus-l (EHV-l) ORF 42 43 27 9 
Varicella zoster virus (VZV) ORF 40 42 26 10 
1 Sequences for comparisons were extracted from the GenBank databases: EHV-2 #U20824; HVS-
2 #QOI006, #PI4346; EBV #X00784; HHV-8 #U40377; HHV-6A #X83413; HCMV #X17403; 
EHV-l #M86664; VZV #P09210. 
2 Deduced amino acid sequences were compared by using the 'Gap' program of the GCG software 
package, setting gap weight and gap extension values to 3.0 and 0.1, respectively. The calculation 
of similarity values is based on the Dayhoff matrices (Dayhoff et al., 1983). 
3 Homology values for equivalent proteins of HCMV (UI70), HHV-6 (U43), EHV-l (ORF 7), VZV 
(ORF 6), HSV-l (UI52) was estimated less than 30% in the corresponding parts. 
4 No ascertained translation for corresponding part of EBV (SeRFl) available; no homologues in 
Q-hetpesvituses. 
relative excess of TpG and CpA, respectively, relative to their mononucleotide frequencies 
(Honess et al., 1989). It has been postulated that CpG suppression in these viral geno-
mes may be driven by high de novo methylating activities in the nucleus of dividing cells, 
leading to methylation of the cytosine residues in CpG dinucleotides. 5-methylcytosine is 
then desaminated to give thymine (Honess et al., 1989). Contradictory to the methylation-
desamination-mutation hypothesis, however, the genomes of the T-Iymphotropic Marek's 
disease herpesvirus and the human herpesvirus-6 (an Q- and a {1-herpesvirus, respectively) 
are not suppressed in CpG frequencies despite the fact that they, biologically, share a number 
of features with ,-herpesviruses. Herpesviruses which establish latency in postmitogenical-
Iy fixed cells such as neurons, in general, are not forced into CpG suppression (e.g. HSV-1 
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Table 2. CpG dinucleotide frequencies in PhHV-2 gene fragments. 
Fragment Dinucleotide frequencies 1 
(GenBank acc. no.) CpG TpG CpA 
78e22 (U54678) 0.272 1.37 1.25 
78e11a (U45682) 0.35 1.28 1.17 
78e11b (U45679) 0.32 1.63 1.27 
U152-W (X34567) 0.15 1.35 1.17 
ORF23-H3 (X34521) 0.22 1.61 1.33 
1 P-values, as a measure of the odds-ratios of frequencies were calculated according to Karlin et 
al., 1994b). 
'2 For values::; 0.78 the relative dinucleotide abundance is regarded to be low, whilst p-values '2: 
1.25 indicate a relative excess of the particular dinucleotide (Burge et al., 1992). 
3 Previously obtained from the PhHV-2 (isolate 7848) EcoRllibrary (Harder el al., 1996a). 
or VZV). When PhHV-2-specilic sequences were analysed for CpG ratios according to the 
method described by Karlin et al. (1994b), a significant CpG suppression and a relative excess 
of TpG and CpA was evident (Tab. 2), similar to other ,),-herpesviruses. 
Possible evolutionary relationships of PhHV-2 were analysed using the deduced aa se-
quences of the major capsid protein (MCP) fragment which is known to be fairly conserved 
among all species of herpesviruses (McGeoch et al., 1995). A total of 281 out of 397 sites 
of the PhHV-2 MCP fragment could be reliably aligned when compared with herpesvirus 
species derived from all subfamilies. In this analysis, the herpesvirus subfamilies and the 
,),-herpesvirus genera were correctly assigned (Fig. 1a). In order to reline the clustering 
patterns and to obtain greater statistical robustness, I-herpesvirus sequences were aligned 
separately, using 396 out of 397 sites of the PhHV-2 MCP fragment. 
According to this analysis, PhHV-2shows particular affinity to EHV-2 (Fig. Ib) which has 
been provisionally classified a ')'3-herpesvirus (Telford et al., 1993; 1995). Unfortunately, there 
is still insufficient sequence data of this region from other ,),-herpesviruses of non-primate 
origin such as, e.g., bovid herpesvirus-4 (which has also been sporadically isolated from cats) 
and the aleephaline herpesviruses to allow for comparisons on a broader base. 
Little is known concerning the seroprevalence of PhHV-2. Neutralizing antibodies specilic 
for PhHV-2 have been detected in a small cohort of harbour seals of the North Sea and, at 
moderate prevalence, in several pinniped species ranging in northern Pacific waters, but not 
in Weddell seals (Leptonychaetes weddell;') of Antarctica (Harder et a/., 1991a; Lebich et al" 
1994; Zarnke el al., 1997). Seroprevalences of PhHV-l and -2 infections in a given pinniped 
species, however, differed considerably. This suggests distinct epizootiological patterns, pos-
sibly due to different transmission modes. While a primary pathogenic role of PhHV-2 in seal 
populations seems highly unlikely, the clinical significance of PhHV-2 infections in individual 
seals remains to be elucidated. In light of the fact that PhHV-2 crosses species borders in 
vitro, the pathogenic potential of PhHV-2 for terrestrial carnivores needs to be assessed. 
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Figure 1. Analysis of phylogenetic relationships of PhHV-2 using deduced amino acid sequences of 
a fragment of the major capsid protein homologue (78e22. Tab. 1). Multiple alignments of herpes-
virus sequences homologous to the PhHV-2 specific fragment were generated using 'Pileup' (GCG). 
Alignment gaps were completely omitted for computation of genetic distances which was finally 
based on 281 sites (Fig. 1a) and on 396 sites (Fig. Ib), respectively. Distances were calculated assu-
ming a ",(-distribution (-y = 2). Trees were constructed by the neighbor-joining principle. Bootstrap 
p values after 500 replications are indicated at nodes. Values;::: 95 indicate significant separation 
of dusters. Phylogenetic inferences were carried out using the 'MEGA' PC software (Kumar et al., 
1994. 
149 
Chapter 4 - Discussion 
Conclusions 
a-herpesviruses, identical or closely related to PhHV-1, appear to be globally prevalent in all 
pinniped species examined so far. While no reliable data on the clinical impact in free-ranging 
seal populations independent from morbillivirus epizootics exist to date, PhHV-1 continues 
to cause significant morbidity and mortality among hospitalized newborn seals. Several seal 
species such as the Hawaiian and Mediterraenean monk seals (Monachus schauinslandii and 
Monachus monachus) are highly endangered and various rehabilitation or breeding program-
mes have been launched. In order to improve the prospects of such initiatives, prevention 
of PhHV-1-induced disease by vaccination may be' desirable. Non-replicating vaccines are 
generally given preference for use in wildlife species because control of modified-live vaccine 
viruses in the field is not feasible. Favourable experiences with a-herpesvirus subunit vac-
cines that consisted of the glycoproteins gB and/or gD have been made for a number of 
herpesviruses (Burke, 1993; Inglis, 1995): Protective immunity, related to neutralizing anti-
bodies and cytotoxic T cells, has been induced against, e.g., bovid herpesvirus-l infection 
in calves (Van Drunen Littel-van den Hurk et al., 1993) and against HSV-1 infection in the 
mouse model (Landolfi et al., 1993; Ghiasi et al., 1994). Phase III trials in humans using an 
ISCOM-enhanced vaccine preparation of HSV-2 gD and gB are about to commence (Morein, 
pers. comm.). With respect to the successful expression of PhHV-1 gB in insect cells, pre-
conditions for a subunit vaccine for use in seals are reasonable. However, in analogy to other 
o:-herp~sviruses, further components, in particular a gO equivalent, need to be included. 
Work on cloning and sequencing the gD gene of PhHV-1 is currently under way (Harder et 
al., unpublished). 
Since 1986, a second herpesvirus species, designated PhHV-2, has been isolated indepen-
dently in at least three different laboratories. PhHV-2 has now been genetically characterized 
as a 'Y-herpesvirus with particular affinity to EHV-2. Preliminary phylogenetic analysis sug-
gested their clustering as a third genus of the 'Y-Herpesvirinae. 
Acknowlegdements - Work on seal herpesviruses in our lab was funded by grants from the 
the Seal Rehabilitation and Research Center, Pieterburen, The Netherlands, and by the European 
Community (Human Capital and Mobility Project ERBCHBGCT920106). 
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4.2 - Morbilliviruses in marine mammals 
Abstract - In recent years, serious disease outbreaks among seals and dolphins were attributed 
to infection with established or newly recognized morbilliviruses. The first identification of a mor-
billivirus as causative agent of a mass mortality among marine mammals was in 1988, when the 
previously unrecognized phocine distemper virus (POV) caused the death of 20.000 harbour seals 
(Phoca vilulina) in northwestern Europe. A similar epizootic among Baikal seals (Phoca sibirica) 
Siberia in 1987 was later attributed to infection with canine distemper virus (COV). A morbillivirus 
isolated from stranded harbour porpoises (Phocoena phocoena) between 1988 and 1990 proved 
to be yet another new member of the genus Morbillivirus, distinct from POV and COV and more 
closely related to rinderpest virus and peste-des-petits-ruminants virus: porpoise morbillivirus. A 
similar was the primary cause of a mass mortality among striped dolphins (Stenella coeruleoal-
ba) in the Mediterranean from 1990 - 92: dolphin morbillivirus. In th present review, the current 
knowledge of the genetic and antigenic relationships of these viruses is presented, and the origin 
and epizootiological aspects of the newly discovered morbilli viruses are discussed. In addition, the 
possible contributory role of environmental contaminant-related immunosuppression in the severity 
and extent of the different disease outbreaks is discussed. 
Morbillivirus infections in pinnipeds 
In 1988, an apparantly contagious disease spread among harbour seals and grey seals (Ha-
lichoerus grypus) in northwestern Europe. Disease symptoms included respiratory, gastro-
intestinal and neurological disorders, and were often complicated by secondary parasitical, 
bacterial or viral infections. Among harbour seals, the disease was accompanied with morta-
lity levels of more than 60% in some areas, while in grey seals mortality was relatively low. 
The first indication of the involvement of a morbillivirus in the outbreak came from sero-
logical studies on paired serum samples, in which CDV neutralizing antibodies were found 
in sera of affected animals (Osterhaus & Vedder, 1988). On the basis of these serological 
data, in combination with the clinical signs and pathological lesions found in infected seals 
which appeared to be quite similar to those observed in dogs with canine distemper, it was 
concluded that 'a morbillivirus closely related if not identical to CDV' was the primary cause 
of the outbreak (Osterhaus et al., 1988). Virus isolation and subsequent characterization 
demonstrated that the virus was not identical to CDV, but should be considered as a new 
member of the genus Morbillivirus, now referred to as phocine distemper virus (Cosby et al., 
1988; Mahy et al., 1988; Visser et al., 1990). Finally, Koch's postulates were fulfilled when 
seals proved to be protected from fatal challenge infection by vaccination with an inactivated 
CDV vaccine, and the virus could be re-isolated from the sham vaccinated animals in this 
experiment (Osterhaus et al., 1989a; Visser et al., 1989). 
After the identification of PDV as causative agent of the northwestern European epizootic, 
a similar outbreak among Baikal seals in Siberia (Lake Baikal), which started in 1987, could 
also be attributed to infection with a morbillivirus (Grachev et al., 1989; Osterhaus et al., 
1989b). Initially, it was suspected that an epizootiological link between this virus, which was 
tentatively called PDV-2, and the northwestern European virus, which we will refer to here 
as PDV-l. PDV-2, like PDV-1, could be isolated from organ materials, and caused mild 
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clinical symptoms in SPF dogs (Visser et al., 1990). However, comparison of PDV-1, PDV-2 
and CDV with respect to biological, morphological, protein chemical and antigenic properties 
confirmed that PDV-1 was a morbillivirus different from CDV, and revealed only minor 
differences between PDV-2 and CDV (Visser et al.1 1990). Nucleotide sequence homologies 
between nucleoprotein (NP), phosphoprotein (P), matrix (M), hemagglutinin (H) and fusi 
(F) protein genes of PDV-1 and CDV ranged from 65 to 85% (Blixenkrone.M¢lIer et al. 
1992; Haas et al., 1991; Kovamees et al., 1991; Sharma et al., 1992; Visser et al., 1993a). 
Comparison of the PDV-2 F gene with other morbillivirus F genes for which sequence data 
are available, revealed a 91 % similarity to the complete CDV F gene, and a 97% similarity 
when only the coding regions of the F genes were compared. This is a level of sequence 
variation similar to that observed when geographically different isolates of e.g. rinderpest 
virus (RPV) are compared (Visser et al., 1993a) 
Morbillivirus infections in cetaceans 
When in 1988 porpoises that had stranded along the Irish coast were shown to be morbillivi-
rus antigen-positive (Kennedy et al., 1988), and the virus involved was subsequently isolated 
from animals stranded along both the Irish and Dutch coasts (McCullough et al., 1991; Visser 
et aI., 1993b), it was assumed that the virus isolated would be identical to PDV-l. In 1990 
we also found evidence for a morbillivirus infection in a white beaked dolphin (Lagenorhyncus 
albirostris) that had stranded on the Dutch coast, by detecting morbillivirus antigen in the 
lungs of this animal (unpublished observation). In that same year, large numbers of striped 
dolphins started to wash ashore along the coasts of the western part of the Mediterranean 
Sea (Domingo et al., 1990; Van Bressem et a/., 1991). The epizootic progressed eastward 
to reach the Turkish coast in 1992. Virus isolates were compared with PDV-1 and CDV, 
and with the above mentioned porpoise isolates. It was shown that the dolphin and porpoise 
viruses were quite similar, but both were distinct from PDV-1 and CDV. They were subse-
quently named dolphin morbillivirus (DMV) and porpoise morbillivirus (PMV) (Van Bressem 
et al., 1993; Visser et al., 1993b). Comparison of a sequence of the P gene encoding the RNA 
editing site from all presently known members of the genus confirmed that DMV and PMV 
Figure 1. Unrooted phylogenetic tree of the fusion protein encoding region (F) and a fragment 
of the gene encoding the polymerase-associated protein (PI) of several morbilli viruses. Genetic 
distances between the nucleotide sequence~ were calculated according to Kimura's 2-parameter 
method (Kimura, 1980). and used to construct phylogenetic trees employing the neighbour-joining 
principle (Saitou & Nei, 1987). Branch lengths are drawn in proportion to genetic distances as 
indicated by bars. The robustne of the tree was tested by bootstrap analysis (Felsenstein, 1985) 
using 2000 replications (Hedges, 1992). Numbers at nodes represent bootstrap percentages. Values 
greater than 95% indicate a statistically significant separation of the respective cluster from of the 
tree. All calcul.tions were carried out using the 'MEGA' PC program (Kumar 01 al., 1993). 
(Continued overleaf ... ) 
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Selected sequences were aligned by 'Pileup' included in the GCG software package (release 8.0). 
setting gap weights to 3.0 and gap length weights to 0.1 Sequences were extracted from the 
GenBank database (accession numbers given between brackets). or from rec~nt pUblications: 
F: Phocid distemper virus-2 (PDV-2, L07075), canine distemper virus vaccine strain Onder-
stepoort (COV-Vac. X65509). phocid distemper virus· I (POV·I. 010371). rinderpest virus (RPV. 
Z30700). measles virus (MV. U03655). dolphin morbillivirus (OMV. Z30086). porpoise morbillivirus 
(PMV. X80757). 
P f: The aligned fragments correspond to positions 420 to 807 (388 bases) of the measles virus 
P gene mRNA. COV·Vac (X51869). POV·2 (Mamaev elal .• 1996), COV isolated from a lion of 
the Tanzanian Serengeti National Park (Harder el al., 1995), COV isolated from a captive Chinese 
leopard from the USA (Harder el al., 1996b), POV·I (010371), MV (M89920), RPV (X68311), 
and OMV and PMV (Barrett el al., 1993). 
Viruses which naturally infect marine mammals are indicated by bold typeface. 
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were closely related members of the genus, but quite different from the other members. 
They form a distinct lineage more closely related to the ruminant morbilli viruses (RPV and 
peste-des-petits-ruminants virus, PPRV) than to the carnivore morbilliviruses (Barrett et al., 
1993). 
Phylogenetic trees of the presently known morbilli viruses, based on sequence analysis of the 
F genes and this P gene region, show the phylogenetic relations of the newly discovered viruses 
with the established members of the genus (Fig. 1). Experimental infection studies showed 
that not only dogs, but also ruminants (cows, sheep and goats) were susceptible to infection 
with DMV and PMV, which caused a mild leukopenia (Visser et al., 1993b). Pre-exposure 
to DMV or PMV protected dogs from developing CDV viraemia and clinical signs upon fatal 
CDV challenge (Visser et al., 1993b). It was speculated as unlikely that DMV or PMV would 
infect ruminants or dogs under natural circumstances, since morbillivirus infections generally 
seem to be restricted to one order of mammalian species (Black, 1991). It is interesting to 
note that in recent years, CDV has been found in many carnivorous species, including seals 
(Grachev et al., 1989; Osterhaus et al., 1989b), javelin as (Appel et al., 1991), and large cats 
both in zoos (Appel et al., 1994), and in the wild (Harder et al., 1995). 
Origin and epizootiology of.the newly recognized 
morbilliviruses 
The origin of PDV-1 was the subject of extensive speculation during and after the outbreak 
in 1988. Initial speculation about a possible link with CDV infections in sledge dogs in 
Greenland, or with the PDV-2 (CDV) outbreak among seals in Siberia, could readily be 
dismissed after the characterization of the virus as a new member of the genus. However, 
interspecies transfer of the virus is still considered the most likely cause of the outbreak. In 
sero-epizootiological studies, the presence of a virus closely related, if not identical, to PDV-1 
was shown in several North American marine mammal populations (Duignan et al., 1993, 
1994; Ross et al., 1992). The virus could have been transmitted by Arctic harp seals (Phoca 
groenlandica), a species that is in contact with both the North American and European seal 
populations and has been shown to be infected with a PDV-like virus (Dietz et al., 1989; 
Stuen et al., 1994). Interestingly, a mass migration of harp seals southwards to continental 
European fishing waters was observed in the period directly preceding the 1988 outbreak. 
Since virus characterization studies showed that PDV-2, the virus that was isolated from 
Baikal seals, should be considered as a strain of CDV, the origin of this virus was probably a 
local terrestrial carnivore. Speculation that the origin might have been a vaccine strain of CDV 
used to vaccinate local dogs had to be dismissed since nucleotide sequences of PDV-2 P genes 
showed a closer relationship to European wild type strains than to the vaccine strain used in 
that area (Mamaev et al., 1996). A similar event may have taken place in the Antarctic region 
in 1955, when a mass mortality among crabeater seals (Lobodon carcinophagus) was possibly 
related to a simultaneous distemper outbreak among sledge dogs. Support for this assumption 
came from serological studies showing the presence of CDV neutralizing antibodies in these 
156 
4.2 - Morbilliviruses in marine mammals 
animals (Bengtson et al., 1991). 
Serological studies have shown that morbilliviruses similar to DMV and PMV are enzootic 
among many cetacean populations (Visser et al., 1993b). Recently, retrospective immuno-
histochemical studies suggested the involvement of a morbillivirus in an epizootic among 
bottlenose dolphins (Tursiops truncatus) along the U.S. Atlanti coast in 1987 (Lipscomb et 
al., 1994). Based on the phylogenetic distinctness from other morbilliviruses, it may be con-
cluded that it is unlikely that the PMV /DMV lineage has a recent origin in terrestrial animals 
(see Fig. 1). Interestingly, the phylogenetic relationship between the different morbilliviruses 
of aquatic mammals largely parallels the phylogenetic relationship of the animal species they 
infect (Visser et al., 1993c). Common viral ancestors may have acquired access to phylogene-
tically related animal species on the basis of biological similarities: CDV and PDV-l probably 
share a common ancestor, which is also likely to be the case for the PMV /DMV and the 
RPV /PPRV lineages. 
Involvement of environmental pollution 
Morbilliviruses have probably been enzootic in pinniped and cetacean species for a long time. 
In general, when these viruses have not been present in a certain population for a long period 
and consequently no specific immunity is present. an introduction by interspecies transmission 
may lead to severe outbreaks accompanied by mass mortalities (Norrby et al., 1992; Norrby 
& Oxman, 1990). However, other factors may have played a role in the recently observed 
incidence of mass mortalities among marine mammals. 
Studies in laboratory animals have shown that exposure to certain environmental conta-
minants may lead to increased suceptibility to infectious agents (Vos et al., 1989; Wong et 
al., 1993). The mammalian immune system has long been recognized as a sensitive target 
for persistent chemicals accumulating in the food chain, including polychlorinated biphe-
nyls (PCBs), -dibenzo-p-dioxins (PCDDs) and -dibenzofurans (PCDFs), hexachlorobenze-
ne (HCB), dieldrin, -hexachloro-cyclohexane (-HCH), and dichlorodiphenyl-trichloroethane 
(DDT). As top predators, seals and dolphins inhabiting coastal waters of industrialized regi-
ons are known to accumulate high levels of some of these xenobiotics (Luckas et al., 1990; 
Tanabe et al., 1983), and may therefore be at particular risk. These high contaminant burdens 
have been associated with several physiological abnormalities, including skeletal deformations 
(Bergman et al. 1992; Mortensen et al., 1992), reproduction toxicity (Helle et al., 1976a, 
1976b; Reijnders, 1986) and hormonal alterations (Brouwer et al., 1989, Subramanian et 
al., 1987). While high levels of xenobiotics in affected animals suggest that contaminant-
induced immunosuppression may have affected the severity and extent of the morbillivirus 
epizootics (Aguilar & Borrell, 1994; Hall et al., 1992), direct cause-effect relationship could 
be established. 
We have addressed this issue in a controlled experiment. in which young harbour seals were 
fed fish contaminated through the food chain of different marine regions. During a 2.5 year 
period, two groups of 11 harbour seals each were fed herring from the heavily polluted Baltic 
Sea or the relatively uncontaminated Atlantic Ocean. Intakes of contaminants were three to 
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ten times higher in seals fed Baltic herring (De Swart et al., 1994), which led to significantly 
higher blubber levels in this group of seals after two years on the respective diets. During the 
feeding study, blood samples were taken at regular intervals, and functional immunological 
parameters were compared. Results demonstrated an impairment of immune function in the 
seals fed on polluted Baltic herring (De Swart et al., 1994), as evidenced by suppressed natural 
killer (NK) cell activity (Ross et al., 1996) and suppressed T lymphocyte-mediated responses 
(De Swart et.al., 1996; Ross et al., 1995). Since NK cells play an important role in the first 
line of defence against virus infections (Welsh & Vargas-Cortes, 1992), and T lymphocytes 
are important in the clearance of virus infections if! general and morbillivirus infections in 
particular (Van Binnendijk et al., 1990), we have postulated that environmental contaminants 
rendered seals inhabiting certain polluted areas more susceptible to morbillivirus infections, 
and may thus have affected the severity and extent of the disease outbreaks. In addition, other 
possible secondary factors including changes in climate, population densities, food stocks and 
migration patterns may also have played a role in the outcome of the epizootics. 
Conclusions 
In the last decade, a seemingly high incidence of previously unrecognized morbillivirus infecti-
ons among marine mammal populations has been unraveled. This may in part be attributed to 
the increased interest in the health status of marine mammals, but may also be related to an 
increased susceptibility of marine mammals to virus infections resulting from environmental 
contaminant related immunosuppression. 
158 
Section 4.3 
Canine distemper virus - a morbillivirus in search of new hosts? 
Timm C. Harder and Albert D.M.E. Osterhaus 
Trends Microbiol. (1997) 5, 120-124 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
4.3 - Molecular epidemiology of COV 
Abstract - Canine distemper morbillivirus (CDV) induces a multisystemic, often fatal disease in 
a wide and seemingly expanding host range among the Carnivora. Several genotypes of an otherwise 
monotypic virus species co-circulate in a geogr'aphically restricted pattern. Interspecies transmissions 
frequently occur, often leading to devastating epizootics in highly susceptible or immunologically 
naive populations. 
Introduction 
Canine distemper virus (COV) is a negative-stranded enveloped RNA morbilJivirus (Paramy-
xoviridae) that infects a broad host spectrum among the Carnivora. This genus also includes 
the human pathogen, measles virus (MV), rinderpest virus (RPV) and peste des petits-
ruminants virus (PPRV) of which the two latter infect Artiodactyla. New members of the 
genus, ph acid distemper virus (POV) and cetacean morbilliviruses, caused widespread severe 
epizootics among pinnipeds 1988 in northwestern European waters and among toothed ce-
taceans 1990 - 1991 in the Mediterreanean, respectively (Osterhaus et aI., 1995; Visser et 
aI., 1993a). The architecture and molecular biology of morbilliviruses are discussed in Box 1. 
Like all morbilJiviruses, COV is highly contagious and transmission occurs predominantly via 
aerosols. In susceptible hosts, acute febrile and multisystemic disease is induced (Krakowka et 
al., 1985); neuroinvasiveness and severe immunosuppression are hallmarks of CDV infections 
(Krakowka et aI., 1980; Vandevelde & Zurbriggen, 1995). Oepending on the host species and 
the immune competence of the indivfdual affected, mortality rates during COV outbreaks can 
exceed 80% . 
It appears that since 1988, an expansion of the already broad natural host spectrum of COV 
has occured. Spontaneous, clinically overt infections with COV-like morbilliviruses have been 
described in captive Japanese primates (Macaca fuscata; Yoshikawa et aI., 1989), collared 
peccaries (Tayassu tajacu; Appel et al., 1991), and Lake Baikal seals (Phoca sibirica; Grachev 
et al., 1989). Furthermore, distemper enzootics caused by COV-like morbilJiviruses have been 
observed for the first time in lions, tigers and jaguars kept in several North American zoos and 
safari parks (Appel et al., 1994). In 1994, similar COV-related disease outbreaks killed up to 
30% of the free-ranging lion population and an unknown number of hyaenas in the Tanzanian 
Serengeti National Park and adjacent areas (Alexander et al., 1995; Harder et al., 1995, 
1996b; Haas et al., 1996; Roelke-Parker et al., 1996). Among the Felidae, domestic cats are 
known to be susceptible to experimental CDV infection, but evidence for natural infections, 
clinical disease or shedding of infectious virus have never been observed (Appel et al., 1974). 
There is evidence for the involvement of COV in Paget's disease of humans (Gordon et al., 
1992). In addition to an apparently expanded host range of COY, a resurgence of distemper 
among dog populations, in which high vaccination rates were maintained, was observed since 
the late 1980's culminating in major epizootic. in France, Germany and Scandinavia during 
1991 - 1995 (Blixenkrone-M~lIer et al., 1993). 
Together, these observations raised questions about the occurence of variants of COV 
which have allowed expansion into new hosts and challenge the suitability of current COV 
vaccines. 
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Box 1. Molecular virology of morbilliviruses 
Negative-stranded genomic RNA, 15.9 kb 
Morbillivirions consist of a single-stranded RNA genome of negative polarity (ca. 15900 bp) which 
is enclosed in a rod-shaped helical nucleocapsid (NC). Six transcription units, from which mono-
cistronic mRNAs are generated, are ordered consecutively along the genome. The entry site of the 
virion polymerase appears to reside in the 3' leader sequence. At each intergenic region (black 
boxes) disintegration of the polymerase-RNA complex may occur. 
III 
mRNA cascade 
Consequently, a steep gradient of mRNAs from the N gene (most abundant) to the L gene (least 
abundant) is created. Exceptionally. the P gene also encodes two nonstructural proteins, termed C 
and V, whose functions are largely unknown. 
Translation and processing 
III N III I p I II M 
IIITIl [2J 
F9 F L II 
, . 
Regions within the morbillivirus genome that have proven useful in the analysis of strain-dependent 
variation in MV and other morbilli viruses are shown as grey boxes in this figure. The long inter-
cistronic region between the M and F genes (hatched box) shows a high degree of plasticity between 
strains but is non-coding and, because of its strong secondary structures, appears difficult to se-
quence (Rima ef a/ .• 1995a). A 388 bp fragment of the P gene (small black box in figure), which 
can be PCR-amplified from any morbillivirus species using so-called 'universal morbillivirus primers' 
has been shown to be highly informative for phylogenetic and taxonomic purposes (Barrett ef a/., 
1993). The NC is mainly formed by the N protein, but also contains copies of the polymerase-
associated protein (P) and the multifunctional RNA- dependent RNA virion polymerase (L). The 
NC is enveloped by a host cell-derived lipid layer in which the viral attachment (H) and fusion (F) 
glycoproteins are embedded. In addition to glycosylation, the F protein undergoes endoproteolytic 
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Biological and antigenic variants of CDV 
Ellicacious modified COV-live vaccines became available in the 1950s and have been widely 
used since the 1960s, leading to a drastically reduced impact of distemper on dog popula-
tions (Gorham, 1966). Owing to the considerable degree of antigenic relationship between 
the different morbillivirus species, partial cross-protection against clinically overt' COV infec-
tions can also be induced in dogs following heterotypic vaccination with MV (Baker, 1970; 
Chalmers & Baxendale, 1994). Current licensed COV vaccines are based on strains that have 
been attenuated by serial passage either (Rockborn strain; Rockborn, 1959) or on hen eggs 
(original Onderstepoort strain; Haig, 1956) and chicken fibroblast cultures (Lederle strain). 
Rockborn strain-based vaccines were shown to induce a higher level of virus neutralizing anti-
bodies compared with Onderstepoort derivates, and consequently avianized CDV vaccines are 
reported to cause higher vaccine failure rates. The Rockborn strain, however, retains a certain 
pathogenic potential. particularly for wild species (Appel & Summers, 1995). Although gene-
rally safe for use in healthy and immunocompetent dogs, both vaccine types remain extremely 
virulent for several carnivorous wild species like red pandas (Ailurus (ulgens) , black-footed 
ferrets (Mustela nigripes) or African wild dogs (Lycaon pictus), emphazising the species-
related differences in susceptibility to COV (Appel & Summers, 1995). Although virulent 
and attenuated COV biotypes can be distinguished by their ability to replicate in various 
macrophage, lymphocyte and epithelial cell cultures, other in vitro markers that differentiate 
unambiguously between these biotypes have not been defined. Vaccine strains replicate in 
all these cell types whereas virulent isolates require adaptation (often several blind passages) 
to replicate elliciently in epithelial cell lines such as Vero cells (Evans et al., 1991; Appel et 
al., 1992). Among virulent COV a certain degree of neuroinvasiveness appears to be strain-
dependent and has been reported to correlate with plaque morphology in epithelial cell cul-
tures (Hirayama et al., 1986; Summers et al., 1984). The molecular basis of morbillivirus 
virulence is unknown. In the case of COV and RPV infections at least, as yet undefined host 
species-specific, and possibly even breed-specific (RPV), factors also play an important role 
(Krakowka et al., 1985). 
Serologically, all morbillivirus species are considered monotypic and the classical methods, 
including, for example, complement- fixation and immunofluorescence staining with polyclo-
nal antibodies, do not distinguish serotypes among COV strains. Nevertheless, vaccine and 
wild-type (wt) COV can be differentiated in cross-neutralization and kinetic neutralization 
assays (Appel et al., 1994; Harder etal., 1993b, 1996b). Sera raised against wt COV isola-
tes have been shown to have neutralization titers against the homologous virus that are up 
to tenfold greater than against vaccine strains of COV (Harder et al., 1996b). Comparable 
serological results have been obtained for current MV wt isolates and vaccine strains (Tamin 
Box 1. - continued: 
cleavage into two disulfide-linked fragments (F1-F2). which is critical for functional activation. The 
arrows mark stretches of hydrophobic amino acids capable of spanning membranes. An internal 
layer of the matrix (M) protein stabilizes the membrane and mediates contact with the NC. 
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Box 2. Phylogenetic analysis of CDV strains. 
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et al., 1994). It is the membrane glycoprotein H, the viral attachment factor, that indu-
ces the majority of neutralizing antibodies. Consequently, the observed differences in cross-
neutralization titers should relate to antigenic variation in the H protein. However, it is difficult 
to differentiate strains using monoclonal antibodies (MAbs) specific for the CDV H protein. 
So far, only one epitope has been identified on the H protein that is consistently expressed by 
CDV vaccine strains but not by most of the recent CDV wt isolates (Blixenkrone-M¢lIer et 
al., 1992; Alldinger et al., 1993; Appel et al., 1994; Harder et al., 1993b, 1996b). Variation 
has been observed in the apparent molecular weight of the CDV H protein: the H protein of 
the Onderstepoort strain migrates significantly faster than those of the Convac and Rockborn 
vaccine strains (6rvell, 1980) or of various field isolates (Harder et al., 1996b). The lack of 
a demonstration of more significant antigenic heterogeneity amongst CDV strains (including 
of other viral proteins such as N, P and F) may, at least in part, relate to the fact that all 
the CDV- specific MAbs used in these studies were raised against vaccine strains (6rvell et 
al., 1985). 
Box 2. - continued: 
Phylogenetic relationships between canine distemper virus (CDV) isolates are based on (a) analysis 
of a 388 bp fragment of the P gene and (b) on the entire coding region of the H gene (1821 bp). 
Genetic distances (see bars for scale), calculated by Kimura's 2~parameter method, have been used 
for tree construction employing the neighbour~joining principle. Identical topologies were obtained 
when sequences were analysed by maxir,num parsimony (not shown). Bootstrap values after 500 
replications are given at tree branchings only when they exceed 80%. Significant cluster separation 
is assumed for values ~ 95%. Computations were,carried out using the MEGA PC software (Kumar 
et a/., 1994). Sequences were extracted from the GenBank database and recent publications (Harder 
et al., 1995. 1996; Haas et al., 1996; Mamaev et a/ .• 1995, 1996) Host species, origin and year of 
isolation are indicated. ONST, Onderstepoort; BUS, Bussell; ROC, Rockborn vaccines. 
When sequences of the respective P gene fragment of CDV strains are used in phylogenetic 
analysis, a clustering of isolates becomes evident, which reflects geographic origin rather than host 
origin (a). A refined picture of the phylogenetic relationships among CDV strains is obtained when 
sequences of the gene encoding the the H protein (1821 bp) are analysed (b). The clusters obtained 
from phylogenetic analysis of the H gene and the P gene fragment are very similar which renders 
recombination events between the lineages unlikely. At least four to five separate clusters of wt CDV 
can be distinguished, which differ by more than 0.5% at the nucleotide· level (H gene). According 
to the definition used in analysis of MV strain variation (Rota et al., 1996), these clusters are 
referred to as genotypes. The vaccine strains form a separate distinct lineage. At the amino acid 
level the greatest difference is observed between the H proteins of the Onderstepoort vaccine strain 
and a wt isolate obtained from a Chinese leopard (10.2%). Wt CDV isolates express up to four 
additional putative N-glycosylation sites located in the extra cytoplasmic domaine of the H-protein 
when compared with the Onderstepoort vaccine strain (Harder et al., 1996; Mamaev et al., 1995). 
Even after prolonged serial passage in vitro, attenuated strains of MV and RPV accumulate 
surprisingly few mutations within the coding regions compared with their virulent parents (Baron 
et al .• 1995; Rima et al .• 1995a; Rota et al., 1996). Consequently, it can be assumed that the 
differences between CDV vaccine strains (which originate from wt isolates made in the 1940s and 
1950s) and modern wt CDV are truely strain- dependent and do not reflect virulence variations. 
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Genetic analysis of a 388 bp P-gene fragment and of the entire H- protein encoding region 
shows that several genotypes of wt CDV circulate in a geographically restricted pattern 
(Box 2). In Europe, at least three different lineages co- circulated between 1989 and 1992. 
The CDV isolated from big cats of North American or African origin does not constitute 
a separate 'felid' distemper virus lineage but resembles the CDV circulating in local feral 
non-felid carnivores. Therefore, the big cat epizootics are likely to be caused by cross-species 
transmission of CDV indigenous to local wildlife or d?mestic carnivores (Harder et al., 1996). 
It remains an enigma why CDV-related epizootics in these species have not occurred earlier or 
have not been noticed. Possibly, aggravating copathogens or predisposing genetic factors in 
these particular populations may have played a role and definitely require closer investigation 
(Roelke-Parker et a/., 1996). 
Within a group of four CDV isolates from European sources, those of canine origin can be 
distinguished from those in mustelids ranging in the same area (Box 2). Differences between 
the 'canine' and the 'mustelid' lineage are on average 3.4% and 4.2% at the nucleotide and the 
amino acid levels (H-gene and protein, respectively). This substantiates the assumption that 
these lineages have been co-circulating separately in this area for some time. However, further 
isolates of canine or mustelid origin from this area have not yet been analysed and interspecies 
transmissions between these lineages can not be excluded. Therefore, any conclusions about 
the existance of CDV lineages with host species (family) restriction in this area, which would 
also implicate that the observed differences indeed reflect a certain advantage to replicating 
in either mustelid or canine hosts, would be rash. 
An intriguing finding is the clustering of an isolate from a distemper-diseased dog (from 
Belfast, Northern Ireland) with vaccine CDV. Provided that laboratory contamination can be 
excluded, this case suggests that the comparatively old lineage from which all. the vaccine 
strains have been derived has survived in the field for more than 40 years. 
Conclusions 
Considering the scarcity of data, the molecular epidemiology of CDV appears to be similar to 
that of RPV (Chamberlain et al., .1993), in that genetic variants form geographical clusters 
of serologically monotypic viruses. In MV, up to eight genotypes have been distinguished so 
far, of which at least four appear to co- circulate globally (Rima et al., 1995a, b). Genetic 
drift with a linear accumulation of mutations has been demonstrated for the N, P, M, F 
and H genes of MV (Rima et al., 1995a; Rota et al., 1992, 1995). and also for the H 
gene of currently circulating wt CDV. All outbreaks of morbillivirus-related disease in species 
previously not listed as natural hosts of CDV are caused by strains deeply rooted in the CDV 
cluster, favouring a scenario of interspecies transmission of CDV from local feral carnivores 
to large felids in the USA and in East Africa. 
Antigenic drift in currently circulating wt CDV should be considered a possible factor of 
a resurgence of distemper cases in well-vaccinated dog populations in Europe. The role of 
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additional putative N-glycosylation sites predicted in the H proteins of modern wt CDV needs 
to be elucidated (Mamaev et al., 1995; Harder et al., 1996). Serological evidence indicates 
that the predicted amino acid changes accumulated in the H protein of circulating wt CDV 
have antigenic and probably immunological implications (Harder et al., 1996), similar to the 
MV situation (Tamin et al., 1994). In light of the fact that even heterotypic MV vaccination 
induces at least partial protection against challenge with virulent CDV in dogs (Baker, 1970; 
Appel & Gillespie, 1972; Chalmers & Baxendale, 1994), it seems unlikely that modern viru-
lent CDV strains are capable of breaking through a solid immunity mounted after vaccination 
with either of the common CDV vaccine strains. Nevertheless, epidemiologically, the situation 
may appear different when facing dog populations with critical CDV-specific herd immunity 
resulting from low vaccination rates or possibly from frequent use of avianized vaccine de-
rivates which have been reported to be less efficient in inducing immunity as compared to 
canine cell culture-adapted vaccine strains (Appel & Summers, 1995). Maintenance of high 
vaccination rates using efficacious vaccines which induce a solid, resilient immunity must still 
be given the highest priority in control of distemper, particularly in areas with high densities 
of dogs and their possible exposure to feral carnivores. 
Recent morbillivirus epizootics have demonstrated that small populations of highly endan-
gered species may well be at risk of extinction when affected. However, efforts aimed at the 
protection of such populations, such as the African wild dog (Lycaon pictus), by vaccinati-
on with proven safe, non-replicating vaccines need to be weighted meticulously against the 
negative impacts resulting from trapping and immobilizing. free-ranging wildlife animals. 
Enlarging the collection of CDV-specific sequences obtained globally from a growing num-
ber of host species would provide the basis not only for understanding the molecular epide-
miology of CDV but also for the improvement of current CDV vaccines. In sharp contrast 
to MV, where humans are the only relevant reservoir (Rota et al., 1995), the broad natural 
host spectrum and the high likelihood of interspecies transmission of CDV make eradication 
impossible. 
Questions for future research: 
• Where are the reservoirs of virulent CDV? 
• Is perpetuation of CDV accomplished in low density multi- species populations? 
• Is there an antigenic drift in CDV? 
• Do commercial CDV vaccine strains protect fully against current wt CDV? 
• What is the molecular basis of virulence in CDV? 
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Summary 
Certain wildlife species, particularly aquatic mammals and the larger carnivorous species 
have always exerted a strong fascination on man. This may, at least in part, explain the 
extraordinary public concern about devastating morbillivirus epizootics in 1988, 1990-1991 
and 1994 in seals, dolphins and lions, respectively, which not least drew virus infections 
of these species also into a scientific focus. The intention of this thesis is to broaden 
the knowledge of morbilli- and herpesvirus infections of aquatic and terrestrial carnivores 
aiming also at a contribution to an improved protection of these partly endangered species. 
A special emphasize is put on the phylogenetic and epidemiological relationships of morbilli-
and herpesviruses. respectively, of these species. 
Part I summarizes molecular and clinical studies on herpesvirus infections in pinnipeds: 
Seals are host to at least two species of herpesviruses. referred to as phocid herpesvirus-l 
and -2 (PhHV-1, -2), which can be readily distinguished by means of their biological pro-
perties in cell culture, by cross neutralization, and by typing with monoclonal antibodies. 
PhHV-1 has been molecularly identified as a distinct member of the Varicellovirus genus of 
the a-Herpesvirinae subfamily. In antigenetic and phylogenetic terms, the authentic her-
pesviruses of terrestrial carnivores, canid and felid herpesvirus, were found to represent the 
closest relatives of PhHV-l. PhHV-1 or other closely related a-herpesviruses appeared to 
be prevalent on a globally in all pinniped populations examined so far. The clinical impact 
of primary PhHV-1 infections, shown to be inversely correlated to the age and immunocom-
petence of the affected individual seal, is considered to be significant and ranged from mild 
upper respiratory disorders to bronchopneumonia and fatal generalized exacerbations. An im-
proved diagnosis of active PhHV-1 infection was enabled by a novel peR assay targeting a 
fragment of the gene encoding the PhHV-1 glycoprotein D equivalent. The glycoprotein B 
homologue of PhHV-1 is shown to be a major immunogenic protein in the course of natural 
infections of seals. The gene encoding gB has been sequenced in completion and its product 
is successfully expressed as an antigenically and immunogenically authentic molecule in insect 
cells. Recombinant gB may serve as a major component of a future PhHV-1 subunit vaccine. 
Described as a novel viral agent of pinnipeds for the first time in this thesis, PhHV-2 is 
molecularly characterized as a member of the "{-Herpesvirinae. Phylogenetic analysis of a 
fragment of the major capsid protein suggested its classification, together with the equine 
herpesvirus-2, in a third genus of this subfamily. As yet, no disease conditions have been 
associated with PhHV-2 infections in pinnipeds although, based on serosurveys, the virus 
appeared to be moderately prevalent in free-ranging pinniped populations. 
Both PhHV-1 and -2 replicated efliciently in cell cultures of feline origin. The possibility of 
a natural interspecies transmission of these viruses to members of the Felidae family cannot 
be ruled out at present. 
In Part II of this thesis, the identity and the relationships of morbilliviruses which have 
caused devastating epizootics in pinnipeds (1988, northwestern European waters) and in 
terrestrial carnivores (1994, Serengeti National Park, Tanzania) are investigated: 
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Canine distemper virus (CDV) was found to be associated with recent losses among big 
cats (tigers, leopards and lions) in North American zoos (1991 - 1993) and with a major 
outbreak affecting the lion population of the Tanzanian Serengeti National Park (1994). 
Phylogenetic analysis of the viruses involved did not support the assumption of an emerging 
'felid distemper' virus, but revealed that the outbreaks among big cats were caused by several 
distinct yet true CDV strains. Since these strains were also found to circulate in local feral 
carnivores, interspecies transmission of 'indigenous', geographically restricted CDV strains 
appeared to be the most likely source of the CDV epizootics in big cats. In contrast, the seal 
mass mortality in northwestern European waters has been caused by a distinct member of 
the morbillivirus genus, the phocid distemper virus (PDV). While the available PDV strains 
appeared to be antigenically homogeneous, genetic drift, and, by circumstantial evidence, 
possibly also antigenic drift, have oceured in CDV strains which could have played a role also 
in the recent resurgence of distemper in domestic dog populations. 
fn conclusion, two distinct herpesvirus species of pinnipeds were identified and molecu-
larly characterized. Promising prerequisites for a subunit vaccine aiming at the protection of 
hospitalized seals (e.g. rehabilitation, breeding programmes) against clinical disorders asso-
ciated with the pathogenic PhHV-1 a-herpesvirus are provided. In addition, the molecular 
epidemiology and the phylogenetic relationships of morbilliviruses which caused recent epi-
zootics among terrestrial wildlife carnivores were partly elucidated, revealing a co-circulation 
of distinct contemporary CDV genotypes which appeared to be restricted geographically and, 
thus, not species-specifically. It therefore seemed unlikely that the apparent expansion of the 
natural host spectrum of CDV, now comprising also pinnipeds and exotic felids, could have 
been due to an emerging CDV type exhibiting an altered host tropism. 
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Samenvatting 
Wilde dieren, in het bijzonder zeezoogdieren en grote op het land levende roofdieren, hebben 
altijd een bijzondere aantrekkingskracht op de mens uitgeoefened. Het is dan ook niet ver-
wonderlijk dat de dramatische uitbraken van morbillivirusinfecties onder zeehonden (1988), 
dolfijnen (1990-1991) en leeuwen (1994) grote publieke aandacht hebben getrokken en her-
nieuwde wetenschappelijke belangstelling hebben gewekt voor virusinfecties in deze diersoor-
ten. 
Dit proofschrift beoogde het inzicht op het gebied van morbillivirusinfecties en herpes-
virusinfecties in zeezoogdieren en op het land levende vleeseters te vergroten en aid us een 
bijdrage te leveren aan de bescherming van deze diersoorten, waarvan er verschillende met 
uitsterven worden bedreigd. 
In dee I I van dit proofschrift werden moleculaire en klinische studies beschreven aangaan-
de herpesvirusinfecties in vinpotigen. een suborder van vleeseteride. zeezoogdieren waartoe 
zeehonden en walrussen behoren. In zeehonden kunnen tenminste twee sorten herpesvirus-
sen voorkomen: phocid herpesvirus-1 en -2 (PhHV-1, -2). Deze twee virussen kunnen van 
elkaar worden onderscheiden op grond van hun biologische eigenschappen in celkweek, door 
kruisneutralisatie en door typering met monoklonale antistofren. Op moleculair niveau werd 
PhHV-1 geidentificeerd als een apart lid van het Varicellovirus geslacht, behoren tot de 
subfamilie van a-Herpesvirinae. De oorspronkelijke herpesvirussen van op het land levende 
vleeseters, de honden- en kattenherpesvirussen, blijken antigenetisch en phylogenetisch het 
meest verwant te zijn aan PhHV-l. Onderzoek tot op heden heeft aangetoond dat PhHV-1 
of andere nauw verwante a-herpesvirussen wereldwijd voorkomen in aile vinpotigen. Aange-
toond werd dat de ernst van de klinische symptomen ten gevolge van een primaire infectie met 
PhHV-1 omgekeerd evenredig is met de leeftijd en het immunologisch reactievermogen van 
een geihfecteerd dier en kan varieren van eem milde aandoening van de bovenste luchtwegen, 
tot een bronchopneumonie en gegeneraliseerde aandoening met fatale afloop. De diagnostiek 
van een actieve PhHV-1 infectie werd aanzienlijk verbeterd door de ontwikkeling van een 
nieuwe peR test, waarbij een fragment werd geamplificeerd van het gen dat codeert voor 
het equivalent van het glykoproteihe D van PhHV-l. Het glykoproteihe B (gB) homoloog 
van PhHV-1 bleek het belangrijkste immunogene eiwit in zeehonden die op natuurlijke wijze 
geihfecteerd zijn met PhHV-l. Het gen dat voor gB codeert werd volledig gesequenced en 
het genprodukt tot expressie gebracht in insektencellen als een antigeen en immunogeen ei-
wit. Dit recombinant gB kan een belangrijk bestanddeel vormen van een toekomstig PhHV-1 
subunit vaccin. 
PhHV-2, dat in dit proefschrift voor het eerst werd beschreven als een nieuw virus van 
vinpotigen, is op moleculair niveau geidentificeerd als een lid van de 7- Herpesvirinae subfa-
milie. Phylogenetisch onderzoek van een fragment van het grootste capside eiwit suggereerde 
dat PhHV-2, samen met het equine herpesvirus-2, behoort tot een derde geslacht van deze 
subfamilie. Hoewel door serologisch onderzoek werd aangetoond dat PhHV-2, zij het op be-
perkte schaal, voorkomt bij in het wild levende populaties van vinpotigen, zijn er tot op heden 
geen ziekteverschijnselen geassocieerd met een PhHV-2 infectie. Zowel PhHV-1 als PhHV-2 
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vermeerden zich in kattencellen. Oat deze viru5sen onder natuurlijke omstandigheden ook 
leden van de familie van de Felidae zouden kunnen besmetten kan vooralsnog niet worden 
uitgesloten. 
In deelll van dit proefschrift is onderzoek beschreven naar de aard van en de verwantschap 
tussen morbillivirussen die uitbraken hebben veroorzaakt onder vinpotigen in Noord-West Eu-
ropese wateren (1988) en onder op het land levende vleeseters in het Serengeti National Park 
in Tanzania (1994). De recente uitbraken van morbillivirusinfecties onder grote katachtigen 
in Noord Amerikaanse dierentuinen (1991-1993) en onder leeuwen in het Serengeti National 
Park in Tanzania (1994) zijn geassocieerd met het. voorkomen van verschillende stammen 
van het canine distemper virus (CDV). Op grond van moleculair onderzoek werd geen bewijs 
verkregen voor een echte adaptatie van CDV aan katachtigen. Phylogenetisch onderzoek 
toonde echter aan dat natuurlijke overdracht van CDV afkomstig van andere wilde dieren, 
maar grote katachtigen zeer waarschijnlijk de belangrijkste factor is in de CDV uitbraken 
onder grote katachtigen. De massale sterfte onder zeehonden in Noord-Europese wateren, 
daarentegen, is echter wei veroorzaakt door een apart lid van het morbillivirus geslacht: het 
phocid distemper virus (PDV). Terwijl de PDV stammen in antigen opzicht homogeen blijken 
te zijn, hebben er in de CDV stammen genetische, en dientengevolge mogelijk ook antige-
ne, veranderingen plaatsgevonden, die wellicht tevens een rol hebben gespeeld in de recente 
opleving van hondenziekte in gedomesticeerde honden. 
Concluderend kan worden gesteld dat in dit proefschrift twee verschillende soorten her-
pesviru5sen van .vinpotigen werden geiaentificeerd en op moleculair niveau gekarakteriseerd. 
Belangrijke vorderingen werden gemaakt op de weg naar de ontwikkeling van een vacdn dat 
bescherming zal bieden tegen de ontwikkeling van klinische symptomen, van een PhHV-1 
a-herpesvirus infectie. Verder werden de moleculaire epidemiologie en de phylogenetische 
verwantschappen opgehelderd Van morbillivirussen, die recente uitbraken onder wilde land-
roofdieren hebben veroorzaakt. Deze studies gaven aan dat er verschillende gelijkttijdig dr-
culerende CDV genotypen zijn die een verschillend verspreidingsgebied hebben. Daarom lijkt 
het onwaarschijnlijk dat de kennelijk opgetreden uitbreiding van het natuurlijk gastheerspec-
trum van CDV, waartoe nu ook vinpotigen en exotische katachtigen behoren, het gevolg is 
geweest Van het ontstaan van CDV stammen met een veranderd gastheer tropisme. 
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Zusammenfassung 
Bestimmte Wildtierarten, insbesondere aber Meeressaugetiere und groBere landlebende Fleisch-
fresser, tiben von jeher eine starke Faszination auf Menschen aus. Dies kann zuminclest 
teilweise die enorme offentliche Anteilnahme an den verheerenden Morbillivirusepizootien 
in wildlebenden Populationen von Seehunden (1988), Delphinen (1990 - 1991) und Lowen 
(1994) begriinden. Nicht zuletzt das Gewicht dieses offentlichen Interesses ermoglichte auch 
eine intensivierte Forschungsarbeit auf dem Gebiet der Virusinfektionen dieser Wildtierarten. 
Das Bestreben der vorgelegten Arbeit gilt der Erweiterung des Wissens iiber Morbilli-
und Herpesvirusinfektionen von Meeressaugern, wie auch landlebenden Fleischfressern, mit 
dem Ziel, zu einem verbesserten Schutz dieser z.T. gefahrdeten Spezies in der Zukunft bei-
zutragen. Ein Akzent dieser Studie liegt auf den phylogenetischen und epidemiologischen 
Beziehungen der jeweiligen Virusspezies. 
Teil I umfaBt Beitrage zu den Herpesvirusinfektionen der FJossenfil8er. 
Robben stellen Wirte fiir zumindest zwei Arten von Herpesviren dar, die als phocides 
Herpesvirus-1 bzw. -2 (PhHV-1, -2) bezeichnet werden und problem los an hand ihrer biolo-
gischen Eigenschaften in Zellkulturen, durch Kreuzneutralisation und mittels monoklonaler 
Antikorper zu unterscheiden sind. Auf molekularer Ebene konnte PhHV-1 als eigenstandige 
Spezies im Genus Varicellovirus der a-Herpesvirina ... Unterfamilie klassifiziert werden. Nach 
antigenetischen und phylogenetischen Gesichtspunkten reprasentieren die genuinen Herpes-
virusarten landlebender Fleischfresser (das felide bzw. kanide Herpesvirus) die engsten Ver-
wandten des PhHV-l. Infektionen mit PhHV-1 oder anderen, eng verwandten Varianten sind 
weltweit verbreitet in allen bislang untersuchten FlossenfiiBerpopulationen anzutreffen. Die 
klinische Bedeutung primarer PhHV-1-lnfektionen, die invers mit dem Alter und der Immun-
kompetenz der jeweils betroffenen Robbe korreliert, muB als beachtlich eingestuft werden 
und variiert von milden Affekten des oberen Respirationstraktes iiber Bronchopneumonien 
bis hin zu todlich verlaufenden Generalisationen. Die Moglichkeiten der Diagnose einer akti-
ven PhHV-1lnfektion konnten durch die Entwicklung eines peR Tests, der auf die spezifische 
Amplifikation eines Fragments des Glykoprotein-D-Gens abhebt, entscheidend verbessert wer-
den. Das Glykoprotein-B (gB)-Equivalent des PhHV-1 wurde als ein immundominantes virales 
Protein im Rahmen natiirlicher Infektionen von Robben charakterisiert. Das gB-Gen wurde 
sequenziert und sein Produkt erfolgreich als ein antigenetisch intaktes und immunogenes 
Molekiil in Insektenzellen exprimiert. Somit erscheinen die Voraussetzungen giinstig, rekom-
binantes gB als eine Komponente einer zukOnftigen PhHV-1 Subunit-Vakzine einzusetzen. 
PhHV-2 wird erstmals im Rahmen dieser"Abhandlung als ein neues Virus von Pinnipeda be-
schrieben und auf molekularer Ebene als I-Herpesvirus charakterisiert. Die phylogenetische 
Analyse eines Fragments des Hauptkapsidproteins des PhHV-2 legt dessen Klassifizierung, 
zusammen mit dem equinen Herpesvirus-2, in einem dritten Genus def 'j'-Herpesviren nahe. 
Bislang konnten PhHV-2-lnfektionen nicht mit Krankheitserscheinungen bei Robben korre-
liert werden, obwohl das Virus, basierend auf serologischen Untersuchungen, mit mode rater 
Pravalenz auch in wildlebenden Robbenpopulationen anzutreffen ist. 
Sowohl PhHV-1 wie auch PhHV-2 replizieren ellizient in Zellkulturen felinen Ursprungs. 
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Chapter 4 - Discussion 
Eine etwaige Vbertragung phocider Herpesviren unter natiirlichen Bedingungen auf Mitglieder 
der Familie der Feliden kann derzeit nicht ausgeschlossen werden. 
Teil " dieser Arbeit befaBt sich mit der Identilizierung und molekular-epidemiologischen 
Charakterisierung von Morbilliviren, die 1988 bei Robben in nordwesteuropaischen Gewassern 
und 1994 bei Lowen und anderen Fleischfressern in der Serengeti (Tansania) zu verheerenden 
Epizootien gefiihrt hatten: 
Eine Beteiligung des Hundestaupevirus (CDV) an jiingsten seuchenhaften Todesfallen unter 
GroBkatzen in nordamerikanischen Zoos (1991 - 1993) sowie an einer Epizootie in der Lowen-
population im tansanischen Serengeti-Nationalpark (1994) konnte nachgewiesen werden. Die 
phylogenetische Analyse der involvierten Viren ergab keine Anhaltspunkte fUr die zunachst 
geauBerte Vermutung, daB es sich hier um eine sich neu entwickelnde CDV-Linie, also um ein 
'Katzenstaupevirus' handeln konnte. 1m Gegenteil: Die einzelnen Ausbriiche wurden durch 
verschiedene, jedoch jeweils eindeutig dem Hundestaupevirus zuzuordnende Virusstamme 
ausgelost. Da dieselben Stamme auch bei verschiedenen ortsansassigen nicht-feliden Fleisch-
fresserarten angetroffen wurden, erscheint die zwischenartliche Obertragung 'einheimischer', 
also geographisch begrenzt vorkommender CDV-Stamme als die wahrscheinlichste Quelle 
der CDV-Epizootien bei GroBkatzen. 1m Gegensatz hierzu wurde das Robbensterben 1988 
durch eine eigenstandige Virusspezies des Genus Morbillivirus ausgelost (phocides Staupevi-
rus, PDV). Wahrend die bislang untersuchten PDV-Isolate antigenetisch einheitlich zu sein 
scheinen, sind CDV-Stamme einer genetischen Drift unterworfen, die sich - aufgrund indi-
rekter Hinweise - auch antigenetisch auswirken und damit eine Rolle in dem seit kurzem 
beobachteten Wiederaufllackern der Staupe bei Haushunden spielen konnte. 
Zusammenfassend bleibt festzuhalten: In dieser Arbeit wurden zwei verschiedenartige, 
bei Pinnipeda vorkommende Herpesvirusspezies identiliziert und auf molekularer Ebene cha-
rakterisiert. Es wurde eine vielversprechende Basis fiir die Entwicklung einer 'Subunit'-Vakzine 
erarbeitet, die vor allem hospitalisierte Robben (z.B. Rehabilitation, Arterhaltungsprogram-
me) vor den klinischen Folgen einer Infektion mit dem pathogenen PhHV-1 a-Herpesvirus 
schiitzen 5011. Weiterhin konnten molekular-epidemiologische und phylogenetische Zusam-
menhange von Morbillivirusinfektionen, die unlangst vehemente Epizootien bei landlebenden 
Fleischfressern verursacht hatten, zumindest partiell aufgeklart werden. Hierbei. wurde deut-
lich, daB unterschiedliche CDV-Genotypen kozirkulieren, deren Vorkommen geographisch, 
also nicht tierartspezilisch beschrankt ist. Es erscheint somit unwahrsche.inlich, daB die offen-
bare Ausweitung des CDV-Wirtsspektrums auf Pinnipeda und GroBkatzen auf das Auftreten 
neuer, bislang unbekannter CDV-Varianten mit einem veranderten Wirtstropismus zuriick-
gefUhrt werden kann. 
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